Optimising Culture Conditions for Tissue Engineering Large Articular Cartilage Constructs by Senior, Richard
 Optimising Culture Conditions for 







Richard Anthony Senior MEng. (Hons) 
 
 
A thesis submitted to The University of Sheffield in partial fulfilment of 
the conditions for the award of the degree of Doctor of Philosophy.  
 
 
The School of Clinical Dentistry 
The University of Sheffield 
December 2014 
Richard A. Senior                                                                                                                                               2014 
 
 Page 1 
 
Table of Contents 
 
Table of Contents…………………………………………………………………………………………………………….. 1 
Abstract.............................................................................................................................. 2 
Acknowledgements........................................................................................................... 3 
List of Abbreviations………………………………………………………………………………………………………… 4 
List of Figures………………………………………………………………………………………………………………….. 5 
List of Tables……………………………………………………………………………………………………………………. 15 
1. Introduction…………………………………………………………………………………………….………..……… 16 
2. Literature Review……………………………………………………………………………………………………… 18 
2.1 Native articular cartilage…………………………………………………………………….................. 18 
2.2 Articular cartilage tissue engineering……............................................................... 31 
2.3 Tissue engineering of large constructs………………………………………………………………… 42 
3. Aims and Objectives………………………………………………………………………………………………….. 49 
4. Materials and Methods................................................................................................ 51 
4.1 Materials................................................................................................................ 51 
4.2 Methods................................................................................................................. 60 
 4.2.1 Bovine articular chondrocyte isolation........................................................  60 
 4.2.2 Scaffold seeding and construct culture........................................................ 62 
 4.2.3 Experimental termination............................................................................ 73 
 4.2.4 Histological and biochemical evaluation...................................................... 75 
 4.2.5 Molecular Biology....................................................................................... 79 
 
5. Results.......................................................................................................................... 81 
5.1 Biological characterisation of native bovine articular cartilage............................. 81 
5.2 Characterisation of tissue engineered articular cartilage...................................... 86 
5.2.1 Tissue engineered using standard culture medium..................................... 86 
5.2.2 Tissue engineering using increased viscosity culture medium....................   120 
    
6. Discussion....................................................................................................................  194 
6.1 Constructs cultured in standard DMEM – the effect of increasing size on biological 
quality……………………………………………………………………………………………………………………..  194 
6.2 The development of a modified viscosity cell culture medium............................   204 
6.3 Constructs cultured in a modified cell culture medium – the effect of increased 
viscosity on the biological quality of both small and large constructs…………......………  211 
6.4 Discussion summary..............................................................................................   219 
 
 
7. Conclusions.................................................................................................................   222 
8. Future Work ................................................................................................................  224 
9. References...................................................................................................................  227 
 
Richard A. Senior                                                                                                                                               2014 
 
 Page 2 
 
Abstract 
Current surgical approaches to treating damage to articular cartilage, a highly 
specialised connective tissue, are limited in their ability to regenerate functional 
hyaline tissue. This has provided a driving force for the development of patient-
specific, tissue engineered treatments. To date the majority of in vitro studies have 
focussed on engineering relatively small-dimension constructs; however 
justification remains for the production of large pieces of cartilage tissue. The aim of 
this research was therefore to investigate the potential for tissue engineering large, 
high quality cartilage constructs using several different culture methodologies 
Both small ‘pin’ (6 mm diameter) and large ‘plate’ (15 x 10 mm) constructs were 
successfully produced using primary bovine articular chondrocytes, a poly(glycolic 
acid) scaffold material and various culture conditions; static, semi-static and a 
rotating wall vessel (RWV) cell culture system. Small pin constructs cultured under 
standard static and semi-static conditions demonstrated a biochemical composition 
similar to that previously reported in published studies. Plate constructs cultured 
under static and semi-static conditions demonstrated an increased sulphated GAG 
and collagen type II content over their small pin counterparts, with an architecture 
possessing numerous lacunae and some zonal organisation. The Synthecon™ 
rotating wall vessel (RWV) bioreactor did not provide a suitable environment to 
engineer large plate constructs in standard cell culture medium. Due to their weight 
the constructs ‘tumbled’, resulting in damaged tissue with a poor quality extra 
cellular matrix rich in fibrous collagen type I. The design of a lightweight PTFE 
scaffold retention frame and the development of a dextran-modified, increased 
viscosity culture medium permitted the support of large constructs even at low 
vessel rotational RPM. The use of high viscosity culture medium in all culture 
environments however was found to have a detrimental impact on tissue quality, 
reduced mass transfer resulting in far lower matrix accumulation.  
It was concluded that large cartilage constructs may be produced under standard 
semi-static conditions that demonstrate hyaline-like features but biological quality 
was sacrificed. It was also concluded that an increased viscosity culture medium can 
demonstrate rheological properties comparable to those of synovial fluid, however 
in conjunction with the low-shear RWV bioreactor does not provide an ideal 
environment for engineering large cartilage constructs. The hydrodynamic 
properties of the increased viscosity culture medium could prove beneficial for the 
tissue engineering of articular cartilage constructs under a different bioreactor 
configuration. 
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1. Introduction 
Hyaline cartilage is a highly specialised connective tissue. Its primary function is to 
provide an ultra-low friction bearing surface that allows easy, pain free articulation 
of a diarthroidal joint. Due to its avascularity, and lack of neuronal and lymphatic 
systems articular cartilage has a very poor innate ability to regenerate, articular 
cartilage damage as a result of trauma therefore presents a significant challenge to 
medicine. Treatment aside, around 50% of people affected by articular cartilage 
focal defects will go on to develop osteoarthritis, a painful, debilitating condition for 
which there is currently no cure.  
The common surgical intervention of microfracture is limited in its ability to 
regenerate functional hyaline cartilage; a fibrous repair tissue is quite often formed. 
Over the past 15 years, autologous cell treatments have become more common, up 
to 80% of patients gain some benefit from ACI (autologous chondrocyte 
implantation) for example, however around half of these patients still form more a 
more fibrous than hyaline repair tissue. Tissue engineering (TE) techniques have the 
potential to provide a patient-specific treatment for the repair and regeneration of 
articular cartilage. These techniques combine the use of the patient’s own cells, a 
scaffold or substrate material and a period of in-vitro cell culture with the aim of 
producing a piece of physiologically identical tissue. While great progress has been 
made in the field of cartilage tissue engineering a key limitation remains, samples 
produced are typically of a very small size. 
Whilst tissue engineering small cartilage constructs is a valid and logical approach, it 
restricts progress in the field in two main areas. The first is in minimising the 
cartilage on cartilage interfacial area requiring a healing response following 
construct implantation. The smaller the construct the higher the number required 
to ‘fill’ a defect of any given size. More joins between constructs are therefore 
required to heal sufficiently thus reducing the likelihood a smooth, consistent repair 
surface will result. Secondly smaller construct dimensions limit the extent to which 
comprehensive ex-vivo characterisation of the tissue can be carried out.  
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Currently, biological analysis techniques are very well developed and quite reliable 
in allowing detailed biological characterisation of tissue to take place. However the 
same cannot be said for the accuracy and relevance of apparatus designed to test 
frictional properties. The limitations on tribometer set-up stem primarily from the 
small size of test samples used.  Physiologically representative lubrication 
conditions cannot be achieved in most configurations involving small samples 
resulting in unreliable coefficient of friction measurements.  
There are however many complications surrounding the engineering of large pieces 
of tissue. Many of these are inherent to standard culture methodologies and 
include, but are not limited to; maintenance of sterility, culture vessel size and 
subsequently the large volumes of media required, achieving sufficient mass 
transfer through the culture media and construct to prevent necrosis and also 
minimising the influence of shear stress on cells. 
It has been shown that the rotating wall vessel (RWV) bioreactor system has great 
potential for tissue engineering articular cartilage. The system is designed to 
suspend cell cultures in conditions of microgravity, minimising the impact of 
damaging shear forces. Medium circulation is greatly increased by the rotation of 
the culture vessel and so it is theorised this set-up could provide the ideal culture 
environment for engineering large pieces of cartilage tissue. 
The aim of this research was therefore to investigate the potential for tissue 
engineering large, physiologically representative hyaline cartilage constructs using 
various culture methodologies, including standard static and semi-static protocols 
and the more advanced rotating wall vessel bioreactor system.  The resulting tissue 
was analysed for its collagen type I and II, glycosaminoglycan and lubricin content 
and distribution through biochemical and immunohistochemical staining, 
quantitative colourimetric assays and quantitative PCR. The results obtained were 
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2. Literature Review 
 
This chapter describes the nature and structure of native articular cartilage, its 
biological and mechanical properties and how tissue engineering research to date 
has approached recreating this in-vitro, thus providing background to this research 
and allowing the data presented in it to be viewed in context. 
 
2.1 Native Articular Cartilage 
 
Hyaline articular cartilage is a highly specialised connective tissue. Depending on 
location it is found in a layer 1.0 – 2.5 mm thick [1] covering the articulating surfaces 
of all diarthroidal joints, its primary role is to provide as near to frictionless relative 
motion between two opposing joint surfaces as possible, whilst at the same time 
acting to transmit load between them thus allowing easy, pain free articulation. It 
achieves this by combining high compressive strength with a very low coefficient of 




The major solid constituents of hyaline cartilage as a percentage of wet weight are 
type II collagen (15 – 22%) and glycoproteins (5 – 10%) [2] [3]. Glycoproteins (or 
more specifically proteoglycans - a highly glycosylated member of the glycoprotein 
family of molecules) act to retain the water which makes up the vast majority (70-
80%) of articular cartilage by volume [4] [5]. Proteoglycans such as aggrecan (the 
most abundant in human articular cartilage at 4 -7% wet weight) are molecules 
comprising a polypeptide ‘backbone’, with a varying number of non-covalently 
attached carbohydrate or glycosaminoglycan (GAG) side chains [2]. The three main 
GAG molecules present in articular cartilage are hyaluronan (HA), chondroitin 
sulphate (CS) and keratan sulphate (KS), the negatively charged sulphate and 
carboxyl groups  of which are responsible for the molecules hydrophillicity and 
subsequent swelling behaviour [6].  
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Type II collagen is a fibrillar polypeptide, one of the 28 types of collagen currently 
known that together comprise 25-35% of the human body total protein content [7]. 
Along with primarily types IX and XI [8] it provides articular cartilage with semi-rigid 
framework that contributes around two thirds of the tissue’s compressive modulus 
[2]. Collagen II fibrils anchor the cartilage matrix to the sub-chondral bone [9], 
protect the chondrocytes  and provide a framework for the attachment and 
subsequent support of proteoglycan molecules. The collagen network traps 
proteoglycan chains in the presence of water creating an extra-cellular matrix (ECM) 
pore diameter of 2 – 10 nm [10]. This allows for the infiltration of water but not 
proteins from the synovial fluid. Negatively charged sulphate and carboxyl groups 
presented by GAG side chains are held in a relatively close proximity to each other 
by the collagen matrix. An electro-neutral environment is maintained despite the 
like-charge repulsion between these groups by the presence of mobile cations such 
as Na+. This further contributes to a net osmotic swelling pressure of 0.02 – 0.2MPa 
[11] in the tissue that allows it to withstand compressive loading up to several times 
body weight [2]. The presence of divalent cations is also thought to mediate binding 
of cartilage specific proteins such as COMP (cartilage oligomeric matrix protein) 
within the collagen network [12]. Cartilage cells or chondrocytes are responsible for 
secretion and maintenance of the extra-cellular matrix, but are interspersed quite 
sparsely within it and typically make up only between 1 and 10% of the tissue total 
volume [13]. Chondrocytes that have undergone division within the mature matrix 
organise themselves into clusters of several cells called isogenous groups, the space 
that each cell occupies in the matrix is called a lacuna [14]. The large inter-cellular 
separation combined with the tissue’s lack of vascular, neural and lymphatic 
physiology means the overall metabolic activity is very low [4]. Gas and nutrient 
mass transfer to and through the chondral tissues occurs through diffusion from the 
synovial fluid, driven by cyclic compression of the joint and cartilage. This in turn 
generates hypoxic conditions around the chondrocytes with oxygen concentrations 
of around 10% at the cartilage surface and <1% in the deepest layers [15]. With 
respect to the cartilage surface, the distribution of cells and ECM components (in 
particular collagen and aggrecans) through the thickness of articular cartilage is very 
heterogeneous [16] [17]; this results in the formation of several distinctive zones 
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[18] (please see figure 2.1). It is this distinct zonal organisation that imparts articular 
cartilage with its highly specialised mechanical properties with the organisation of 
each layer playing an important role [17]. 
 
 
Figure 2.1 The zonal organisation of articular cartilage 
 
 Synovial fluid 
Synovial fluid is a pale yellow, highly viscous blood plasma dialysate. In the average 
adult around 2-4 ml fill the joint cavity providing shock absorbing and lubricating 
properties whilst acting as a nutrient transfer medium to the avascular cartilage 
tissue [19].  Non-pathological synovial fluid comprises on the majority water, 
modified in composition by components such as hyaluronan (3-4 mg/ml) and 
surface zone protein / lubricin that are secreted by the synovial membrane [19]. It is 
largely accepted that the hyaluronic acid is responsible for the ‘normal’ viscosity of 
synovial fluid, but not completely for its lubricating properties [20]. The cartilage 
matrix is permeable to and allows passage of water, ions, nutrients and metabolites 
to and from the synovial fluid. Unloaded cartilage tissue is in a naturally hydrated 
state with the penetrating fluid known as interstitial fluid [21] and accounting for 
70-80% of articular cartilage wet weight. 
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 Superficial zone and lamina splendens 
The superficial or tangential zone is the uppermost layer, immediately adjacent to 
the joint cavity. It is the thinnest and only accounts for around 10% of the total 
tissue thickness [10]. The highest concentrations of collagen II are found here, the 
fibrils densely packed and lying in parallel to one another adjacent to the tissue 
surface – a layout optimised for the resistance of shear stresses generated through 
relative motion of the joint surfaces [22]. Glycosaminoglycan concentration is 
initially low in the superficial zone and increases with depth through the tissue. Cell 
density is greater in the superficial zone than anywhere else in the tissue [13]. The 
cells possess a flattened morphology  [23] and it is the only zone in mature cartilage 
where progenitor cells have been found. Comprising the initial 0.5-5 µm of the 
superficial zone, the lamina splendens or surface amorphous layer (SAL) is 
morphologically distinct from the rest of the tissue composition [24] [9]. It is most 
often described not as a separate zone of the cartilage thickness in its own right but 
more a distinctive part of the superficial zone, brought about by mechanical loading 
of the surface of the superficial zone tissue. Graindorge et al (2006) [25] described 
how the SAL can be stripped away and it subsequently regenerates through loading 
of the underlying tissue, the SAL plays an important role in joint lubrication through 
surface zone protein and surface active phospholipid binding [25]. 
 
 Middle zone 
The middle zone comprises around 40-60% of the total tissue thickness [4]. The 
collagen fibrils are more randomly aligned around abundant glycosaminoglycans, 
and chondrocytes assume a much more rounded morphology. 
 
 Deep zone 
The deep zone is also known as the radial zone due to the layout of collagen fibres 
in an arrangement perpendicular to the tissue surface, this is thought to manage 
compressive normal forces acting on the tissue. Chondrocytes maintain their 
rounded morphology, sitting in more obvious lacunae and are arranged in stack 
formation known as isogenous groups [26] . 
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 Calcified zone 
The calcified zone lies inferior to the tide mark, a collagen type X rich area that 
separates the true articular cartilage from the underlying bone. The tissue here 




 Resistance to compression 
Articular cartilage in the human knee is able to withstand compressive loading 
forces of several times body weight [27], in the human hip this can reach 18 MPa 
during normal day to day activities [28]. The highly hydrated nature of articular 
cartilage plays a key role in all of its mechanical properties. Approximately one third 
of the tissue’s compressive modulus can be attributed to the rate of change of 
osmotic pressure with applied compressive strain. The rest is provided by the 
structural modulus of the solid matrix [2]. The biphasic model originally described 
by Mow et al (1980) [29] describes this behaviour well, accounting for the fact that 
the interstitial fluid can exude from the tissue at a rate dependent on the 
compressive load applied to it. The fluid is modelled as an incompressible liquid 
phase and the extra cellular matrix is modelled as an incompressible solid phase. 
The biphasic model can very accurately describe the tissue under a wide range of 
loading conditions, however a key limitation remains that articular cartilage is vastly 
stiffer in tension (1 - 20 MPa [4]) than in compression (0.53 – 1.82 MPa [30]), due to 
the arrangement of the collagen fibres in the extra cellular matrix [31]. The 
aggregate modulus of the entire tissue thickness is routinely used due to the 
difficulty in assessing each tissue zone individually, the modulus of each being 
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 Low Coefficient of Friction 
o Mechanics 
Relative sliding motion between two opposing cartilage surfaces is resisted by the 
friction force. Coulomb friction, the simplest description is an approximation and is 
governed by the equation; 
 
Ff = µ x Fn 
Equation 2.1 The relationship between coefficient of friction, normal force and frictional 
force between two bodies in contact under relative motion  
 
The coefficient of friction (µ) is a dimensionless, scalar quantity which defines the 
ratio between the normal force (Fn) pushing two bodies, or surfaces together and 
the force of friction between them (Ff). Both the static (µs) and kinetic (µk) 
coefficient of friction can be considered, the latter usually being lower due to 
relative motion lessening the contribution to friction of interlocking surface 
asperities. Hydrated articular cartilage has an extremely low coefficient of friction, 
between 0.003 (µk) - 0.02 (µs) under normal, non-pathological conditions [5]. When 
compared to that of ice on ice (0.03 – 0.1) or PTFE on PTFE (0.04 – 0.04) [32] it can 
be easily seen how smooth, pain free joint articulation can occur through a loaded 
joint. When considering the friction between two opposing cartilage surfaces in-
vivo, it is more appropriate to consider lubricated friction whereby a thin layer of 
fluid separates and penetrates the two cartilage surfaces. Due to the fluid’s viscous 
resistance to motion loading of the joint is carried through pressure generated 
within it. The contribution of both the solid and fluid components of cartilage to the 
overall frictional force can be shown by [24]; 
 
Ff
total = (µsolid x Fn
solid) + (µfluid x Fn
fluid) 
Equation 2.2 The relationship between coefficient of friction, normal force and frictional 
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o Lubrication 
It is widely accepted that there is as yet no definitive explanation accounting for all 
synovial joint lubrication characteristics [4, 33]. It is generally accepted that more 
than one lubrication mechanism is at work at any one time to provide the observed 
ultra-low friction behaviour. These lubrication mechanisms known most commonly 
as fluid film,  boundary and together the mixed lubrication regime attempt to 
account for all these phenomena that impart the tissue with its exceptionally low 
friction properties [4]. The effective lubrication of synovial joint is therefore 
multifactorial and relies on the interaction between synovial fluid in the joint 
capsule and surface active phospholipids, hyaluronic acid, and lubricating proteins 
such as lubricin at the tissue interfaces [34] [35]. Synovial fluid can be easily 
characterised by its high content of hyaluronic acid. It is known that this molecule is 
responsible for the fluids high viscosity and non-Newtonian, shear-thinning 
behaviour [36]. High viscosity allows synovial fluid to transmit the hydrostatic forces 
necessary to support fluid film lubrication in the articulating joint, however 
hyaluronic acid is currently thought not to play a part in boundary lubrication [37] 
[33].  
 
Surface active phospholipids are amphiphilic molecules also found in the synovial 
fluid. It is thought these molecules bind to the tissue surface during rest [38], 
forming lamellar sheeted structures that shear apart under relative motion greatly 
decreasing the coefficient of friction [35]. Their exact mechanism of action however 
is still a matter of some contention [33, 39-41]. Lubricin, otherwise known as 
surface zone protein and encoded for by the gene PRG4 is a  345 kDa mucinous 
glycoprotein secreted into the synovial fluid from tissue surrounding the joint cavity 
[42]. Although relatively little is still known about its actual mechanism of 
lubrication studies have suggested that lubricin exists in two distinct forms [43] [42], 
in a form bound to the tissue surface and also free in solution perhaps providing 
evidence to back up the previously mentioned mixed lubrication regime. Coles et al 
(2010) [44] showed that deletion of the PRG4 gene in mice resulted in significant 
changes in the biochemical structure of their articular cartilage with increasing age 
such as a fragmented surface and progressive loss of ECM proteoglycans.  
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Most changes were consistent with osteoarthritic degeneration, suggesting that 
PRG4 has an important part to play in both joint lubrication and structure and 
function preservation [44] [45]. These observations have been seen in other recent 
studies involving rodent gene knock-out models [46], as well as other animal 
models of arthritis [47, 48]. The failure of any one part of this complex lubrication 
mechanism has been shown to increase susceptibility to osteoarthritis development 
[49] . 
 
2.1.3 Degeneration and injury 
 
Both traumatic injury and degeneration through wear or pathological condition 
have the same fundamental consequence – the loss of the aforementioned ability 
for a joint to withstand loading and provide easy, pain-free articulation. There are 
many conditions in existence whereby the cartilage surface undergoes 
degeneration and subsequent breakdown, apart from simply ageing these include 
but are not limited to; diabetes, obesity,  chondrodysplasia, osteochondritis 
desicans and rheumatoid arthritis [7]. In many cases it is increased collagenase 
activity resulting in cleavage of the type II collagen ECM framework that results in a 
loss of mechanical integrity and increased wear under loading [50]. These enzymes 
are produced by the chondrocytes themselves and in conjunction with matrix 
metalloproteinases such as MMP-13 have been found to cause a breakdown in the 
collagen type II framework originating at the cartilage surface and progressing 
steadily through the thickness of the tissue [51]  As previously stated the biological 
structure of articular cartilage is key in providing it’s specialist mechanical 
properties, a reduction in glycosaminoglycan content for example has been shown 
to result in an increase in the coefficient of friction [52]. Kalson et al (2010) [53] 
recently found that 62% of patients who underwent arthroscopic investigation for 
knee pain presented articular cartilage damage. Of these people, 72% presented 
focal defects, injuries of a well-defined size and shape which were most commonly 
traumatic in origin.  
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Cartilage degeneration resulting from disease or pathological condition can be very 
hard to treat as loss of the articulating surface is usually widespread and damage 
isn’t usually limited to the cartilage tissue alone. Focal defects can more commonly 
be treated, with a wide array of surgical options currently available. Unfortunately 
around 50% of focal lesions, however treated, still ultimately result in the 
development of osteoarthritis in the surrounding tissues, a debilitating condition 
that in 2010 affected 40% of individuals over the age of 65 in the UK, around 8 
million people [54]. 
 
 Innate repair mechanisms 
Apoptotic turnover of mature articular chondrocytes is very limited, they maintain a 
stable phenotype for an extensive period of time secreting the components 
required for hyaline matrix maintenance [55]. Hyaline cartilage located elsewhere in 
the human physiology, for example the auricle, possesses a perichondrium that 
supports chondroblasts. These form a stem cell population that secretes a hyaline 
rather than fibrous extra cellular matrix [53] thus allowing for a repair response in 
the case of injury. This feature is lacking in articular cartilage, its chondrocytes are 
mitotic during growth in younger years, but this is limited in adult tissue [56]. 
Whether or not any innate repair response is activated by damage to the tissue 
depends on the depth of the injury [57], but is intrinsically restricted by the 
avascular nature of the tissue wherever its location. Lacerations that do not 
penetrate the tidemark can elicit a local response leading to some chondrocyte 
proliferation and matrix synthesis. Growth factors and cells can migrate from 
synovial fluid, however this is known to be hindered by the anti-adhesive properties 
of the ECM proteoglycan content [57]. Damage that penetrates the calcified zone 
into the subchondral bone can result in fibrocartilage healing (the basis of the 
microfracture treatment) [58]. Via penetration into the wound of undifferentiated 
bone marrow mesenchymal stem cells (bMSC’s), a fibrous repair tissue rich in 
collagen type I forms within the lesion. The repair tissue, however, demonstrates 
mechanical properties that are inferior to native hyaline cartilage [58]. 
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 Treatment interventions 
o Current surgical approaches 
A broad spectrum of treatments are currently available for the treatment of 
clinically relevant articular cartilage lesions, generally accepted to be those 1.5 – 6.5 
cm2 [59]. The most appropriate intervention is chosen taking into account various 
factors [60]; lesion size, volume and location, condition of the surrounding tissue 
and age and physical condition (level of pain, mobility, treatment history, 
concurrent conditions) of the patient are all critical considerations. The size of 
defect means not only the width or joint surface area affected but importantly the 
depth. This dictates whether the lesion is limited to the cartilage thickness 
(chondral) or whether the underlying bone is also affected (osteochondral). 
Cartilage lesions are graded I – IV by International Cartilage Repair Society (ICRS). 
Grade I lesions describe superficial damage to the tissue or shallow fissuring. Grade 
II lesions penetrate up to 50% of the cartilage depth. Grade III describes severe 
abnormality, extending more than 50% of the AC depth but not into the 
subchondral bone whereas lesions penetrating through to the subchondral bone 
are classed as grade IV [53].   
 
Debridement 
Debridement of the wound bed and lesion edges will be employed before any more 
complicated procedure such as autologous chondrocyte implantation, however for 
very small, shallower lesions may sometimes be employed as a treatment in itself. 
The process involves the arthroscopic cutting and grinding away of the rough lesion 
edges to leave a smoother articulating surface. This may allow smoother joint 
articulation with less pain in the short term however is not a long term solution. 
 
Marrow stimulating techniques 
Deep cartilage lesions covering a small area (<2.5cm2) can be treated with the 
marrow stimulating techniques – namely sub-chondral drilling or more recently 
microfracture. These techniques introduce very small fractures into the subchondral 
bone surface, aiming to induce bleeding into the lesion, followed by invasion of 
mesenchymal progenitor cells [61] in the hope subsequent chondrogenic 
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differentiation will occur. The technique is minimally invasive and carried out 
arthroscopically in a short period of time – usually 30-90 minutes. However the 
technique is only really suited to younger patients with a more active healing 
response and also results in the formation of fibrocartilaginous repair tissue in a 
high number of cases [53]. Fibrocartilage has a lower collagen II content that hyaline 
cartilage and is predominantly composed of collagen type I, this possesses a 
reduced capacity to withstand physiological loading and so the tissue inevitably 
undergoes progressive degeneration [62],  in a recent study Kreuz et al (2006) [63] 
reported significant improvement (ICRS score and MRI analysis) in 85 patients 18 
months following microfracture. This was followed by significant deterioration in 




Mosaicplasty involves the harvesting of <1 cm2 cylindrical cartilage plugs from a 
non-weight bearing donor site such as the lateral femoral condyle. The procedure is 
appropriate for deep lesions covering a large area as several plugs will be harvested 
and tessellated together within the lesion.  Some good results have been reported 
in younger patients, however the graft has to be completely flush to the plane of 
the AC surface to maintain the articulating surface and issue with the individual 
plugs never fully adhering to one another means that the lifetime of the graft is 
ultimately limited [64]. 
  
Joint replacement (arthroplasty) 
Arthroplasty or a full joint replacement is really a last resort for younger patients 
due to the replacement requiring revision surgery later in life. It is used where 
damage to the articulating surface may be too widespread to repair. In older 
patients however it is much more commonly used to restore joint mobility in 
patients with severe osteoarthritis who have pain and reduced mobility in the 
affected joints [65]. Patients typically have extensive grade IV cartilage lesions and 
are not suitable for mosaicplasty or ACI. 
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o Regenerative medicine approaches 
Autologous Chondrocyte Implantation (ACI) 
Pioneered in the early 1990’s by Brittberg et al [59] [21], the ACI procedure involves 
arthroscopically harvesting a cartilage tissue biopsy, enzymatically isolating the 
chondrocytes and then expanding the cell number in vitro. The cells are then re-
implanted into the cartilage lesion and secured in place with traditionally a sutured 
flap of autologous periosteum.  ACI is fully autologous which removes any risk of 
immune-rejection, and is now a well-established commercially available treatment, 
for example Carticel® by Genzyme™. It is currently the most successful treatment 
for full thickness focal lesions approximately 2-6 cm2 in size [66], the upper size 
restriction being due to the low cell number available from a harvested tissue 
biopsy [67]. Results however are still mixed; up to 75% of patients gain some 
benefit from ACI, but around 50% form a more fibrous than hyaline repair tissue 
[68] - progressive in-vitro passaging of chondrocytes results in chondrogenic 
phenotype loss, consequently a more fibrous collagen type I than hyaline collagen 
type II [69] ECM is formed. A recent study by Peterson et al (2010) [66] found that 
92% of 341 patients at 10 years after implantation were “satisfied and would have 
ACI again”. The technique is however technically demanding and expensive, with 
the harvesting of a periosteal covering often introducing complications such as 
donor site morbidity [70] and surrounding tissue hypertrophy in 18% of cases [53]. 
This has been surpassed somewhat by the advent of second generation ACI 
treatments employing a type I or III collagen membrane instead of periosteal tissue 
flap [71], the requirement for suturing the membrane to otherwise healthy cartilage 
tissue however is still a drawback [72].   
 
Matrix-induced Autologous Chondrocyte Implantation (MACI) 
Matrix-induced autologous chondrocyte implantation (MACI®, Genzyme™) is really 
the first clinically available treatment for articular cartilage lesions that broaches 
the field of tissue engineering. Isolated and in vitro expanded autologous 
chondrocytes are applied to a collagen membrane, which is then rolled and 
implanted into the lesion site [73].  
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The MACI technique offers distinct advantages such as; the removal of the 
requirement for periosteum use, the surgical procedure is less time consuming and 
it can also be performed arthroscopically [71]. After five years following MACI 
treatment Ventura et al 2012 [71] report 30% of 54 patients demonstrating 
complete tissue integration with no complications and 70% demonstrating a 
completely repaired defect with only minor subchondral bone abnormality. These 
findings that have been echoed in other studies [74, 75] [76, 77] demonstrating that 
a ‘cells plus scaffold’ approach could have good future potential for the complete 
and successful treatment of articular cartilage lesions. This work shows that 
cartilage regeneration is possible; however this procedure is only appropriate for 
patients under 50 years of age who do not have arthritis. Although it is currently 
NICE (National Institute for Health and Care Excellence) approved, is not available 
on the NHS unless part of a clinical trial due to the high associated costs. 
 
o Summary of current treatment interventions 
Surgical intervention aside, around 50% of patients will go on to develop 
osteoarthritis at some stage later in life [78] [79]. Currently more than half of the 
global population are in some way affected by osteoarthritis, and within the next 7 
years it is forecast that it will be the 4th biggest cause of functional disability 
worldwide [80, 81]. 
 
Considering the altogether unpredictable success of current treatments for articular 
cartilage lesions coupled with the tissue’s limited innate capacity for self-repair, 
there is a strong driving force for the development of an autologous and patient-
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2.2 Articular Cartilage Tissue Engineering 
 
The field of tissue engineering was very well described by Robert Langer and Joe 
Vacanti in 1993 [82]; 
 
"an interdisciplinary field that applies the principles of engineering and life sciences 
toward the development of biological substitutes that restore, maintain, or improve 
tissue function or a whole organ“   
 
Tissue engineered approaches have the potential to provide high quality, 
economical and reproducible cartilage constructs for the treatment of focal AC 
lesions. These treatments can be patient specific, using autologous cells to remove 
the possibility of immune rejection, designed to fully integrate with the scaffold 
material dissolving away at a rate that matches neo-matrix formation,  and 
potentially be designed with custom shape and size from data obtained from MRI or 
CT scans [83]. At first glance articular cartilage appears an ideal candidate tissue for 
straight forward engineering in vitro. Hyaline cartilage is avascular, aneural and 
contains a low density of only one cell type [84]. This is misleading however, it is 
exactly this low cell density that is hard to replicate, whilst achieving a 
physiologically representative zonally arranged, hierarchical extra cellular matrix. 
 
The field of articular cartilage tissue engineering can be broken down into cells and 
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2.2.1 Cell sources 
 
 Fully differentiated chondrocytes 
Mature primary chondrocytes are used widely as a cell source in cartilage tissue 
engineering, they are already programmed to synthesise the correct matrix 
components and cartilage tissue contains only this one cell type. The number of 
cells that can be harvested from a single human patient without introducing further 
complications to the donor site however is approximately 180,000 – 455,000 per 
300 – 500 mg tissue biopsy [59, 85], a very low number in terms of the number of 
the cell number required to seed a tissue engineered construct [86]. Chondrocytes 
however are well known to undergo phenotypic de-differentiation in vitro [87]. This 
is thought to be caused by a number of factors including the use of laboratory cell 
number expansion techniques used to compensate for the small number of cells 
available from each tissue biopsy, intrinsic chondrogenic capacity has been shown 
to be lost after 3.57 - 4.19 population doublings in vitro [88-90]. De-differentiated 
chondrocytes pose various problems such as reduced collagen type II and 
proteoglycan expression, synthesis and accumulation leading to inferior 
compressive,  tensile and frictional mechanical properties [91]. At the same time 
collagen I synthesis has been shown to increase resulting in a more fibrous, less 
hyaline matrix [90]. Gel contraction assays are widely used to assess the influence 
of cell culture conditions on the contractile behaviour of both fibroblasts and 
chondrocytes [226] [328]. Whilst contraction of a chondrocyte seeded matrix is not 
desirable, it can provide a valuable tool for assessing the contractile behaviour of 
the cells under different culture conditions and correlating this with the subsequent 
extent of cell de-differentiation [226]. Tran-Khanh et al (2005) [91] showed that 
bovine articular chondrocytes (BAC’s) taken from 18 month old calves possessed 
twice the proliferative capacity of those from cows aged 5 – 7 years, the older cells 
also accumulated around 20% less proteoglycans and 55% less collagen per cell than 
their younger counterparts [91]. Various approaches to limiting chondrogenic 
phenotype loss have been reported [92-94], however the most straightforward is to 
simply minimise the length of time isolated cells spent under in vitro expansion 
conditions as far as possible, seeding to a scaffold no later than passage 2 (P2) [91]. 
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This considered, donor age and therefore skeletal maturity is critical in the potential 
for isolated primary chondrocytes capability to produce a tissue engineered 
construct of high biological and mechanical quality [91]. 
 
 Stem cells 
Mesenchymal stem cells (MSC’s) isolated from the synovial fluid [95], bone marrow 
[96, 97]  and adipose tissue [98] have all been used to engineer articular cartilage 
but with mixed success [99].  These cells respond to particular chemical stimuli and 
can be persuaded to differentiate down a chondrogenic pathway, avoiding the 
phenotype loss issues associated with the use of primary chondrocytes [100, 101]. 
A major limitation on the use of MSC’s however is the difficulty associated with 
identifying the cells with highest chondrogenic potential from an extracted mixed 
population. In theory MSC’s have the potential to differentiate into any type of 
mesenchymal tissue; however in reality each cell is slightly predispositioned 
towards one tissue type [102]. The issue is currently being addressed by Hollander 
et al at the University of Bristol [103], who are developing a technique whereby 
MSC’s with the highest chondrogenic potential can be identified within a mixed 
population using FACS (fluorescence activated cell sorting) and labelling of the ROR2 
receptor. The use of embryonic stem cell (ES) and induced pluripotent (iPS) stem 
cell derived progenitor cells has been of increasing interest in recent years due to 
the potential to harvest large cell numbers [104]. Achieving stable and reproducible 
differentiation is still an issue however, both cell types carry the risk of teratoma 
development and the use of embryonic stem cells to date still is highly contentious 
from an ethical viewpoint [104].  
 Cell source summary 
The premise of cartilage tissue engineering is based on the realisation that the 
regeneration of a functional hyaline surface could be more successfully attained 
through implantation of a “pre-engineered” tissue rather than a simple cell 
suspension [61] as in the case of ACI. The presence of an extra cellular matrix pre-
implantation has been shown to not only improve cell retention at the lesion site 
post-implantation [105], but protect the cells from environmental factors such as 
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inflammatory molecules [106]. Until the in-vitro behaviour of MSC’s, ES and iPS cells 
can be more closely controlled and characterised, it is likely the use of fully 
differentiated articular chondrocytes offer more potential with this. 
 
2.2.2 Scaffold materials 
 
A large variety of scaffold materials has been, and is being used for cartilage tissue 
engineering. There are numerous basic requirements of the material; it must be 
biocompatible, produce no cytotoxic breakdown products, allow cell adhesion and 
migration through the material [107] and also demonstrate biodegradation rates 
that complement the development of the extra cellular matrix taking its place. Cost 
of production and reproducibility are of course also important however become 
more of an issue should a tissue engineered product reach the point of 
commercialisation. All scaffold materials tried so far fall mainly into two categories, 
naturally occurring and synthetic materials. 
 
 Natural materials 
Scaffolds manufactured from naturally occurring materials are more likely to offer 
high levels of biocompatibility, hyaluronan [108, 109] and collagen [110] offer a 
growth substrate as close as it is possible to get to the native environment. 
However results are still unpredictable, Schneider et al (2011) [45, 111] showed 
how chondrocytes implanted within a collagen type I hydrogel scaffold produced no 
better quality of matrix than the collagen gel implanted alone. Other naturally 
occurring materials such as silk [112, 113], agarose [114, 115] and chitosan [116] 
have been widely used due to their ease of processing and characterisation, and 
also a proven ability to stabilise chondrogenic phenotype loss in in vitro culture 
[115]. Batch to batch variation however remains a concern, with non-human 
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 Synthetic materials 
Scaffolds manufactured from synthetic materials have found increasing favour over 
the past decade. These materials offer the advantages of reproducibility and low 
cost mass production [118, 119], tuneable degradation rate, porosity and 
compressive and tensile modulus and the potential for functionalization with 
growth factors [120], chemokines [121] and lentiviral vectors [122, 123]. Sharma et 
al (2013) [124] for example report a poly(ethylene glycol) diacrylate (PEGDA) 
hydrogel that, when implanted in 15 patients with focal cartilage defects and in 
conjunction with the microfracture technique showed significantly more tissue infill 
than microfracture alone. Polyesters including polyglycolic acid (PGA) polylactic acid 
(PLA) and their copolymers – poly(lactic-co-glycolic acid) are amongst the most 
commonly used synthetic scaffold materials in cartilage tissue engineering [118]. 
Their ready availability in various physical forms, relatively low cost and highly 
predictable physicochemical properties being behind their selection in many 
promising studies reported to date [125-127]. 
Pure polyglycolic acid for example has been shown in vitro to halve in tensile 
strength after a period of 14 days, with 100% loss after 28 days when in contact 
with water [118]. The polymer’s ester bonds are cleaved by water that easily 
diffuses into the amorphous regions, this exposes and leaves vulnerable to 
hydrolytic attack the crystalline regions of the polymer. The rate of degradation has 
been shown to accelerate in vitro under conditions of culture medium agitation, 
and in vivo due to enzymatic activity [127]. A rapid rate of degradation is desirable 
in a tissue engineering scaffold material, ideally being comparable to the rate of 
development of the tissue’s extra cellular matrix. This way the burden of cellular 
support and provision of specific mechanical properties to the overall construct 
should transfer as seamlessly as possible between the scaffold material and neo-
extra cellular matrix. 
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The field of cartilage tissue engineering has experienced a paradigm shift in recent 
years away from the implantation of cell-seeded scaffolds, towards bioactive, 
acellular scaffolds designed to encourage cellular migration, infiltration and 
chondrogenic differentiation [128, 129]. This is best illustrated through the recent 
clinical introduction of Trufit® and Maioregen® [130-132], off the shelf treatments 
that are appropriate for any patient. The introduction of such products however is 
so recent that little or no post-implant performance data is available [130, 133, 
134]. The approach is also not without drawbacks; once such a product has been 
implanted it is very difficult to assess in vivo the level of cell infiltration, tissue 
regeneration and the quality of repair tissue without excision. The composition of 
the developing tissue’s biology can be monitored to an extent through ultrasound 
or MRI imaging; however assessment of the repair tissue’s mechanical properties 
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2.2.3 Culture conditions  
The design of the culture environment used for tissue engineering articular cartilage 
is focussed on three main areas; controlling cell proliferation, maintaining the 
chondrogenic phenotype and encouraging extra-cellular matrix component 
production and incorporation. Most approaches aim to recapitulate in some way 
the conditions experienced by the chondrocytes in vivo. 
 Static culture 
The most basic reported culture configuration comprises simply a Petri dish, tissue 
culture flask or similar vessel, containing the cell-seeded scaffold material and cell 
culture medium. Due to its well established and straightforward culture 
methodology undertaking static culture alongside a more advanced set-up can 
provide valuable control or comparison data. Engineered tissue however tends to 
be of poor biological and mechanical quality, with high water and low collagen 
content and random GAG accumulation and localisation [135] due to low, non-
physiologically representative diffusion rates and levels of mechanical stimulation 
[136]. Completely static culture is therefore of limited value as a stand-alone 
methodology. Chondrocytes are largely anaerobic cells that quickly deplete 
nutrients from the cell culture media [137, 138]. Whilst static culture conditions 
(diffusive mass transfer only) have been shown to results in the production of 
cartilage-like tissue, it is well established that even low levels of agitation resulting 
in convective mass transfer of both nutrients and metabolites can improve tissue 
formation [139]. 
 
 Semi-static culture 
Semi-static culture refers to a tissue culture plate or flask in a set-up as outlined 
under ‘static culture’, with the addition of agitation brought about by the use of an 
orbital shaker [140]. Increased mass transfer has been shown to result in an 
increase in hyaline-like features [140], however if the medium movement relative to 
the tissue is too vigorous, the resulting shear stress can induce the formation of a 
fibrous capsule rich in collagen type I at the construct periphery [135]. 
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 Spinner flasks 
The spinner flask is considered to be the simplest design of bioreactor for cartilage 
tissue engineering. Simultaneously addressing the mass transfer issues associated 
with static culture, and cell-seeding inefficiencies associated with both static and 
semi-static culture [141], the spinner flask consists of vertically suspended medical-
grade steel filaments on which chondrocyte-seeded scaffolds are fixed. The flask is 
then filled with tissue culture medium, which undergoes variable rotational 
agitation via the addition to the flask of a magnetic stirrer bar [141, 142].  Improved 
cell seeding efficiencies have been routinely reported under spinner flask 
conditions, as high as 100% after only 24 hours [119]. Improved cellular distribution 
within the developing construct has also been seen [143]. Engineered tissue has 
also been shown to demonstrate an increase in percentage glycosaminoglycan and 
collagen type II content [144, 145]. This considered however some studies still 
report the formation of a shear-induced fibrous, collagen type I ‘capsule’ to the 
tissue, suggesting the medium agitation and dynamics of its motion cannot be 
controlled closely enough [143, 146, 147]. 
 
 Bioreactors 
In the field of cartilage tissue engineering a bioreactor can be defined as a 
cultivation system in which the culture conditions are closely controlled, with the 
aim of inducing specific, desirable behaviour in living cells or tissue constructs [148-
150]. Although simple agitation in culture can be beneficial in terms of nutrient 
replenishment, this can also inflict unwanted, unquantifiable and potentially 
damaging mechanical stimuli on the cells [139] due to the complex and as yet not 
fully understood mechanobiology of chondrocytes [151]. Most designs of bioreactor 
for cartilage tissue engineering have been aimed at; improving nutrient mass 
transfer through for example perfusion culture, reducing the impact of undesirable 
forces such as shear, or enhancing the impact of desirable forces such as 
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o Perfusion culture 
Perfusion bioreactors are so named due to the construct being perfused with a 
constant flow of cell culture medium rather than being cultured in a defined volume 
of it with regular replenishments. The primary aim of this is to improve mass 
transfer to, and away from the developing tissue. The flow of medium can also be 
tailored however such that it delivers a known level of mechanical stimulation to 
the seeded chondrocytes [149, 153, 154]. In its most basic set-up a perfusion 
system consists of a chondrocyte seeded scaffold contained within a perfusion 
chamber, to either end of which are attached the medium inlet and outlet channels. 
Cell culture medium is passed through via the attachment of a medium reservoir 
and peristaltic pump connected with, most commonly, silicone rubber tubing. 
Results are generally very positive when compared with standard static culture. 
Several years ago Pazzano et al (2000) [155] showed that by using a 7.6 μl / minute 
flow rate articular chondrocytes could be encouraged to produce  184% more 
sulphated glycosaminoglycans. More recently Grogan et al (2012) [156] 
experimented with a flow rate of 100 µl / minute in conjunction with a shear-
protecting alginate hydrogel scaffold material and showed significantly higher 
COL2α1 expression levels, GAG synthesis and S-35 GAG retention. 
 
The main drawback of perfusion culture is a discontinuity seen in the extra-cellular 
matrix of some constructs due to the tissue culture medium flowing through it [143, 
157]. This results not only in cellular damage but potentially compromised 
mechanical properties. Recently some studies have described efficient, low flow 
rate, low shear perfusion bioreactor set-ups. Gharravi et al (2013) [158] for example 
reported good matrix accumulation levels, with lacunae-contained chondrocytes 
stacked in isogenous groups within it. Dahlin et al (2012) [159] report a 
configuration that achieved a significant increase in extra cellular matrix retention 
compared to more basic bioreactor design. However in both cases the studies were 
of limited scale, and so it cannot be said conclusively overcame the drawbacks 
associated with standard perfusion culture. 
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o Cyclical compressive loading 
Guilack and Mow (2000) [160] stated “the stress-strain and fluid-flow fields at the 
macroscopic "tissue" level and those at the microscopic "cellular" level are not fully 
understood”. The relationship between the two is complex, under conditions of 
even simple compressive loading; chondrocytes are subjected to a mechanical 
environment consisting of fluid pressure, tension, compressive and shear forces. 
However it is well established that this mechanical environment imparts a 
regulatory influence on the development of articular cartilage tissue [161], and 
many studies [115, 162, 163] have shown that exposing a construct to a 
compressive loading regime over as short a time period as 10 minutes in every 24 
hours in culture [164] can result in greatly enhanced tissue quality. Of particular 
note is a study by Lee and Bader (1997) [115] that demonstrated the application of 
physiologically representative cyclical compressive stress (15% strain, 1 Hz) over 48 
hours resulted in a 40% increase in proteoglycan synthesis. In recently years many 
novel bioreactor designs have emerged that employ a compressive loading regime 
to the benefit of the tissue’s biochemical quality. For example; Shahin and Doran 
(2012) [164] describe a mechano-bioreactor that exerts simultaneous mechanical 
shear and compression, whereas Grogan et al (2012) [156] combined a compressive 
regime with perfusion culture.  
o Low shear 
Whilst direct mechanical stimulation as previously stated has been shown to be 
beneficial to the biological quality of the cartilage construct, it has been widely 
established that shear stress acting on cultured chondrocyte constructs is 
detrimental to the formation of hyaline cartilage [149, 150, 165, 166]. The 
mechanism by which shear stress affects chondrocytes is complex and depends on 
the intensity and duration of application. It is thought to generally result in the up 
regulation of NFκB and interleukin 6 (IL6), then subsequently matrix-degrading 
metalloproteinase and collagenase activation coupled with down regulation of 
collagen II and GAG production as more collagen type I is synthesised [167]. For this 
reason may studies involve the minimisation of shear forces in culture as their 
primary focus [168].  
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Studies suggest that above shear levels as low as 0.092 Pa (0.92 dyne/cm2) the 
chondrocytes will respond by producing a shear protecting, fibrous collagen type I 
rich capsule. Whilst flow based bioreactors such as that recently described by 
Gharravi et al (2013) [158] (maximum wall shear stress  0.001237 dyne/cm2) have 
come some way in approaching the issue of shear reduction, rotating, microgravity 
based bioreactors rather than those in which the culture medium flows relative to 
the construct potentially show more promise.  
 
Originally described by Von Sachs et al in 1872 [169], the clinostat was an early 
bioreactor design on which more modern rotating wall vessel (RWV) bioreactors are 
based, it utilised rotation to negate the influence of gravitational pull on the growth 
and development of plant matter. The rotating cell culture system (RCCS) or 
rotating wall vessel (RWV) bioreactor pioneered by NASA (National Aeronautics and 
Space Administration); is a system based on this concept whereby cultured cells or 
tissue engineered constructs within a rotating body of medium experience very low 
shear, high-diffusion conditions [170]. In articular cartilage tissue engineering the 
vessel rotational speed must be increased throughout the culture period to 
compensate for the increased effects of gravitational pull on the developing tissue 
and keep them under conditions of constant free-fall [144]. The system has been 
used very successfully in the culture of bone and cartilage cells, muscle, liver and 
pancreatic cells and cancer spheroids of many sorts to give a few examples [170-
173]. In the case of hyaline cartilage its use has been shown in many cases to result 
in much higher glycosaminoglycan content, lower collagen type I content and higher 
compressive and tensile modulus than tissue cultured under conditions exerting 
higher levels of shear stress [152, 174, 175]. Whilst the tissue engineered in these 
studies has been shown to also demonstrate more hierarchical tissue organisation, 
lower permeability and a higher equilibrium modulus than tissue cultured in other 
bioreactor systems [136, 176], the general consensus is that the engineered tissue is 
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o Hypoxia 
Hypoxic culture of chondrocytes is defined as being around 5% atmospheric O2, 
although the term hypoxia can cover anything that is lower than atmospheric 21% 
(normoxia). The vast majority of cartilage tissue engineering studies involve culture 
under ambient oxygen concentrations, but there is increasing evidence for the use 
of hypoxic culture to obtain better quality tissue. Hypoxia has been shown in several 
studies to be advantageous in cartilage tissue engineering [15] in several respects, 
GAG accumulation increases of up to 65% for example [168] and an increase in 
Young’s modulus [15]. Whereas hypoxia has been shown to be beneficial, below a 
minimum dissolved oxygen threshold of around 1% (O2 in the gas phase) [137] 
conditions become anoxic and this has been shown to be severely detrimental. 
 
 Modification of the tissue culture medium 
Various additions to the cell culture medium during both cell number expansion 
prior to scaffold seeding and also during construct culture have been found to help 
regulate chondrocyte proliferation and also preserve the chondrogenic phenotype. 
These additions help to simulate the environment the chondrocytes would 
experience in-vivo. Growth factors such as basic fibroblastic growth factor (bFGF) 
have been shown to stimulate DNA synthesis and encourage chondrocyte 
proliferation [177, 178], TGFβ1 and TGFβ3 upregulate surface zone protein [34] and 
proteoglycan synthesis [162] respectively and Insulin-like growth factor 1 (IGF1) has 
been shown to stimulate DNA and cartilage matrix synthesis in mature articular 
cartilage. Ascorbic acid, or L-ascorbate is a form of vitamin C. It has long been 
known to play a vital role in collagen synthesis [179] [180]. Ascorbate is a necessary 
cofactor in the hydroxylation of prolines and lysines by prolyl and lysyl hydroxylases 
to produce hydroxyproline and lysine respectively. This step is vital in the formation 
phases of procollagen – a precursor in all types of collagen. A lack of hydroxylation 
of prolines and lysines results in the formation of a much looser collagen triple helix. 
For this reason it is commonly added to the culture media in cartilage tissue 
engineering as a relatively inexpensive and reliable way of maximising the quality of 
the ECM collagen components [163].  
Richard A. Senior                                                                                                                                               2014 
 
 Page 43 
 
2.3 Tissue Engineering Large Cartilage Constructs 
Over the past two decades significant advances have been made in the field of 
cartilage tissue engineering. Areas covered in this literature review such as cell 
sources, scaffold materials and culture technology have been the focus of many 
studies and subsequently the advances in improving both the biological structure 
and bulk mechanical properties of TE cartilage have been great. However, the vast 
majority of reported studies have involved the culture of cartilage constructs of 
relatively small dimensions, typically 5 mm Ø by 1 mm depth and smaller [61, 129, 
181]. Whilst the reasons behind this are based on the logistics of cell and tissue 
culture and also economic considerations, the fact remains that the majority of 
focal cartilage lesions currently treated through ACI and MACI are of significantly 
larger size at 2 - 6 cm2 (please see section 2.1.3).  
 Clinical relevance 
The ultimate goal of most cartilage tissue engineering studies is the development of 
a clinically relevant treatment, which would circumvent the issues associated with 
current treatments such as microfracture, mosaicplasty and ACI improving post-
operative recovery and patient quality of life [182, 183]. As previously stated, most 
current in vitro research would result in the production of very small dimension 
constructs, the implantation of multiple smaller constructs in place of one larger 
piece of tissue could have a negative impact in terms of construct integration into 
the wound bed and surrounding native tissue. Many smaller constructs would also 
require a successful healing response at the interface between each other to avoid 
any one of these becoming a point of weakness in the tissue and a future focal 
lesion itself [183, 184]. The integration of cartilage on cartilage is poor due to the 
negatively charged, anti-adhesive properties of the dense ECM and the low cellular 
presence at the interface [184]. Whilst the immediate goal of cartilage tissue 
engineering remains the successful treatment of focal cartilage lesions, the future 
capacity for replacing much larger areas of tissue loss such as the requirement in 
cases of osteoarthritis for example should also be taken into account.  
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 Ex-vivo characterisation 
Clinical considerations aside, there is to date still much less emphasis placed on 
characterising the surface mechanical properties of tissue engineered cartilage 
constructs in-vitro than there is placed on assessing its biological quality [4, 185]. 
This is surprising bearing in mind that fundamental mechanical properties such as 
compressive strength and low coefficient of friction are so inherent to the very 
surface of articular cartilage and without these being replicated the likelihood is the 
implant would fail [4, 175, 186]. There are a plethora of studies, some covered in 
this literature review that have succeeded in investigating the biological structure, 
mechanical properties and lubrication methods in isolation, however very few 
actually follow on to physically test the mechanical properties of the tissue 
engineered constructs and relate this back to either the biological analysis or 
compare it to similar measurements carried out on native cartilage samples.  
 
There have been several studies carried out that directly measure the coefficient of 
friction and tribological properties of native articular cartilage [24, 49, 187], but very 
few to date have carried out this kind of analysis on tissue engineered articular 
cartilage [95, 186, 188, 189]. The studies that have tended to utilise a tissue 
engineered ‘pin’ in a reciprocating pin-on-plate set-up to analyse the coefficient of 
friction of the engineered tissue. This approach is flawed however from a 
physiologically representative point of view. The very nature of the pin-on-plate set 
up means the reciprocating pin is in constant, loaded contact with the test, usually 
steel counterface leaving no unloaded rest period whereby native tissue would have 
the opportunity to rehydrate. For this reason the pin on plate test configuration 
would need to be inverted, with a steel or native cartilage pin against a tissue 
engineered cartilage plate, thus allowing any unloaded area of the engineered 
cartilage plate the opportunity to rehydrate whilst the test pin is in contact 
elsewhere. This has been considered before [190], by for example Plainfosse et al 
(2009) [185], however the ‘plate’ counterface was still of limited size at 12 x 6 mm. 
In order to avoid the generation of edge effects and subsequent artificial lowering 
of the recorded coefficient of friction the cartilage ‘plate’ counterface would need 
enlarging [191]. 
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 Current research 
There are several well-known issues surrounding the culture of large pieces of 
tissue. The two most prominent are; the difficulty associated with sourcing a large 
enough initial population of cells and maintaining mass transfer through an 
increased construct thickness so as to not compromise cellular activity.  Brenner et 
al (2013) [85] describe the difficulties experienced when attempting to engineer 
large constructs from a small number of available cells. They showed the potential 
for an initial population of 20,000 rabbit articular chondrocytes to produce a 3 cm2 
construct. The constructs were of good biological quality however they were 
relatively thin and no tribological testing was undertaken. Buckley et al (2012) [192] 
describe comparable results using a similar scaffold material. However they did not 
carry out any analysis of the tissue’s coefficient of friction and the cylindrical shape 
of the construct would not lend itself to testing in a pin on plate tribometer. The 
most relevant was undertaken in 1998 by Vunjak-Novakovic et al [119]. The group 
engineered very large 10 mm diameter, 5 mm thick constructs, reporting some 
tissue necrosis towards the centre of the construct. The reported results were more 
focussed however on cell seeding kinetics rather than the final construct biological 
and biochemical composition.  
 
As previously described in section 2.2.3, the rotating cell culture system (RCCS) or 
rotating wall vessel (RWV) bioreactor could provide the ideal set-up for the tissue 
engineering of large dimension articular cartilage constructs due to the high-
diffusion conditions [170]. This could counteract tissue necrosis towards the centre 
of a thicker construct and potentially counteract the negative effects associated 
with a lower initial cell-seeding density. Initial studies reported that due to their 
weight, larger constructs remained towards the ends of the chamber, not 
distributing as widely through it as smaller, simpler cell aggregates would [193]. 
Synthecon® developed higher aspect culture vessels for the purpose of engineering 
larger dimension constructs [193, 194], it is thought however that the culture 
environment is still not completely ideal for larger constructs, these have been 
shown to slowly ‘tumble’ through the culture medium rather than remaining in a 
suspended, stable orbit [193]. This in turn imparts higher levels of shear stress on 
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the seeded cells, exactly what the rotating wall vessel bioreactor was designed to 
avoid. This was highlighted well in a study reported by Freed et al (1995) [195] 
whereby it was found a construct contained within the RWV bioreactor rotating at 
19 RPM experienced a wall shear stress of 0.15 Pa or 1.5 dyne / cm2. This was 
significantly higher than that experienced by microcarrier beads cultured under the 
same conditions at 0.0005 Pa or 0.005 dyne / cm2, however the higher wall shear 
stress experienced by larger constructs is still considered to be vastly lower than 
that inflicted by alternative culture conditions such as spinner flasks [196]. The main 
concern regarding the culture of larger cartilage constructs within a RWV bioreactor 
has remained the ultimately random nature of their motion within the medium, 
especially where multiple constructs are contained within one vessel. Their motion 
is very hard to characterise and so model, meaning the result of construct on 
construct and construct on vessel contact is impossible to accurately predict. For 
larger constructs in the RWV bioreactor stabilising their position within the culture 
medium is very important to minimise the risk of damage and potentially 
generating poor quality, fibrous tissue. 
 
o Vessel design modification 
In approaching the issues associated with construct positioning in the RWV 
bioreactor, the rotating shaft bioreactor (RSB) described by Chen et al (2004) [197] 
immobilises the constructs relative to the central shaft. Whilst oxygenation is 
improved, the constructs are forced to move relative to the body of medium and so 
levels of shear are inevitably increased [198]. An approach described by NASA in 
their development of microgravitational culture was the design of the 
hydrodynamic focussing bioreactor (HFB) [193]. Instead of a cylindrical vessel the 
rotation of a domed vessel is claimed to enhance mass transfer whilst stabilising 
construct positioning [199]. In neither case however could the concurrent issues of 
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o Tissue culture medium modification 
Mechanical fixation of tissue within the rotating vessel may solve the problems 
associated with construct ‘tumbling’, however as already stated, forcing the tissue 
to move with respect to the body of medium can only result in an increase in 
inflicted shear forces. Increasing the cell culture medium viscosity is one possible 
way of offering increased support to heavier constructs without the need for 
physical fixation. The use of increased viscosity culture medium is well established 
in commercial bioengineering, most commonly for the shear protection of bacteria 
and plant cells in the production of pharmaceuticals and recombinant products 
[200-204]. Kuemmerli et al (2009) reported several years ago that increasing the 
viscosity of the bacterium Pseudomonas aeruginosa culture environment is highly 
beneficial to certain exhibited cooperative traits, a conclusion shared by Huang et al 
(2009) [204] in a very comprehensive review article. The use of increased viscosity 
medium for the culture of plant cells for the purpose of recombinant protein 
production was reviewed by Huang et al in 2012 [202]. The conclusion was again 
that increasing viscosity could stabilise cultures leading to less damage and cell 
death and ultimately higher yields. Han et al (2014) [200] report the development 
of a polysaccharide based viscosity modifying ingredient purified exopolysaccharide 
(EPS). Appropriate for the various industrial applications the ingredient is not only 
cost-effective and economical in its use but offers a higher intrinsic viscosity and 
much higher emulsion-stabilising capacity than standard culture medium alone.  
 
The use of an increased viscosity culture medium for the purpose of large  construct 
support, has not yet, to the author’s knowledge been attempted in tissue 
engineering with bioreactors (please see section 2.3). The use of an increased 
viscosity medium for engineering large pieces of articular cartilage specifically 
would not be an illogical approach. The superior surface of articular cartilage is in 
direct contact with synovial fluid in-vivo, a highly viscous blood plasma dialysate 
that provides shock absorbing and lubricating properties and acts as a nutrient 
transfer medium to the avascular cartilage tissue [19]. At a physiologically 
representative strain rate of 2000, bovine synovial fluid for example offers a 
dynamic viscosity of approximately 7.6x that of standard tissue culture medium 
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(DMEM). The addition of synovial fluid to tissue culture medium would provide not 
only a more physiologically representative culture system, but could provide the 
increase in viscosity required to support large constructs during in-vitro culture.  
 
Due to the very limited volume of synovial fluid available from a typical joint capsule 
however, its use would not be economically realistic due to the large volumes 
required for the modification of the culture medium viscosity in a standard 
bioreactor vessel (55 – 110 ml with the Synthecon RCCS for example). The use of 
synovial fluid could also introduce an unquantifiable biological effect due to its high 
content of bioactive molecules, hyaluronic acid, growth factors and cytokines to 
name but a few [33, 36]. Early research by Andrish and Holmes (1979) [205] and 
Nuverzwart et al (1988) [206] suggested the presence of synovial fluid could 
suppress chondrocyte metabolism. More recent thought is that the presence of 
synovial fluid reduces cell division but stimulates GAG synthesis [207] preserving the 
mature cartilage matrix. Either way its presence would likely not be beneficial for a 
developing cartilage construct. A viscosity modifying ingredient would have to be 
biocompatible but preferably not bioactive, easily characterisable and also 
economically available. Molecules that have been used for the purpose of viscosity 
modification in other applications with similar requirements include, for example, 
Polyvinylpyrrolidone [208] and dextran [209] as a human blood volume expansion 
agents. 
  
Following a comprehensive search of existing literature there are, as far as the 
author is aware, no reported studies involving the tissue engineering of cartilage 
constructs large enough to make them both of a clinically relevant size (of 
dimensions such that fewer would be required to treat an osteochondral defect of 
any given size) and suitable for both tribological analysis of the tissue’s friction 
coefficient. It is the author’s opinion therefore that there is sufficient justification to 
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3. Aims and Objectives 
 
As established in the literature review (chapter 2), there is both a research and 
clinical need for large articular cartilage constructs. Large constructs have not only 
the potential to overcome the limitations associated with the smaller test 
specimens in tribological studies reported to date, but might also form the basis for 
a therapeutic intervention for the treatment of traumatic tissue defects. 
 
Few published studies to date have pursued the tissue engineering of large articular 
cartilage constructs. Moreover some culture techniques such as the use of high 
viscosity culture medium have been overlooked entirely in the tissue engineering 
field. Previous work has concluded, however, that with more advanced culture 
conditions engineered tissue could demonstrate characteristics more 
representative of those of native hyaline cartilage. The aim of this research was 
therefore to investigate the potential for tissue engineering large, high quality 
cartilage constructs using several different culture methodologies.  
 
The specific objectives of this work were; 
 
 To use standard static and semi-static tissue engineering techniques, 
primary bovine articular chondrocytes and a poly(glycolic acid) (PGA) 
scaffold material to prepare large cartilage constructs. For the purpose of 
this study, large constructs were considered to be those greater than 15 mm 
x 10 mm in size. 
 
 To investigate the potential for the Synthecon rotating cell culture system 
(RCCS) to overcome the limitations of static and semi-static culture 
 
 To identify potential tissue culture medium additives that could increase 
viscosity, and determine which approach would be best suited to supporting 
large cartilage constructs during culture. 
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 To characterise all engineered tissues using biochemical and 
immunohistological staining techniques with particular focus on collagen 
types I and II, glycosaminoglycan and lubricin (SZP) content and localisation. 
This characterisation was also supported by a preliminary investigation using 
molecular biology techniques. The relative change in gene expression for 
GAG (aggrecan – ACAN), collagen type I (COL1α2), collagen type II (COL2α1) 
and lubricin (PRG4) was analysed where possible using PCR.  
 
Where relevant or necessary other methodological developments or molecules of 
interest were investigated. This includes the production of smaller ‘pin’ constructs 
under all the culture methodologies of interest, thus allowing comparison with 
published studies and with work undertaken in a previous PhD within the group. For 
the purpose of this study, small pin constructs measured 6 mm diameter (Ø). 
Upon completion of the above objectives this thesis will describe, for the first time 
in detail, the tissue engineering of large articular cartilage constructs using a variety 
of culture methods, including a low shear bioreactor system coupled with a 
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4. Materials and Methods 
4.1 Materials 
4.1.1 Bovine articular chondrocyte isolation 
 Table 4.1 Materials used for cartilage excision 
Material Source Information 
Bovine 
metacarpophalangeal joints 
N Bramall & Sons Ltd 
Near Coates Farm Coates 
Lane, Sheffield, South 
Yorkshire, S36 8YB 
From healthy, skeletally 
mature animals (18 
months old) with a 
complete joint capsule. 
Collected  within 6 
hours of commercial 
slaughter 
Post mortem knife  Swann Morton, Sheffield, 
UK 
Model PM40 





Aluminium foil Tesco Standard kitchen foil 
70% Industrial methylated 
spirit 
Genta Medical, York, 
UK 
Diluted 7 parts IMS with 3 
parts de-ionised water 





buffered saline (PBS) 
Sigma Aldrich, UK Without calcium chloride 
and magnesium chloride, 
filter sterilised 
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 Table 4.2 Materials used for chondrocyte isolation and expansion 
Material Source Information 
Galaxy R Plus CO2 
incubator 
Eppendorf, UK 37°C, 5% CO2, 95% 
humidity 
Class 2 laminar flow 
cabinet 
Walker Safety Cabinets 
Ltd, UK 
NA 
Sturat mini orbital shaker Scientific Laboratory 
Supplies, UK 
Set to 30 RPM unless 
otherwise specified 
Syringe filter (sterile) Nalgene, Hereford, 
UK 
0.2 μm pore size, cellulose 
acetate membrane 
2 ml Luer syringe BD Biosciences, Oxford, 
UK 
NA 
Cell strainer (sterile) BD Biosciences, Oxford, 
UK 
70 μm pore size, nylon 
mesh 
T75 tissue culture flasks Greiner Bio-One, 
Stonehouse, UK 
Sterile, treated 
polystyrene for cell 
attachment 
Trypsin solution Sigma-Aldrich, Poole, 
UK 
2.5 g porcine trypsin per 
litre in Hanks' Balanced 
Salt Solution 
Bacterial collagenase Sigma-Aldrich, Poole, 
UK 
From clostridium 
histolyticum type I, 2 
mg/ml in complete 
medium, filter sterilised 
Trypsin-EDTA solution Sigma-Aldrich, Poole, 
UK 
1 x, 0.5 g porcine trypsin + 
0.2 g EDTA/L 
Expansion Culture Media 
Dulbecco’s modification 
of 
Eagle’s medium (DMEM) 
Sigma-Aldrich, Poole, 
UK 
High glucose (4500 mg/L), 
sodium bicarbonate 
buffered without L-
glutamine and sodium 
pyruvate 




Batch number F9665. 
Added 10 v/v% to DMEM 
L-alanyl-L-glutamine Sigma-Aldrich, Poole, 
UK 
200 mM stock, added 10 





10 000 units/ml penicillin 
and 10 mg/ml 






100x stock, added 10 
µl/ml (1x) 
HEPES buffer Sigma-Aldrich, Poole, 
UK 
1 M stock, added 10 µl/ml 
(10 mM) 
Human basic fibroblastic 
growth factor (bFGF) 
PrepoTech, London, UK 
 
Added 1 µl/ml from stock 
solution of 10 μg/ml in 
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Continued from previous Continued from previous PBS, containing 1 mg/ml 
bovine serum albumin 
 
4.1.2 Scaffold seeding and construct culture 
 Table 4.3 Materials used for scaffold preparation 
Material Source Information 
Poly(glycolic acid) Biofelt Cellon, Luxembourg 1 mm thick x 70 mg / CC. 
Supplied non-sterile  





PTFE construct retention 
frames 
Plastok, Birkenhead, UK 15 x 10 mm, custom 
made. 5 x 1 mm Ø drilled 
at each end for nylon 
stitching 
Guru nylon fishing line www.tedcarter.co.uk 0.25 mm Ø monofilament  
Sewing needle Groves, Aylesbury ,UK Size 10 stainless steel 
beading needle 




 Table 4.4 Materials used for scaffold seeding and subsequent culture 
Material Source Information 




Polystyrene, treated for 
cell non-attachment 




Polystyrene, treated for 
cell non-attachment 
Synthecon RCCS Cellon, Luxembourg 55 ml culture vessel 
Standard differentiation medium – As shown in table 4.2, without bFGF but with; 
Insulin Sigma-Aldrich, Poole, 
UK 
From bovine pancreas, 27 
IU/MG. Stock solution of 1 
mg/ml insuling in 100 mM 
acetic acid (filter 
streilised) added 1 µl/ml 
to medium 
L-Ascorbic acid Sigma-Aldrich, Poole, 
UK 
20-200 mesh. Stock 
solution of 50 mg/ml 
made in basic DMEM, 
filter sterilised and added 
1 µl/ml to media 
Modified viscosity differentiation medium – as above but with; 
40 w/v% dextran in PBS 
stock solution 
 
Dextran – see table 4.5, 
PBS – see table 4.1 
 
Stock prepared and 
sterilised by autoclaving 
prior to each media 
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Continued from previous 
 
Continued from previous 
change. Appropriate 
volume added to DMEM 
to achieve desired final 
w/v% content 
 
 Table 4.5 Materials used for the development of a modified viscosity 
differentiation medium 
 
Material Source Information 
Dextran Sigma-Aldrich, Poole, 
UK 
From Leuconostoc spp. 





Low viscosity sodium salt  
Polyvinylpyrrolidone (PVP) Sigma-Aldrich, Poole, 
UK 
Mr ≈ 360,000 
Viscosity modifying addition rheological analysis 
Anton Paar Physica MCR 
cone and plate rheometer 
Anton Paar GmbH, Graz, 
Austria 
CP50-1 cone, 100 µm test 
separation and 30 mm lift 
position 




buffered saline (PBS) (see 
table 4.1) 
  
Viscosity modifying addition biocompatibility analysis 
Tecan Spectrophotometer 
(see table 4.10) 
Tecan, Switzerland Infinite M200 with 
Magellan 6 software 
96 well plate Greiner Bio-One, 
Stonehouse, UK 
NA 





Viscosity modifying addition physicochemical analysis (pH, osmolality, DOT) 




Roebling freezing point 
depression osmometer 
Camlab, Cambridge, UK NA 
300 mOsm kg-1 calibration 
standard 
Camlab, Cambridge, UK NA 
Lutron PDO-520 dissolved 
oxygen meter 
Heatmiser Digital 
Meters, Blackburn UK 
Accuracy: Dissolved O2 
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4.1.3 Experimental termination 
 Table 4.6 Materials used for construct measurement and weighing 
Material Source Information 
DC-04150 Digital 
Micrometer 
digitalmicrometers.co.uk Accuracy ±0.02 mm 
Mettler AE50 Digital 
weighing scales 
NA NA 







 Table 4.7 Materials used for cryopreservation and preparation for analysis 
Material Source Information 
Aluminium foil Tesco Standard kitchen foil 
20 mm Ø cork circles Fisher Scientific, 
Loughborough, UK 
NA 
Iso-pentane Fisher Scientific, 
Loughborough, UK 
NA 
Liquid nitrogen NA NA 
Optimal cutting 
temperature (OCT) 
sample mounting media 
VMR International, UK NA 
Monensin Sigma-Aldrich, Poole, 
UK 
1 µl/ml of 1mM monensin 
in methanol stock added 
to culture media 
 
4.1.4 Histological and biochemical evaluation 
 Table 4.8 Materials used for sample cryosectioning 
Material Source Information 
Leica CM3050S cryostat Leica Biosystems, Milton 
Keynes, UK 
NA 
OCT (see table 4.6)   
Scalpel Scientific Laboratory 
Supplies, UK 
Size 4 blade 
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 Table 4.9 Materials used for biochemical staining 
Material Source Information 
Microscope and camera NA NA 
Automated H&E staining 
line 
NA NA 
Glass slides (See table 4.7)   
Glass coverslips VWR International, UK NA 
Paraformaldehyde (PFA) Sigma-Aldrich, Poole, 
UK 
4% solution 
Mayer’s Haematoxylin Fisher Scientific, 
Loughborough, UK 
NA 
Eosin Y stain Fisher Scientific, 
Loughborough, UK 
NA 
Toluidine Blue Sigma-Aldrich, Poole, 
UK 
1% toluidine blue in 0.5% 
sodium borate 
Alcian Blue Sigma-Aldrich, Poole, 
UK 
1 g Alcian blue dissolved 
in 100 ml, 3% acetic 
acid (pH 2.5) 
Scott’s tap water Fisher Scientific, 
Loughborough, UK 
NA 
Absolute alcohol Fisher Scientific, 
Loughborough, UK 
NA 
Xylene Fisher Scientific, 
Loughborough, UK 
NA 






 Table 4.10 Materials used for collagen types I and II and lubricin 
immunohistochemical staining 
Material Source Information 
Glass slides (See table 4.7)   








30% hydrogen peroxide Sigma-Aldrich, Poole, 
UK 
NA 




aminomethane, plus 8.1 
g/L NaCl and 0.86% (v/v) 5 
M HCl in distilled water 
TBS / Tween20® Sigma-Aldrich, Poole, 
UK 
TBS supplemented with 
0.05% Tween®20 
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Triton X100 Sigma-Aldrich, Poole, 
UK 
NA 
Methanol Fisher Scientific, 
Loughborough, UK 
NA 
PBS (See table 4.1)   
Distilled water NA NA 
Hyaluronidase Sigma-Aldrich, Poole, 
UK 
From bovine testes, 618.4 
units/mg activity 
Pronase Sigma-Aldrich, Poole, 
UK 
From Streptomyces 
griseus, 5.55 units/mg 
activity 




Crystalline grade, from 
bovine serum 
BSA blocking solution Sigma-Aldrich, Poole, 
UK 
PBS plus 1% BSA, 1% NHS 
and 0.05% Triton X100 
Collagen type I primary 
antibody 
Southern Biotech, UK Anti-bovine type I 
collagen, made in goat. 
0.4 mg/ml diluted 1:100 in 
TBS/ Tween20® 
Collagen type II primary 
antibody 
Southern Biotech, UK Anti-bovine type II 
collagen, made in goat. 
0.4 mg/ml diluted 1:100 in 
TBS/ Tween20® 
SZP primary antibody A gift from Professor 
Bruce Caterson, Cardiff 
University 
Anti-bovine 3A4 SZP, 
made in goat. Diluted 1:50 
in BSA blocking solution 
Normal goat serum Vector Laboratories, UK NA 
Normal horse serum Vector Laboratories, UK NA 
Biotinylated rabbit anti-
goat IgG  
Vector Laboratories, UK Made in rabbit 
Biotinylated mouse anti-
goat IgG 
Vector Laboratories, UK Made in mouse 




peroxide substrate kit  
Vector Laboratories, UK NA 
Xylene (See table 4.8)   
DPX slide mounting 
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 Table 4.11 Materials used for DMB quantitative GAG measurement 
Material Source Information 
Lyophiliser Home-made setup NA 
Techne 60-well Heat Block Scientific Laboratory 
Supplies, UK 
Dri-block DB-2D 




(see table 4.5) 
  
96 well plate Greiner Bio-One, 
Stonehouse, UK 
NA 
Digestion buffer NA 1 ml per sample of 100 
mM phosphate buffer 
containing 0.5 mg 
papain and 0.96 mg n-
acetyl cysteine 
Phosphate buffer NA 15.6 g sodium 
dihydrogen phosphate + 
0.15 g EDTA in 500ml 
dH2O added to 14.2 g 
disodium phosphate + 
0.15 g EDTA in 500ml 
dH2O until pH6.8 













Papain Sigma-Aldrich, Poole, 
UK 
From papaya latex, 2x 
crystallised 19 units/mg 







0.008 g DMB dissolved 
with 1.52 g glycine and 
1.185 g NaCl in 500ml 
dH2O 
Glycine Sigma-Aldrich, Poole, 
UK 
NA 
Sodium chloride Fisher Scientific, 
Loughborough, UK 
NA 
Hydrochloric acid Sigma-Aldrich, Poole, 
UK 
NA 
Chondroitin sulphate A  Sigma-Aldrich, Poole, 
UK 
Sodium salt, from bovine 
trachea 
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4.1.5 Molecular biology  
 Table 4.12 Materials used for RNA extraction, rtPCR and qPCR 







Tissue Pulveriser NA NA 
Liquid nitrogen NA NA 
Dulbecco’s phosphate 
buffered saline (PBS) (see 
table 4.2) 
  
ISOLATE II® RNA mini kit Bioline, London, UK With deoxyribonuclease I 
(DNaseI) for complete 
genomic DNA removal  
Reverse Transcription PCR (rtPCR) 
DNA Engine DYAD® 
thermal cycler 
Bio-Rad, Life 
Technologies, Paisley, UK 
NA 




200µl PCR tubes Fisher Scientific, 
Loughborough, UK 
NA 
Nuclease free water NA NA 
Quantitative PCR (qPCR) 
7900HT Fast Real-Time 
PCR System 
Applied Biosystems, Life 
Technologies, Paisley, UK 
In conjunction with SDS 
2.4 software 
Nuclease free water NA NA 




buffer and reference dye 
Aggrecan target primer Life Technologies, Paisley, 
UK 
ACAN (Bos Taurus) 
Collagen type I target 
primer 
Life Technologies, Paisley, 
UK 
COL1α1 (Bos Taurus) 
Collagen type II target 
primer 
Life Technologies, Paisley, 
UK 
COL2α1 (Bos Taurus) 
Surface zone protein 
target primer 
Life Technologies, Paisley, 
UK 
PRG4 (Bos Taurus) 
18s RNA endogenous 
control primer  
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4.2 Methods 
4.2.1 Bovine articular chondrocyte isolation 
 
Bovine tissue was collected from N. Bramall and Son on an ‘as-required’ basis, and 
was sourced from 18 month old, skeletally mature cattle within 4 hours of 
commercial slaughter. Methods concerning the harvesting of bovine articular 
cartilage, isolation of articular chondrocytes and the expansion of their number in 
vitro were based on Crawford et al. protocol [210]. 
 
 Cartilage excision 
The entire joint was at first sprayed down with both 70% industrial methylated 
spirit (IMS) and Trigene to reduce the risk of contamination. The skin was then 
removed under non-sterile conditions, from the limit of the severed shin to the top 
of the hoof using a post-mortem knife. Great care was taken throughout to avoid 
piercing the joint capsule. The joint was then once again sprayed down with both 
IMS and Trigene, following which both extremes were carefully wrapped in 
aluminium foil leaving only the joint area exposed and transferred to a sterile, class 
II cabinet for dissection.  
 
To prepare for dissection, the joint was positioned in a flexed pose, with the capsule 
anterior extended upwards (see figure 4.1). The front of the joint was then opened 
using a sterile number 22 scalpel blade, cutting through the soft and connective 
tissue holding the joint together. At this point care was taken to not only preserve 
the sterility of the capsule interior, but to collect some of the synovial fluid for 
experimental purposes. A sterile number 11 scalpel was then used to carefully slice 
full thickness slithers of cartilage tissue from the joint’s superior surfaces, taking 
care not to cut into the subchondral bone. Tissue slithers were gently placed into a 
50 ml universal tube containing Dulbecco’s Phosphate Bufffered Saline solution. At 
this point samples were separated, with most going on to be enzymatically digested 
but some being kept for native tissue characterisation.  
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Figure 4.1. Preparation of the metacarpophalangeal joint for cartilage excision 
 
 Chondrocyte isolation and expansion 
The cartilage pieces were washed twice in PBS, and the chondrocytes then isolation 
through sequential enzymatic digestion. The tissue was submerged in 0.25 w/v % 
trypsin, for 30 min at 37°C whilst under gentle agitation on an orbital shaker. It was 
then washed in Dulbecco’s Modified Eagle’s Medium (DMEM) + 10% foetal calf 
serum (FCS) or complete media (please see table 4.2) in order to inhibit any further 
enzymatic action of the trypsin.  The tissue was then submerged in a 2 mg/ml 
collagenase in complete medium solution, and incubated overnight at 37°C again 
under gentle agitation. The following day the digested tissue suspension was passed 
through a 70 µm cell sieve to separate out the isolated chondrocytes from the 
undigested material. The isolated cell suspension was centrifuged at 1000 RPM for 5 
minutes, with the resulting cell pellet washed of any remaining collagenase solution 
through several subsequent re-suspension and centrifugation steps. Finally the 
chondrocytes were re-suspended in complete medium, and their number counted 
using a haemocytometer. The freshly isolated chondrocytes were then either 
cryogenically frozen at passage 0 (P0) for later use or expanded in number in vitro to 
prepare for experimental set-up. The chondrocyte number was expanded taking 
into account the number required at passage two (P2) to set-up a particular 
experimental repeat. Chondrocytes were not used beyond passage two due to the 
well-known phenomenon of in vitro de-differentiation and subsequent loss of 
phenotype (please see literature review section 2.2.1).  
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In order to counteract this problem complete medium used during cell number 
expansion was supplemented with 10 ng/ml bFGF and was then referred to as 
expansion medium.   
  
Prior to experimental set-up P0 chondrocytes were seeded to T75 tissue culture 
flasks at a density of approximately 1x106 per flask in 12 ml expansion medium. 
Three to four days later or when each flask had reached confluency it was passaged. 
This involved first removing all expansion medium from the flask, initially by 
pipetting the majority of the fluid off and then by washing twice with PBS. Trypsin-
EDTA was added 2-3 ml per flask and incubated at 37° for 5 minutes until all cells 
had detached from the tissue culture plastic. The trypsin-cell suspension was then 
collected, and 10% FCS added to the total volume to inhibit any further action of 
the trypsin-EDTA. The suspension was centrifuged at 1000 RPM for 5 minutes, and 
then re-suspended in complete medium. The total cell number was measured using 
a haemocytometer, and the process repeated again – with 1x106 passage 1 (P1) 
chondrocytes seeded per fresh T75 flask. 
 
Instead of undergoing enzymatic digestion, the freshly harvested cartilage pieces 
destined for native tissue characterisation were processed in the same manner as 
engineered constructs as described in sections; 4.2.3 (experimental termination) 
and 4.2.4 (histological and biochemical evaluation).  
 
4.2.2 Scaffold seeding and construct culture 
 
Foetal calf serum (FCS) sourced from the same batch was used throughout this 
study (F9665, Sigma Aldrich UK). Prior to the start of experimental work a batch test 
was carried out following a standard pellet culture protocol involving a range of sera 
from various suppliers. Primary bovine articular chondrocyte pellets cultured using 
F9665 were found to produce and retain in their extra cellular matrix the highest 
levels of glycosaminoglycans and so its use was carried forward. This work was 
carried out by Miss Katie Bardsley (University of Sheffield, School of Clinical 
Dentistry 2010 – 2014) and the results very kindly made available to me. 
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 Scaffold preparation 
Two sizes of polyglycolic acid (PGA) scaffold were used; the first was a 6 mm 
diameter (Ø) circular ‘pin’, and the second a 15 x 10 mm ‘plate’.  Both sizes of 
scaffold were fashioned from 1 mm thick, non-woven PGA Biofelt® material. This 
material was selected due to its known biocompatibility and well characterised 
degradation profile (please see section 2.2.2).  
 
Pin scaffolds were cut from a larger sheet of material using a sharp edged bone 
corer, with a 6 mm internal diameter then placed in a tissue culture plate. Large 
plate scaffolds were cut with scissors, and trimmed to exact dimensions using a 
number 11 scalpel then placed also in a tissue culture plate. All scaffold handling 
was done with sterile tweezers, and all cutting implements were sterilised by 
autoclaving at 121ᵒC for 15 minutes prior to use to minimise risk of contamination. 
All scaffold material was sterilised by submersion in isopropanol for ten minutes, 
and then washed twice in PBS, and once in complete medium before being placed 
in expansion medium to equilibrate prior to cell seeding.    
 
Plate scaffolds were then sutured to custom made 15 x 10 mm 
polytetrafluoroethylene (PTFE) retention frames, designed and manufactured in 
partnership with Mike Topham of Plastok UK, using 0.25 mm Ø nylon drag line. This 
process ensured that the large pieces of PGA did not immediately roll up or distort 
in any other way upon being placed in culture. All materials including the frames, 
nylon sutures and sewing needle were individually sterilised via the same procedure 
as previously described for the PGA scaffold material. 
 
 Large scaffold retention frame development 
The PTFE retention frame design was the culmination of a several week 
optimisation process where various materials were tried and tested. Engineered 
PTFE was ultimately found to provide an ideal balance between biocompatibility 
and most importantly in terms of the rotating wall vessel bioreactor – light weight. 
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Figure 4.2. Images show; PGA plate scaffolds in PBS (top left), PTFE scaffold retention 
frames (top right), cut sections of nylon suture line (bottom left) and PGA constructs 
stitched to PTFE frames prior to cell seeding (bottom right) 
 
 
 Cell seeding 
Methods concerning the seeding of chondrocytes on to all scaffold types were 
based on a Crawford et al protocol [210]. The seeding protocol was the same and 
seeded cell density remained constant for all sizes and shapes of scaffolds used. 
Once all scaffolds were prepared, confluent P2 chondrocytes were trypsinised and 
collected as described in section 4.2.1 (articular chondrocyte isolation and 
expansion). Scaffolds were placed either three 6 mm Ø pins or two 15 x 10 mm 
plates per 90 mm Ø suspension culture dish, the use of which encourages cell-
scaffold attachment by preventing them from attaching to the tissue culture plastic.    
Trpsinised chondrocytes were counted, and seeded to each scaffold at a density of 
112x106 cells per cm3 of material in 25 ml total expansion culture medium per plate. 
These were then placed on an orbital shaker set at 30 RPM, and incubated at 37ᵒC 
for 72 hours. This gentle agitation encourages cell penetration into the scaffold 
material. 
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After three days, each construct, whether ‘pin’ or ‘plate’ was placed in a separate 
well of a 6 well suspension culture plate and covered with 10 ml expansion medium. 
All plates were returned to the orbital shaker and incubated for a further 72 hours, 
following which they were considered ready for ‘maturation’. The start of this next 
step was referred to as ‘day 0’, and involved placing constructs in static, semi-static 
or bioreactor conditions in differentiation medium for a further 33 days until 
experimental completion. Differentiation culture medium comprises of DMEM + 10 
% FCS, with the additions of 50 ng / ml ascorbic acid and 1 µg / ml insulin. The use 
of this medium promotes the maintenance and development of a chondrogenic 
phenotype. This medium was then either used as standard, or for the reasons 
outlined further into section 4.2.2 “developing a modified viscosity differentiation 
culture medium” supplemented with 5 or 10 w/v% high molecular weight dextran. 
Initially a 40 w/v% dextran in PBS stock solution was produced and autoclaved at 
121ᵒC for 15 minutes to ensure sterility. The concentrated stock was added to 
DMEM to comprise 12.5 and 25% of the total required media volume to produce 5 
and 10 w/v% dextran modified DMEM solutions respectively.  
 
o Static culture 
Constructs cultured under static conditions remained in 6 well suspension culture 
plates, were removed from the orbital shaker and placed on a shelf in a humidified, 
5% CO2 incubator at 37ᵒC.  
 
o Semi-static culture 
Constructs cultured under semi-static conditions simply remained in 6 well 
suspension culture plates and on an orbital shaker set to 30 RPM. 
 
o Bioreactor set-up 
The Synthecon RCCS was initially set-up prior to day 0 according to the 
manufacturer’s instructions. The motorised base unit was cleaned thoroughly with 
both IMS and TriGene, before being placed in a humidified, 5% CO2 incubator at 
37ᵒC. The control unit was placed on top of the incubator with all wiring being 
cleaned with IMS and fed carefully between the door and rubber seals.  
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The 55 ml culture vessel was dismantled and cleaned gently with detergent and 
distilled water before being reassembled and autoclaved at 121ᵒC for 15 minutes. 
At day 0, either 6 pin or 4 plate constructs were placed within the sterile 55 ml 
vessel and the cavity filled up with differentiation medium.  The sample port of the 
vessel was then stoppered, and two 20 ml syringes were attached to the syringe 
ports on the top of the vessel. These were used to simultaneously pump in small 
volumes of medium and remove any air bubbles that had collected at the top of the 
vessel. These bubbles if left would introduce turbulence to the body of media upon 
rotation of the vessel, subsequently inflicting detrimental shear forces on the 
cartilage constructs (the principles behind the operation of the rotating wall 
bioreactor are discussed in section 2.2.3, low shear bioreactors). The culture vessel 
with constructs inside was then attached to the motorised base within the 
incubator and the power switched on. The RPM of the vessel was adjusted until it 
matched the gravitational force acting on the constructs, thus suspending them in a 
stable orbit within the bioreactor and appearing stationary relative to the body of 
media. The RPM was increased gradually throughout the 33 day culture period to 
compensate for the mass increase seen in the constructs due to the developing 
tissue. In this report rotating wall vessel constructs will be referred to as RWV 
constructs for ease of notation. Following set up, the differentiation culture 











Figure 4.3. Images show; The Synthecon RCCS set up in a tissue culture incubator (left) and 
large plate constructs at the bottom of a rotational orbit (right) 
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 Developing a modified viscosity culture medium 
It was quickly realised that due to their weight, large plate constructs could not be 
supported by standard cell culture medium (DMEM) in a satisfactory minimal shear 
orbit in the rotating wall vessel bioreactor. Large constructs cultured under these 
conditions exhibited significant damage as illustrated in results section 5.2.1. 
 
The viscosity of the differentiation medium was modified in order to counteract this 
issue and ensure that large plate constructs would be sufficiently supported. 
Following consultation of the literature, three viscosity modifying additions were 
selected, dextran [211-213], carboxymethylcellulose (CMC) [213-216] and 
polyvinylpyrrolidone (PVP) [217, 218]. Extensive physicochemical property 
characterisation was carried out (please see the following sections for 
methodology) leading to the decision to carry dextran forward as the viscosity 
modifying addition of choice.   
 
Rheology 
Rheological assessment using a cone and plate viscometer of a range of direct 
addition (dissolved directly into the media) dextran, CMC and PVP w/v % 
concentrations in DMEM was carried out. The viscosity change with increasing 
shear rate was initially characterised using strain-sweep analysis. Viscous behaviour 
with increasing time was then observed. For this a constant shear rate of 2000 was 
chosen, approximately representative of movement in the adult human knee this 
was calculated by dividing a sliding distance of 10 cm (0.1 m) by 50 µm (50x10-6 m) 
in a time period of one second. For both tests, viscometer set up was essentially the 
same with the only difference being the computer software (RheoPlus®) test 
template selected. The rheometer was set-up following standard procedure as 
outlined in the equipment manual, great care was taken to ensure that air-line 
pressure to the equipment was maintained above 4 Bar at all times to prevent air 
bearing damage and artificially high viscosity measurements being recorded. The 
test plate was pre-heated to 37ᵒC and this was maintained throughout all 
measurements being taken, the zero-gap between cone and plate was calibrated 
before each sample measurement.  
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With the 50 mm diameter cone attached and set to the ‘lift’ position, approximately 
0.6 ml of sample was pipetted in to the centre of the plate taking care to minimise 
air bubbles in the fluid. The cone was then lowered into the measuring position and 
the sample ‘trimmed’ with the edge of a plastic spatula to remove any fluid not 
contained between the cone and plate. The measurement procedure was then 
initialised via the RheoPlus software control interface and automatic measurement 
allowed to take place. Following measurement the cone was returned to the lift 
position, the cone detached and cleaned and the plate thoroughly cleaned with 
distilled water. As this study developed the requirement for a higher w/v% dextran 
concentration became apparent. Subsequent issues with sterilisation meant that 
analysis of the viscous behaviour of a 40 w/v% dextran in PBS stock solution pre and 
post-autoclave at 121ᵒC for 15 minutes was required. Following this a comparison 
of the viscous behaviour of dextran containing medium produced via both direct 
addition and via the addition of a 40 w/v% stock solution was carried out. This later 
stage characterisation was carried out following the aforementioned methodology.  
 
pH 
Measurement of the change in pH brought about by the addition of a range of 
dextran, CMC and PVP concentrations to standard DMEM was carried out using a 
temperature compensated bench-top pH probe. Each sample was prepared in a 
separate 50 ml centrifuge tube, to a sufficient depth to ensure both the 
temperature and pH probe were fully submerged. Samples were then set-up within 
a humidified 5% CO2 incubator, allowed to equilibrate at 37ᵒC and pH readings 
taken in-situ. This step was necessary to ensure that false-basic pH readings were 
not recorded due to the fact that sodium bicarbonate buffered Dulbecco’s Modified 
Eagle’s Medium was designed for use under conditions of 5-10% CO2. Before each 
measurement the equipment was calibrated using two commercially available 
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Osmolality 
Any change in solution osmolality brought about by the addition of a range of 
dextran, CMC and PVP concentrations to standard DMEM was measured using a 
freezing point depression osmometer. The equipment was first ‘zeroed’ using 
distilled water, then calibrated against a 300 mOsm kg-1 standard solution. Each test 
sample was then loaded one by one, 100 µl in a 1.5 ml Eppendorf by attachment to 
the measuring head. The measuring head was then quickly inserted into the cooling 
cone, the sample was rapidly cooled and any depression in the freezing point 
brought about by the viscosity modifying addition to the media analysed and 
expressed as an osmolality value (mOsm kg-1). In line with standard protocol three 
readings were taken per sample and the mean average of these used.  
 
Biocompatibility 
Rheological and physicochemical property analysis allowed the identification of a 
promising concentration of each modifying chemical addition that could be carried 
forward into biocompatibility testing (please see section 5.2.2). The PrestoBlue® cell 
viability reagent is a cell-permeable resazurin based product that, upon reaching the 
cytoplasm and mitochondria of a living cell is reduced from a blue, non-fluorescent 
compound to a red fluorescent one. The amount of fluorescent product is directly 
proportional to the number of metabolically active cells that are present in a 
sample. Briefly, P2 primary bovine articular chondrocytes were seeded, 0.1 x 10
6 
cells per well to two 24 well tissue culture plates. Concentrations of 5 w/v% 
dextran, 1 w/v% CMC and 2.5 w/v% PVP were added in triplicate to each plate 
alongside standard DMEM plus 10 % FCS for control comparison, one plate was 
cultured under static and the other semi-static conditions in a humidified 5% CO2 
incubator at 37ᵒC. After 72 hours the culture medium was removed from each well 
and replaced with 2 ml serum-free DMEM plus 10% PrestoBlue® Cell Viability 
Reagent, the plates were then returned to the incubator. After 15, 30 and 60 
minutes incubation time, 200 µl of the PrestoBlue® containing medium  was 
pipetted in triplicate from each well into separate wells of a 96 well plate, thus 
allowing measurements to be made in triplicate for each well at each time point.  
Richard A. Senior                                                                                                                                               2014 
 
 Page 70 
 
The rate of dye reduction was calculated by dividing the fluorescence unit value by 
the respective number of minutes at 15, 30 and 60 minutes, and averaging the 
resulting values obtained over the three time points. Following analysis each well 
was restored with its respective high or normal viscosity culture medium and 
returned to the incubator for a further three days. The same process was repeated 
after 144 hours of culture thereby providing information on the effect of each 
media type on more long term cell proliferation. 
 
Following biocompatibility and physicochemical property analysis, dextran was 
selected as the viscosity modifying addition that provided the best compromise 
between ease of processing and handling, biocompatibility and predictable 
rheological behaviour (again please see section 5.2.2). A concentration of 5 w/v % 
was first selected due to its very similar rheological behaviour to native bovine 
synovial fluid under physiologically representative strain rates (please see section 
4.2.2) [212] however further investigation revealed that this concentration was in 
fact insufficient to support the weight of large plate constructs, plus their associated 
PTFE retention frames in the rotating wall vessel bioreactor at a reasonable RPM. 
For this reason a concentration of 10 w/v % was carried forward for use in the RWV 
bioreactor, whereas 5 w/v % was used only in static and semi-static cultures to 
provide an interesting comparison. The above biocompatibility analysis protocol 
was repeated in order to provide a comparison between that and the originally 
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Dissolved Oxygen Tension (DOT) 
In order to quantify the effect the addition of dextran to the culture medium has on 
levels of dissolved oxygen, concentrations of 2.5, 5 and 10 w/v % in DMEM were 
produced as described in section 4.2.2 and then incubated at 37ᵒC in a humidified, 
5% CO2 incubator for 24 hours to allow the dissolved oxygen concentrations in each 
sample to equilibriate. Prior to each measurement being taken, the meter was 
calibrated against atmospheric oxygen levels in a well-ventilated area (20.9 % ± 0.1 
%). Samples were then removed from the incubator one by one for as short a 
period of time as possible to allow probe insertion, the DOT probe was immersed in 
each sample to a depth that sufficiently covered both the measuring head and 
temperature sensor and placed immediately back into the incubator, being allowed 
further time to re-equilibrate before the stabilised measurement was taken (around 
60 seconds). All dissolved oxygen measurements were made with samples between 
35 and 37ᵒC. The measuring head was then rinsed thoroughly in de-ionised water 
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PGA 6 mm Ø pin 0.028 3.17 Static, standard 
DMEM 
PGA 6 mm Ø pin 0.028 3.17 Semi-static, 
standard DMEM 
PGA 6 mm Ø pin 0.028 3.17 RWV bioreactor, 
standard DMEM 
PGA 15 x 10 mm plate 0.15 16.8 Static, standard 
DMEM  
PGA 15 x 10 mm plate 0.15 16.8 Semi-static, 
standard DMEM 
PGA 15 x 10 mm plate 0.15 16.8 RWV bioreactor, 
standard DMEM 
PGA 6 mm Ø pin 0.028 3.17 Static, DMEM + 5 
w/v% dextran 
PGA 6 mm Ø pin 0.028 3.17 Semi-static, DMEM 
+ 5 w/v% dextran 
PGA 6 mm Ø pin 0.028 3.17 RWV bioreactor, 
DMEM + 5 w/v% 
dextran 
PGA 15 x 10 mm plate 0.15 16.8 Static, DMEM + 5 
w/v% dextran 
PGA 15 x 10 mm plate 0.15 16.8 Semi-static, DMEM 
+ 5 w/v% dextran 
PGA 6 mm Ø pin 0.028 3.17 Static, DMEM + 10 
w/v% dextran 
PGA 6 mm Ø pin 0.028 3.17 Semi-static, DMEM 
+ 10 w/v% dextran 
PGA 6 mm Ø pin 0.028 3.17 RWV bioreactor, 
DMEM + 10 w/v% 
dextran 
PGA 15 x 10 mm plate 0.15 16.8 Static, DMEM + 10 
w/v% dextran  
PGA 15 x 10 mm plate 0.15 16.8 Semi-static, DMEM 
+ 10 w/v% dextran 
PGA 15 x 10 mm plate 0.15 16.8 RWV bioreactor, 
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4.2.3 Experimental termination 
 
After the 33 day maturation culture period had elapsed, constructs were treated 
differently depending on whether or not they were intended for surface zone 
protein (SZP) immunohistolocalisation. Constructs for SZP analysis were incubated 
at 37ᵒC for a further 4 hours with a 1 µl/ml monensin solution. Monensin is a 
polyether antibiotic that blocks intra-cellular protein transport, surface zone protein 
expressed by chondrocytes in the engineered constructs is therefore retained in the 
immediate area of expression and not ejected out into the culture media. Following 
this the constructs were fixed for 30 minutes in 4% paraformaldehyde at 4ᵒC, 
washed twice in PBS and cryopreserved in optimal cutting temperature (OCT) prior 
to cryosectioning (procedure described below). The same protocol was followed 
with slithers of native bovine articular cartilage to prepare them also for SZP 
immunohistolocalisation. 
 
All pin constructs not intended for SZP analysis were removed from the culture 
medium, washed twice in PBS and then carefully patted dry. Each construct was 
then measured carefully using a digital micrometer, Six measurements were taken 
of both the diameter and thickness at equal spacing around the circumference of 
each construct and the average values of each recorded. Plate constructs not 
intended for SZP analysis were removed carefully from the retention frames and 
using a scalpel and tweezers, washed twice in PBS and gently dried. Pin constructs 
were then cut in half, and plate constructs divided into four using a number 11 
scalpel. Half of each pin and a quarter of each plate construct was then processed 
for quantitative glycosaminoglycan analysis (qGAG) and half of each pin and three 
quarters of each plate processed for RNA extraction or cryopreserved in OCT in 
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 Preparation for qGAG analysis 
Pieces of construct allocated to quantitative glycosaminoglycan analysis were 
placed in individual 1.5 ml microcentrifuge tubes and weighed. Each tube had been 
previously weighed empty and so the difference could be used to calculate the 
tissues wet weight.    
 
 Preparation of samples for histological and biochemical evaluation 
Strips of aluminium kitchen foil of approximate dimensions 8 cm x 3 cm were cut 
out and fashioned into a cup shape with 2.5 cm high sides using a 5 ml universal as a 
template. A small hole was made in the bottom of the vessel, this meant once 
placed on a 2.5 cm diameter cork circle and filled with OCT some of the liquid 
passed through the bottom and adhered the OCT filled foil cup to the cork tile. One 
by one the pieces of cartilage construct were placed into separate OCT filled 
vessels, ensuring they were fully submerged and suspended longitudinally in the 
liquid. This ensured more effective cryosectioning later and also permits the 
orientation of the tissue relative to its place in the original construct to be recorded. 
The whole thing was next placed in a small glass beaker containing isopentane that 
had been chilled, but not frozen in liquid nitrogen. This allowed a more gradual 
freezing of the OCT surrounding the piece of tissue, and reduced the chances of it 
fracturing during the next step of full submersion in liquid nitrogen at -196ᵒC. 
Following this all tissue was encased in frozen OCT, including samples intended for 
surface zone protein immunohistolocalisation and so was ready for cryosectioning. 
The samples were stored at -20ᵒC in clearly labelled plastic bags until required. 
 
 Preparation of samples for molecular biology (rtPCR and qPCR) 
Samples intended for reverse transcription and quantitative PCR (polymerase chain 
reaction) were dealt with quickly due to the time sensitive nature of RNA isolation. 
Each half-pin or quarter-plate segment was flash-frozen in liquid nitrogen, then 
straight away homogenised with a heavy steel pestle and mortar taking care to 
ensure the sample was completely liquefied. The homogenised tissue was then 
carefully washed from the steel well with 1 ml PBS and decanting into separate 1.5 
ml Eppendorf. These samples were then processed as described in section 4.2.5. 
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4.2.4 Histological and biochemical evaluation 
 
Prior to biochemical and histological staining, sections 10 µm thick were cut at -20ᵒC 
using a Leica CM3050S cryostat. These were picked up by bringing them into 
contact with APES (3-aminopropyltriethoxysilane) coated glass slides. These were 
allowed to air dry overnight and then fixed in 4% paraformaldehyde for 30 minutes 
at 4ᵒC the next morning.  All slides were then washed in deionised water to remove 
any remaining traces of OCT and again allowed to air dry for one to two hours 
 
 Haematoxylin and eosin staining 
The slides were mounted onto an automatic Shandon H&E staining line and taken 
sequentially through; running tap water, Mayer’s haematoxylin, running tap water, 
0.1% HCl in 70% alcohol, running tap water, Scott’s tap water substitute, eosin, 
running tap water, 95% alcohol, absolute alcohol, 1:1 absolute alcohol in xylene, 
xylene. Slides were then allowed to air dry, fully cleared in xylene again and 
mounted in DPX. 
 
 Alcian and toluidine blue staining 
o Alcian blue 
Fixed tissue sections were rinsed in 3% peracetic acid for 5 minutes then submerged 
in Alcian blue stain overnight. All slides were subsequently washed in deionised 
water, cleared in xylene, allowed to air dry and then mounted in DPX.  
 
o Toluidine blue 
Fixed tissue sections were submerged in toluidine blue dye stain solution for 5 
seconds and then immediately rinsed in deionised water, cleared in xylene, allowed 
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 Collagen types I and II immunohistochemistry 
Collagen type I and II immunohistolocalisation was undertaken following a standard 
indirect immunoperoxidase staining protocol. The method was the same for both 
collagen type I and type II with the exception of the primary antibody used. Fixed 
tissue sections were first treated with a 10 mg/ml hyaluronidase / 3 mg/ml pronase 
in PBS solution, incubating at 37ᵒC for 30 minutes in order to fully expose the 
collagen network in the cartilage extra cellular matrix. Enzymatic activity was then 
quenched through the application of 3 v/v% hydrogen peroxide in methanol / PBS 
solution for 5 minutes. A 1% BSA blocking solution was applied for one hour at 
room temperature to prevent any non-specific hydrophobic binding interactions. 
The BSA solution was then removed from all slides except the non-specific staining 
controls. The purpose of having these controls is to demonstrate that the secondary 
antibody and subsequently ABC complex is binding only to primary antibody 
labelled collagen type I and II collagen. Primary collagen type I and II antibodies 
were then added to separate sections of the same construct and incubated 
overnight at 4°C. 
 
The following day all sections including non-specific controls were washed three 
times in TBS/Tween20® for 5 minutes per wash. The secondary antibody was added 
to all slides and left for 1 hour at room temperature. The ABC reagent was prepared 
according to the manufacturer’s instructions during secondary antibody incubation 
as this was required to stand for 30 minutes before use. All slides were then washed 
three times TBS/Tween20® for 5 minutes per wash and then incubated at room 
temperature for 30 minutes with the ABC reagent added. During this time the DAB 
substrate solution was prepared according to the manufacturer’s instructions. All 
sections were next washed three times again with TBS/Tween20® for 5 minutes per 
wash, and the DAB substrate solution applied for 5 minutes. All slides were washed 
in distilled water and allowed to air dry, before being cleared in xylene and 
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 Surface zone protein immunohistochemistry 
The protocol followed for the immunolocalisation of surface zone protein was 
adapted from that described by Schumacher et al [219]. 
 
Fixed tissue sections were first washed three times in PBS to remove any traces of 
OCT from the APES coated slide, then treated with 10 mg/ml hyaluronidase in PBS 
for 30 minutes at 37°C. Enzymatic activity was quenched through the application of 
a 3 v/v% hydrogen peroxide in methanol / PBS solution for 5 minutes. All sections 
were then permeabilised by washing in a 0.1% Triton X100 in PBS solution, and then 
blocked with a 1% BSA solution for one hour at room temperature. The BSA solution 
was then removed from all slides except the non-specific staining controls (please 
see section 4.2.4 Collagen type I and II immunolocalisation for explanation) and the 
primary SZP antibody added. Following incubation overnight at 4°C all slides were 
washed three times in PBS. The secondary antibody was then added to all sections 
for one hour at room temperature, alongside which the ABC reagent was prepared 
according to the manufacturer’s instructions and allowed to stand for 30 minutes. 
All slides were then washed three times in a 0.1% Triton X100 in PBS solution and 
then incubated with the ABC reagent for 30 minutes. During this time the DAB 
substrate solution was prepared according to the manufacturer’s instructions. All 
sections were next washed three times again with TBS/Tween20® for 5 minutes per 
wash, and the DAB substrate solution applied for 5 minutes. All slides were washed 
in distilled water and allowed to air dry, before being cleared in xylene and 
mounted in DPX.  
 
 Quantitative glycosaminoglycan analysis 
 
Samples that had been weighed and stored in 1.5 ml microcentrifuge tubes 
following experimental termination were retrieved from storage at -20°C. These 
were then vacuum dried in a lyophiliser overnight, and their dry weight recorded 
the following morning. At this point the weight of water contained in the original 
construct or slither of native tissue could be calculated by subtracting the weight of 
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the lyophilised tissue from the original wet tissue’s weight (taking into account the 
mass of the microcentrifuge tube). Digestion buffer (see table 4.10) was then added 
1 ml per tube ensuring the tissue was fully submerged, and incubated overnight at 
60°C. The following morning each tube was spun down at 15,000 RPM for 15 
minutes in a microcentrifuge. The supernatant was then pipetted off into a fresh 
microcentrifuge tube taking care to leave any undigested construct and scaffold 
material behind.  The supernatant was then diluted down with distilled water to 
produce a range of concentrations, from 1:2 for smaller pieces of engineered 
construct to 1:500 for large pieces or slithers of native tissue. Due to the variation in 
glycosaminoglycan present between samples this was a necessary step to ensure 
the optical density measured upon application of the appropriate colourimetric 
assay was within the standard curve range.  
 
The method used for quantifying the amount of sulphated glycosaminoglycans 
present in both engineered and native cartilage tissue was based on a protocol 
described by Farndale et al [220] 
 
A standard curve was produced by adding in triplicate to a 96 well plate dilutions of 
50 µg/ml chondroitin sulphate in distilled water ranging from 0 to 100% 
concentration. The optical density at 525 nm of this was read alongside that of the 
50 µl of each sample dilution following the addition to each well of 250 µl (DMB). 
Both the weight (mg) and concentration of sulphated GAG in each sample was 
calculated with reference to the standard curve, taking into account the dilution of 
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4.2.5 Molecular Biology 
 
 RNA isolation 
Following sample processing as described in section 4.2.3 homogenised samples 
were centrifuged at 13,000 g for two minutes, the supernatant was then carefully 
removed and discarded and the resulting pellet submerged in 450 µl cell lysis buffer 
(Bioline™ ISOLATE II® RNA mini kit). The lysate was then passed through a series of 
purification and washing steps as described in the isolation kit protocol and the 
resulting purified RNA eluted into a fresh nuclease free microcentrifuge tube using 
50 µl nuclease free water. Isolated RNA yield and quality was spectophotometrically 
assessed to ensure a minimum concentration of 9 ng/µl before either proceeding 
straight on to PCR or being stored at -80ᵒC.  
 
 Reverse transcriptase polymerase chain reaction (rtPCR) 
Samples of isolated RNA were removed from storage and defrosted. An Invitrogen™ 
High Capacity RNA-to-cDNA kit™ (Life Technologies, UK) was used to synthesis cDNA 
from 100 ng of each RNA sample. Each RNA sample was first diluted down with the 
appropriate volume of nuclease free water to ensure a final concentration of 10 
ng/µl. Ten microliters of each sample was then combined with 2 µl reverse 
transcription buffer, 2 µl random primers, 0.8 µl deoxyribonucleotide triphosphate 
(dNTPS), 1 µl Multiscribe Reverse Transcriptase and 4.2 µl nuclease free water. Each 
sample was placed in a thermal cycler set to run at 25ᵒC for 10 minutes, 37ᵒC for 
two hours, 85ᵒC for 5 minutes and finally 4ᵒC for ten minutes, before being stored 
at -20ᵒC until required for qPCR. 
 
 Quantitative polymerase chain reaction (qPCR) 
Quantitative or real-time PCR was carried out in order to assess the expression of 
genes encoding for collagen type I (identified via the procollagen COL1α2 gene), 
collagen type II (procollagen COL2α1), aggrecan (ACAN) and surface zone protein 
(PRG4) in each sample at experimental termination compared to that at 72 hours 
after scaffold seeding. Analysis was carried out in 96 well PCR plates, with a reaction 
volume of 10 µl per well comprising 5 µl Taqman Mastermix™, 3.5 µl nuclease free 
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water, 0.5 µl target gene primer (COL1α2, COL2α1, ACAN, PRG4), 0.5 µl 18S RNA 
endogenous control primer and 0.5 µl cDNA sample at a concentration of 5 ng/µl. A 
non-template control (Taqman Mastermix, target and control primer minus cDNA) 
was added to each reaction plate in triplicate which was then processed in a 
7900HT Fast Real-Time PCR System  
 
The expression of each gene relative to the endogenous control was calculated 
using the 2−ΔΔCT method [221], and then shown graphically as a fold increase or 
decrease with respect to the level of expression seen in a 72 hour reference sample. 
Reference samples for each experimental condition were obtained by processing as 
described in section 4.2.3 small pin or large plate scaffolds seeded with cells 
immediately after the 72 hour seeding period had elapsed. As constructs destined 
for each experimental condition were seeded for 72 hours in exactly the same way, 
the baseline data provided for qPCR was therefore identical for each condition.  It is 
well established that the phenotype of chondrocytes cultured in a two dimensional 
environment such as tissue culture plate or flask will change dramatically upon 
being transferred to a 3D scaffold environment [222]. Of more interest to this study 
however was how this genetic profile would change between the initial seeding to a 
3D scaffold environment and the end of the culture period. 
 
The number of constructs that could be cultured under each condition was limited 
by factors including; the number of chondrocytes isolated at P0, the number 
available for scaffold seeding at P2 and the amount of space available in each 
culture environment at any one time. A sufficient number of constructs could 
therefore only be produced under each combination of culture conditions to allow 
PCR analysis at culture termination. This approach can only show the level of 
expression of each gene at culture termination in comparison to the 72 hour 
reference sample. The expression of each gene could vary widely over the duration 
of the culture period and to assess this PCR analysis at several time points 
throughout would be required, however for the abovementioned reasons this was 
not possible in this investigation..  
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5. Results 
Statistical analysis was carried out using Microsoft Excel (One-way ANOVA) followed 
by GraphPad Prism 6 (Tukey post-test) to compare all columns in each data set. The 
significance level is stated in each figure legend with * = P < 0.05, ** = P < 0.01 and 
***P < 0.001. 
 
5.1 Biological characterisation of native bovine articular cartilage 
 Structure 
 
Figure 5.1 Representative H&E stained sections of native bovine articular cartilage. 
 
Figure 5.1 shows representative haematoxylin and eosin (H&E) stained sections of 
native bovine articular cartilage. The eosin stained protein matrix is dense 
throughout but particularly concentrated in the surface amorphous layer. Mayer’s 
haematoxylin stained chondrocyte nuclei are clearly visible within individual 
lacunae, with flattened cell morphology in the superficial layer, and more rounded 
morphology in the tangential and deep zones. Overall cell density is very low and 
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 Water content 
 
Water accounted for 73.85 ± 2.81% (Mean ± SD, n=12) of the native cartilage 
tissue’s wet weight. This was calculated by weighing each sample before (wet 
weight) and after (dry weight) freeze drying through lyophilisation. 
 
 Collagen content 
o Type I 
 
Figure 5.2 Light micrographs showing the immunohistochemical localisation of type I 
collagen in native bovine articular cartilage. Non- specific staining shown inset to the top 
right of the images 
 
 
Figure 5.2 shows low intensity but still positive levels of collagen type I labelling 
compared with non-specifically stained slides, with higher intensity staining in the 
lamina splendens and pericellular areas. This suggests low levels of collagen I are 
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o Type II 
Figure 5.3 Light micrographs showing the immunohistochemical localisation of type II 
collagen in native bovine articular cartilage. Non-specific staining shown inset to the top 
right of the images. 
 
Figure 5.3 shows strong collagen type II labelling, suggesting high levels of collagen 
type II in the tissue throughout the tissue. Non-specific staining showed very little 
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 Glycosaminoglycan (GAG) content 
o Toluidine and alcian blue staining 
 
Figure 5.4 Representative native bovine articular cartilage sections stained with toluidine 
blue for glycosaminoglycans. 
 
 




Figure 5.4 (toluidine blue) and figure 5.5 (Alcian blue) both show very strong 
glycosaminoglycan staining. This confirms the presence of GAGs in the tissue, with 
intense staining in the surface amorphous layer and then with increasing intensity 
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o Quantitative dimethylmethylene blue assay 
 
Glycosaminoglycan content in native articular cartilage wet weight was quantified 
as 8.85 ± 1.74 % (mean ± SD, n=12) or 0.088 ± 0.007 mg per mg wet weight (mean ± 
SD, n=12) using the method as described in section 4.2.4. 
 
 Surface zone protein localisation 
 
Figure 5.6 Representative native bovine articular cartilage sections immunohistologically 




Figure 5.6 shows immunolocalisation of surface zone protein (SZP). Strong labelling 
can be seen in the surface amorphous layer compared to non-specific staining 
controls suggesting an intense presence of lubricin in this area. No staining can be 
seen any deeper into the tissue section implying SZP is synthesized by only 
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5.2 Characterisation of tissue engineered articular cartilage 
5.2.1 Tissue engineering using standard culture medium 
 Engineered pins (6 mm Ø) 
 
 General appearance 
Tissue from all three environments was dense, easily handled with tweezers and 
demonstrated a cartilaginous texture. Figure 5.7 illustrates the high level of 
contraction seen in both semi-static and rotating wall vessel constructs, 
representative constructs have been selected from each culture environment.  
 
 
Figure 5.7 Representative static, semi-static and RWV bioreactor constructs shown to the 
left, centre and right respectively 
 
 
 Dimensions and weight 
 
The diameter of pin constructs cultured under static conditions was 7.39 ± 0.31 mm 
(Mean ± SD, n=6), the thickness was 1.51 ± 0.11 mm (Mean ± SD, n=6) and the wet 
weight was 62.28 ± 15.84 mg (Mean ± SD, n=19). 
The diameter of pin constructs cultured under semi-static conditions was 
4.12 ± 0.05 mm (Mean ± SD, n=6), the thickness was 0.69 ± 0.11 mm (Mean ± SD, 
n=6) and the wet weight was 48.67 ± 23.40 mg (Mean ± SD, n=23). 
The diameter of pin constructs cultured in the rotating wall vessel (RWV) 
bioreactor was 3.53 ± 0.21 mm (Mean ± SD, n=6), the thickness was 0.54 ± 0.06 mm 
(Mean ± SD, n=6) and the wet weight was 5.1 ± 1.3 mg (Mean ± SD, n=9). 
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Figure 5.8 Graphical representation of percentage change in pin construct volume between 
day 0 and 33 under static, semi-static and RWV bioreactor conditions in standard DMEM. 
Error bars represent the standard error of the mean (SEM). 
 
Figure 5.8 above represents graphically the percentage volume change seen in 
constructs cultured under static (129.6%), semi-static (-67.7%) and rotating wall 
vessel bioreactor culture (-81.33 %). From the initial standard volume of 0.028 cm3, 
mean percentage volume increase or decrease is shown. 
 
 Water content 
 
Water accounted for 86.09 ± 2.79 % (Mean ± SD, n=19) of the pin constructs 
cultured under static conditions’ wet weight. This was calculated by weighing each 
sample before (wet weight) and after (dry weight) freeze drying through 
lyophilisation. 
 Water also accounted for 87.74 ± 3.92% (Mean ± SD, n=23) of the pin 
constructs cultured under semi-static conditions’ wet weight, and 92.31 ± 5.75% 
(Mean ± SD, n=9) of the pin constructs cultured in the RWV bioreactors’ wet weight. 
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 Structure  
Figure 5.9 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
cultured under static conditions in standard DMEM. 
 
Figure 5.10 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
cultured under semi-static conditions in standard DMEM. Bright pink residual PGA scaffold 
fibres can be seen throughout the section.  
 
Figure 5.11 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
cultured under RWV bioreactor conditions in standard DMEM. 
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Figures 5.9, 5.10 and 5.11 show H&E staining of pin constructs cultured under static, 
semi-static and rotating wall vessel bioreactor conditions respectively.  Eosin 
staining of the extra cellular matrix (ECM) in figure 5.9 was not successful for 
unknown reasons. No reliable comment on the composition of the ECM can 
therefore be made. The cell density was high in all constructs, as apparent from the 
number of haematoxylin stained nuclei, with the majority of cell nucleii possessing a 
rounded morphology. Constructs in figures 5.10 and 5.11 demonstrate a certain 
degree of tissue heterogeneity, with visibly distinctive superficial layer containing 
more flattened chondrocytes visible in each.  
 The highest density of bright pink stained residual  PGA scaffold fibres was 
visible in semi-static constructs, whereas the lowest was visible in constructs 
cultured under static conditions. Static constructs also suffered from very poor 
tissue quality towards the centre, meaning most were easily damaged during 
cryosectioning. This is visible in figure 5.9 where large cavities and a much lighter 
matrix density in the centre of the construct can be seen. 
 
Collagen type I immunohistological staining of constructs cultured under static, 
semi-static and RWV bioreactor conditions can be seen in figures 5.12, 5.13 and 
5.14 (overleaf) respectively.  Collagen type I staining is positive and strong 
throughout the construct in all conditions implying high levels of collagen type I are 
present in each. The non-specific staining controls show low levels of cross-
reactivity with other components in the matrix; however remaining fibres of PGA 
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 Collagen content 
o Type I 
Figure 5.12 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in standard 
DMEM. Non-specific staining shown inset to image top right. 
 
Figure 5.13 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under semi-static conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
 
Figure 5.14 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under RWV bioreactor conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
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Figure 5.15 Fold change in COL1α2 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under 
static, semi-static and RWV bioreactor conditions in standard DMEM. For each condition 
n=6. No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown * = P < 0.05. 
 
Figure 5.15 above illustrates the relative expression of COL1α2 between static, 
semi-static and RWV bioreactor constructs at termination of culture. Noticeable 
differences can be seen between RWV and both static and semi-static conditions, as 
demonstrated by a fold-increase in expression relative to their respective 72 hour 
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o Type II 
Figure 5.16 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in standard 
DMEM. Non-specific staining shown inset to image top right 
Figure 5.17 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under semi-static conditions in 
standard DMEM. Non-specific staining shown inset to image top right 
Figure 5.18 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under RWV bioreactor conditions in 
standard DMEM. Non-specific staining shown inset to image top right 
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Figures 5.16, 5.17 and 5.18 all show immunohistochemical staining for collagen type 
II. Constructs from all three culture conditions showed strong positive staining 
suggesting high levels of collagen II were present throughout the extra cellular 
matrix. Staining was particularly strong in static and RWV bioreactor constructs, but 
in both cases also showed a more homogenous distribution than that demonstrated 
by semi-static constructs. Non-specific staining controls show low levels of cross-
reactivity with other components in the matrix; however again, remaining fibres of 
PGA scaffold have stained in most cases. Figure 5.19 below shows the relative 
expression of COL2α1 at experimental termination, with a statistically significant 
difference in expression between static (114.56 x 72 hour control) and RWV 
bioreactor (69.05 x) conditions, semi-static conditions show a 80.54 x increase. 
 
o QPCR analysis – COL2α1 expression 
 
 
Figure 5.19 Fold change in COL2α1 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under 
static, semi-static and RWV bioreactor conditions in standard DMEM.For each condition 
n=6. No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown ** = P < 0.01. 
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 Glycosaminoglycan (GAG) content 
o Toluidine and alcian blue staining 
Figure 5.20 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under static conditions in standard DMEM. 
 
Figure 5.21 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under semi-static conditions in standard DMEM. 
 
Figure 5.22 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under RWV bioreactor conditions in standard DMEM. 
 
Richard A. Senior                                                                                                                                               2014 
 
 Page 95 
 
Figure 5.23 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 
constructs cultured under static conditions in standard DMEM. 
 
Figure 5.24 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 
constructs cultured under semi-static conditions in standard DMEM. 
 
Figure 5.25 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 
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Figure 5.20, 5.21 and 5.22 show toluidine blue stained static, semi-static and RWV 
bioreactor construct sections respectively. A strong, positive, light-purple staining 
for glycosaminoglycans (GAG’s) can be seen in static constructs, this confirms the 
presence of GAGs in the tissue, an observation further backed up by figure 5.23 
where the tissue is stained with alcian blue. Staining in both cases is very 
heterogeneous with no tissue stained more strongly than any other. Both semi-
static and RWV bioreactor constructs also stained positively for GAG’s as 
demonstrated in figures 5.21 and 5.22, 5.24 and 5.25. Staining was much weaker 
however with a much bluer than purple colouring visible in toluidine blue staining. 
 
Figure 5.26 (overleaf) illustrates graphically the percentage sulphated GAG content 
in the tissue’s wet weight established by dimethylmethylene blue (DMB) assay.  . 
Glycosaminoglycan content could not be shown as mg GAG per half (6 mm ø pin) or 
quarter (15 x 10 mm plate) construct analysed due to the variation in tissue wet 
weight to begin with, i.e. constructs could not be halved and quartered to exactly 
comparable sizes.  
 Glycosaminoglycan content of engineered pin constructs cultured under 
static conditions’ wet weight was quantified as 1.87 ± 0.49 % (mean ± SD, n=19) or 
0.018 ± 0.002 mg per mg wet weight (mean ± SD, n=19) using the method as 
described in section 4.2.4. Statistically, this is significantly more than was found in 
semi-static and RWV bioreactor constructs at 1.15 ± 0.64 % (Mean ± SD, n=23) or 
0.012 ± 0.002 mg per mg wet weight (Mean ± SD, n=23) and 0.76 ± 0.17 % (Mean ± 
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o Quantitative dimethylmethylene blue assay 
 
Figure 5.26 Percentage sulphated glycosaminoglycan (GAG) content in the digested and 
lyophilised matrix of tissue engineered pin constructs (6 mm ø) cultured in standard DMEM. 
Error bars represent the standard error of the mean (SEM), significance levels shown ** = P 
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o QPCR analysis - ACAN expression 
 
Figure 5.27 Fold change in ACAN expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in standard DMEM. For each condition n=6. No 
change in 18s RNA endogenous control was observed. Error bars represent the standard 




Figure 5.27 above illustrates the relative expression of ACAN seen between static, 
semi-static and RWV bioreactor pin constructs cultured in standard DMEM at the 
end of the culture period.  At day 33 chondrocytes seeded to RWV bioreactor 
constructs expressed ACAN to a much greater level (7.88 x 72 hour control) than 
their semi-static counterparts (3.56 x) which in turn demonstrated a statistically 
significant higher level of expression than those cultured under static conditions 
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 Surface zone protein content 
Figure 5.28 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 6 mm Ø pin constructs cultured under static conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
 
Figure 5.29 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 6 mm Ø pin constructs cultured under semi-static conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
Figure 5.30 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 6 mm Ø pin constructs cultured under RWV bioreactor 
conditions in standard DMEM. Non-specific staining shown inset to image top right. 
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Figure 5.28, 5.29 and 5.30 shows the immunohistolocalisation of surface zone 
protein (SZP) in static, semi-static and rotating wall vessel bioreactor constructs 
respectively. Both semi-statically and bioreactor cultured constructs demonstrate 
intermittently intense SZP staining around the periphery of the constructs in an area 
penetrating around 10 µm in depth. Tissue cultured under static conditions apart 
from one small area of intense positive staining as can be seen in figure 5.28 
demonstrated no apparent localisation of surface zone protein in the construct 
periphery. All three constructs however demonstrate extensive lower level staining 
throughout the tissue. Tissue cultured under static conditions presented two or 
three sporadic areas of intensive SZP staining.  
 
Constructs cultured under all three conditions showed very little cross reactivity 
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o QPCR analysis – PRG4 expression 
 
Figure 5.31 Mean fold change in PRG4 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under 
static, semi-static and RWV bioreactor conditions in standard DMEM. For each condition 
n=6. No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance levels shown ** = P < 0.01 and *** = P < 
0.001. 
 
Surface zone protein expression (PRG4) in 6 mm ø pin construct chondrocytes 
cultured in standard DMEM showed a relative increase in all culture conditions as 
can be seen in figure 5.31 above. Chondrocytes seeded to semi-statically cultured 
constructs (10.41 x 72 hour control) demonstrated a statistically significant 4.6 fold 
increase in expression over those cultured under static conditions (2.26 x 72 hour 
control), as did those cultured under RWV bioreactor conditions, with an increase of 
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 Engineered plates (15 x 10 mm) 
 General appearance 
 
 
Figure 5.32 A representative construct cultured under static conditions, shown separated 
from the PTFE retention frame. 
 
Figure 5.32 illustrates a typical construct cultured under static conditions for 33 
days. Static constructs had very good mechanical integrity and were easily released 
from the PTFE retention frames upon removal of the nylon sutures. The constructs 
held their shape very well whilst being handled with tweezers, and cut with a 
cartilaginous ‘crunch’ when being divided up with a scalpel blade at culture 
termination. Constructs cultured under semi-static conditions did not possess the 
same mechanical integrity, were much more flexible when being handled with 
tweezers upon removal from the PTFE retention frame and hence were much 
harder to handle. 
 
Large plate constructs cultured in the rotating wall vessel bioreactor were too heavy 
to be sustained in a stable orbit within the culture medium, and so unavoidable 
construct ‘tumbling’ and contact with the vessel walls occurred. This resulted in all 
but two constructs being completely destroyed, with the tissue being torn from the 
PTFE frames. The two remaining constructs were analysed but were of very poor 
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Figure 5.33 Representative phase contrast images of large plate constructs cultured under 
static conditions at experimental termination. 
 
Figure 5.34 Representative phase contrast images of large plate constructs cultured under 
semi static conditions at experimental termination.  
 
Figure 5.33 above illustrates the surface appearance of two (left and right) typical 
large plate constructs cultured under static conditions at the end of the culture 
period. Phase contrast microscopy highlights well the porosity of the tissue and 
areas in which tissue development has not progressed well beyond localisation 
around the PGA scaffold fibres. Figure 5.34 above shows the surface appearance of 
two representative large plate constructs cultured under semi static conditions, 
again at culture termination using phase contrast microscopy. In contrast to figure 
5.33 this tissue demonstrates much more complete development with very little 
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 Construct weight 
 
The wet weight of 15 x 10 mm plate constructs cultured under static conditions was 
149 ± 5.3 mg (Mean ± SD, n=9), under semi-static conditions 159 ± 11.7 mg (Mean ± 
SD, n=9) and in the rotating wall vessel bioreactor 47 ±  3.8 mg (Mean ± SD, n=2). 
 
 Water content 
 
Water accounted for 88.93 ± 1.12 % (Mean ± SD, n=9) of the plate constructs 
cultured under static conditions’ wet weight. This was calculated by weighing each 
sample before (wet weight) and after (dry weight) freeze dying through 
lyophilisation. 
 
Water also accounted for 87.32 ± 1.10 % (Mean ± SD, n=9) of the plate constructs 
cultured under semi-static conditions’ wet weight, and 67.49 ± 8.44 % (Mean ± SD, 
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 Structure  
Figure 5.35 Representative H&E stained sections of engineered 15 x 10 mm plate constructs 
cultured under static conditions in standard DMEM. 
 
Figure 5.36 Representative H&E stained sections of engineered 15 x 10 mm plate constructs 
cultured under semi-static conditions in standard DMEM. 
 
Figure 5.37 Representative H&E stained sections of engineered 15 x 10 mm plate constructs 
cultured under rotating wall vessel bioreactor conditions in standard DMEM. 
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Figures 5.35, 5.36 and 5.37 show H&E stained sections of tissue engineered 15 x 10 
mm plate constructs cultured in standard DMEM under static, semi-static and RWV 
bioreactor conditions respectively. Static tissue (figure 5.35) demonstrates a dense, 
cohesive eosin stained extra cellular matrix with a high density but disordered 
distribution of chondrocytes. Some remnants of PGA scaffold fibres also remain and 
can be seen particularly towards the periphery of the tissue. Chondrocyte density 
appears lower and more ordered in figure 5.36 where semi-static culture conditions 
appear to have imparted the beginnings of some zonal organisation to the extra 
cellular matrix. Considerably more lacunae are visible particularly towards the 
centre of the tissue; chondrocytes here show a generally more rounded 
morphology in comparison with a more flattened one towards the tissue periphery.   
 Figure 5.37 illustrates the damage inflicted on large plate constructs culture 
in the RWV bioreactor. For reasons as already stated (section 5.2.1.2 Engineered 
Plates, General Appearance) and discussed in section 6.3 (discussion) the constructs 
were simply not supported in the bioreactor in standard culture medium and so a 
detrimental tumbling effect resulted. The H&E stained tissue in figure 5.37 shows a 
fragmented, porous construct with no visible hierarchical organisation. Areas of 
increased cell density are visible distributed unpredictably throughout the tissue; 
likewise chondrocyte morphology demonstrates no correlation with depth within 
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 Collagen content 
o Type I 
Figure 5.38 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 15 x 10 mm plate constructs cultured under static conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
Figure 5.39 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 15 x 10 mm plate constructs cultured under semi-static conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
Figure 5.40 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 15 x 10 mm plate constructs cultured under RWV bioreactor 
conditions in standard DMEM. Non-specific staining shown inset to image top right. 
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Collagen type I immunohistological staining of large plate constructs cultured under 
static, semi-static and RWV bioreactor conditions can be seen in figures 5.38, 5.39 
and 5.40 respectively.  Collagen type I staining is positive strong throughout the 
construct in all conditions implying high levels of collagen type I are present in each. 
Constructs cultured under static conditions were again of poor quality in the centre, 
the subsequently weak tissue tearing upon cryosectioning. Semi static constructs 
(figure 5.39) demonstrated weaker tissue to the underside however the distribution 
of collagen type I was slightly more zonally organised, with lacunae visible to the 
centre of the construct. Large plate constructs cultured in the rotating wall vessel 
bioreactor were badly damaged, and stained very strongly for collagen type I 
implying there was very high levels of the protein in the tissue. 
 
The non-specific staining controls show low levels of cross-reactivity with other 
components in the matrix except in the case of bioreactor cultured tissue where 
some cross-reactivity has possibly occurred. Remaining fibres of PGA scaffold have 
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Figure 5.41 Mean fold change in COL1α2 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured 
under static and semi-static conditions in standard DMEM. For each condition n=6. No 
change in 18s RNA endogenous control was observed. Error bars represent the standard 
error of the mean (SEM). 
 
 
Figure 5.41 above shows the mean relative expression of COL1α2 in chondrocytes 
seeded to both static and semi-static large plate constructs at termination of culture 
in standard DMEM. Both culture conditions resulted in an increase in COL1α2 
expression, 18.87 and 15.32 x 72 hour reference respectively. Unfortunately due to 
the damage inflicted by the RWV bioreactor insufficient tissue remained at culture 
termination to allow RNA extraction, therefore no PCR data for RWV bioreactor 
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o Type II 
Figure 5.42 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 15 x 10 mm plate constructs cultured under static conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
Figure 5.43 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 15 x 10 mm plate constructs cultured under semi-static conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
Figure 5.44 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 15 x 10 mm plate constructs cultured under RWV bioreactor 
conditions in standard DMEM. Non-specific staining shown inset to image top right. 
 
 
Richard A. Senior                                                                                                                                               2014 
 
 Page 111 
 
Collagen type II immunohistological staining of large plate constructs cultured under 
static, semi-static and RWV bioreactor conditions can be seen in figures 5.42, 5.43 
and 5.44 respectively. Sections of construct from all three culture conditions 
demonstrate positive staining with intense colouration; suggesting high levels of 
collagen type II were present in the extra cellular matrix. Rotating wall vessel 
bioreactor constructs again demonstrate a weak, porous extra cellular matrix. 
Tissue cultured under static and semi-static conditions both possess numerous 
lacunae, with semi-static constructs also demonstrating flattened chondrocyte 
morphology in the peripheral 100 µm and increasingly rounded morphology 
towards the construct centre.  
 
The non-specific staining controls show low levels of cross-reactivity with other 
components in the matrix except in the case of bioreactor cultured tissue where 
some cross-reactivity has possibly occurred. Remaining fibres of PGA scaffold have 
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o QPCR analysis – COL2α1 expression 
 
 
Figure 5.45 Mean fold change in COL2α1 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured 
under static and semi-static conditions in standard DMEM. For each condition n=6. No 
change in 18s RNA endogenous control was observed. Error bars represent the standard 
error of the mean (SEM). 
 
Figure 5.45 above shows the mean relative expression of COL2α1 in chondrocytes 
seeded to both static and semi-static large plate constructs at termination of culture 
in standard DMEM. Both culture conditions resulted in an increase in COL2α1 
expression, 48.15 and 75.48 x 72 hour reference respectively. Again due to the 
damage inflicted by the RWV bioreactor insufficient tissue remained at culture 
termination to allow RNA extraction and subsequent PCR analysis. 
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 Glycosaminoglycan (GAG) content 
o Toluidine and alcian blue staining 
Figure 5.46 Light micrographs showing toluidine blue staining of engineered 15 x 10 mm 
plate constructs cultured under static conditions in standard DMEM. 
 
Figure 5.47 Light micrographs showing toluidine blue staining of engineered 15 x 10 mm 
plate constructs cultured under semi-static conditions in standard DMEM.  
 
Figure 5.48 Light micrographs showing toluidine blue staining of engineered 15 x 10 mm 
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Figure 5.49 Light micrographs showing alcian blue staining of engineered 15 x 10 mm plate 
constructs cultured under static conditions in standard DMEM. 
Figure 5.50 Light micrographs showing alcian blue staining of engineered 15 x 10 mm plate 
constructs cultured under semi-static conditions in standard DMEM. 
Figure 5.51 Light micrographs showing alcian blue staining of engineered 15 x 10 mm plate 
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Figures 5.46 and 5.47 show positive toluidine blue glycosaminoglycan staining in 
large plate constructs cultured in standard DMEM under static and semi-static 
conditions respectively. The deep purple colouring confirms the presence of GAGs 
in the tissue. Both static and semi-static constructs demonstrate a lighter purple 
staining in the construct periphery, with more intense colouration in the construct 
centre suggesting an increased GAG concentration with increasing depth.  Tissue 
cultured under rotating wall vessel bioreactor conditions as shown in figure 5.48 
stained positively but much less intensely for GAG’s with a more blue than purple 
colouration. These observations are reinforced by positive alcian blue staining for 
glycosaminoglycans as shown in figures 5.49, 5.50 and 5.51. Static and semi-
statically cultured tissue (figures 5.49 and 5.50 respectively) demonstrate an intense 
light blue colour throughout the section, this time however with no apparent 
intensity to depth relationship. Tissue cultured under RWV bioreactor conditions as 
shown in Figure 5.51 demonstrates a slightly fainter light blue staining, limited 
largely to the centre of the construct.  
 
Figure 5.52 (overleaf) illustrates graphically the percentage sulphated GAG content 
in the tissue’s wet weight established by dimethylmethylene blue (DMB) assay.  . 
Glycosaminoglycan content of engineered plate constructs cultured under static 
conditions’ wet weight was quantified as 4.18 ± 0.82 % (mean ± SD, n=9) or 0.042 ± 
0.0004 mg per mg wet weight (mean ± SD, n=9) using the method as described in 
section 4.2.4. Glycosaminoglycans also accounted for 8.75 ± 1.47 % (Mean ± SD, 
n=9) or 0.088 ± 0.001 mg per mg wet weight (mean ± SD, n=9) of the plate 
constructs cultured under semi-static conditions’ wet weight and 3.02 ± 0.42 % 
(Mean ± SD, n=2) or 0.030 ± 0.0005 mg per mg wet weight (mean ± SD, n=9) of the 
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o Quantitative dimethylmethylene blue assay 
 
Figure 5.52 Percentage sulphated glycosminoglycan (GAG) content in the digested and 
lyophilised matrix of tissue engineered plate constructs (15 x 10 mm) cultured in standard 
DMEM. Error bars represent the standard error of the mean (SEM), significance level shown 
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o QPCR analysis – ACAN expression 
 
 
Figure 5.53 Fold change in ACAN expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured under 
static and semi-static conditions in standard DMEM. For each condition n=6. No change in 
18s RNA endogenous control was observed. Error bars represent the standard error of the 
mean (SEM), significance level shown ***P < 0.001. 
 
 
Figure 5.53 above shows the mean relative expression of ACAN in chondrocytes 
seeded to both static and semi-static large plate constructs at termination of culture 
in standard DMEM. Static culture conditions resulted in a decrease in ACAN 
expression at 0.62 x 72 hour reference. Noticeably higher than this is the expression 
seen under semi-static conditions of 1.46 x 72 reference sample. Again due to the 
damage inflicted by the RWV bioreactor insufficient tissue remained at culture 
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 Surface zone protein content 
Figure 5.54 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 15 x 10 mm plate constructs cultured under static conditions in 
standard DMEM. Non-specific staining shown inset to image top right. 
 
Figure 5.55 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 15 x 10 mm plate constructs cultured under semi-static 
conditions in standard DMEM. Non-specific staining shown inset to image top right. 
 
Figures 5.54 and 5.55 shows the immunohistolocalisation of surface zone protein 
(SZP) in static and semi-static large plate constructs respectively. Constructs 
cultured under both conditions demonstrate positive but low intensity staining; in 
both cases this is quite diffuse throughout the tissue with no obvious localisation 
within the tissue periphery. Some pericellular localisation of SZP can be seen at 
higher magnification in tissue cultured under semi-static as shown in figure 5.55. 
Constructs cultured under all three conditions showed very little cross reactivity 
with other matrix components in their non-specific staining controls.  
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o QPCR analysis – PRG4 expression 
 
 
Figure 5.56 Fold change in PRG4 expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured under 
static and semi-static conditions in standard DMEM. For each condition n=6. No change in 
18s RNA endogenous control was observed. Error bars represent the standard error of the 
mean (SEM). 
 
Figure 5.56 above shows the mean relative expression of PRG4 in chondrocytes 
seeded to both static and semi-static large plate constructs at termination of culture 
in standard DMEM. A statistically significant difference can be seen between static 
and semi-static conditions, both of which resulted in a large increase in PRG4 
expression, 150.55 and 49.45 x 72 hour reference respectively. Again due to the 
damage inflicted by the RWV bioreactor insufficient tissue remained at culture 
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5.2.2 Tissue engineering using increased viscosity culture medium 
 
 Development of a synovial fluid-like viscosity medium 
As described in section 5.2.1 large plate constructs could not be supported by 
standard cell culture medium in the rotating wall vessel bioreactor. Large constructs 
cultured under these conditions exhibited significant damage, increasing the culture 
medium viscosity was chosen as the ideal way to proceed. Following consultation of 
the literature (please see section 4.2.2) three of the most promising viscosity 
modifying medium additions for the purpose of supporting large plate constructs in 
the rotating wall vessel bioreactor were identified as polyvinylpyrrolidone (PVP), 
dextran and carboxymethylcellulose (CMC). These were further characterised as 




Figure 5.57 Graphical representation of culture medium pH change with increasing PVP, 
dextran and CMC w/v % addition. Error bars represent the standard error of the mean 
(SEM). 
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Figure 5.57 illustrates the change in culture medium pH brought about by the 
addition of a range of w/v percentages of PVP, dextran and CMC. All three additions 
bring about a general increase in pH as the viscosity modifying addition content is 
increased from 1 to 10 w/v %. This is most pronounced where CMC is added with an 
overall increase in pH of 0.42. DMEM containing PVP and dextran  demonstrated an 




Figure 5.58 Graphical representation of culture medium osmolality change with increasing 
PVP, dextran and CMC w/v % addition. Error bars represent the standard error of the mean 
(SEM). 
 
Figure 5.58 illustrates the change in culture medium osmolality brought about by 
the addition of a range of w/v percentages of PVP, dextran and CMC. PVP and CMC 
both bring about a general increase in osmolality as the viscosity modifying addition 
content is increased from 1 to 10 w/v %. The addition of dextran does not appear to 
have any impact on the osmolality of the culture medium. 
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o Rheological analysis 
 
Figure 5.59 Strain sweep analysis illustrating the change in dynamic viscosity with increasing 
shear rate for bovine synovial fluid and 2.5, 5 and 10 w/v % PVP in DMEM. 
 
Figure 5.59 above represents graphically the relationship between shearing rate and 
subsequent dynamic viscosity for bovine synovial fluid and a range of w/v% PVP 
concentrations in DMEM. Bovine synovial fluid again exhibits clear non-Newtonian 
shear thinning behaviour whereby the measured dynamic viscosity decreases with 
increasing shear rate. Concentrations of 5 and 10 w/v% PVP exhibit relatively stable 
Newtonian behaviour – a constant dynamic viscosity over a range of shear rates. 
The dynamic viscosity for a concentration of 10 w/v% PVP begins to decrease at a 
shear rate of approximately 800 whilst that of 2.5 w/v% PVP demonstrates some 
instability in its rheological behaviour below a shear rate of approximately 50. 
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Figure 5.60 Strain sweep analysis illustrating the change in dynamic viscosity with increasing 
shear rate for bovine synovial fluid and 2.5, 5 and 10 w/v % dextran in DMEM. 
 
Figure 5.60 above represents graphically the relationship between shearing rate and 
subsequent dynamic viscosity for bovine synovial fluid and a range of w/v% dextran 
concentrations in DMEM. Bovine synovial fluid exhibits clear non-Newtonian shear 
thinning behaviour whereby the measured dynamic viscosity decreases with 
increasing shear rate. All three concentrations of dextran in DMEM exhibit shear 
thinning behaviour at low shear rates, above a shear rate of approximately 70, 
viscous behaviour becomes more Newtonian with the dynamic viscosity more 
stable.  The lowest concentration of dextran tested (2.5 w/v%) appeared to increase 
again in viscosity past a shear rate of approximately 4000 however this is most likely 
due to experimental error. 
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Figure 5.61 Strain sweep analysis illustrating the change in dynamic viscosity with increasing 
shear rate for bovine synovial fluid and 1, 2.5, 5 and 10 w/v % CMC in DMEM. 
 
Figure 5.61 above represents graphically the relationship between shearing rate and 
subsequent dynamic viscosity for bovine synovial fluid and a range of w/v% CMC 
concentrations in DMEM. Bovine synovial fluid again exhibits clear non-Newtonian 
shear thinning behaviour whereby the measured dynamic viscosity decreases with 
increasing shear rate. All four CMC concentrations exhibit shear thinning behaviour 
to varying degrees, with 1 w/v% CMC demonstrating some instability in its 
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Figure 5.62 the change in dynamic viscosity with time of bovine synovial fluid and 2.5, 5 and 
10 w/v% PVP in DMEM at a constant shear rate of 2000. 
 
Figure 5.62 above illustrates the rheological behaviour of bovine synovial fluid and a 
range of w/v% PVP concentrations in DMEM with time at a constant shear rate of 
2000. With constant shear rate Bovine synovial fluid again exhibits a stable dynamic 
viscosity of 0.0062 PaS. At this constant shear rate a concentration of 2.5 w/v% PVP 
in DMEM exhibits a similar viscosity of 0.0067 PaS, additions of 5 and 10 w/v% 
dextran exhibit viscosities of 0.0267 and 0.1338 PaS respectively. 
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Figure 5.63 The change in dynamic viscosity with time of bovine synovial fluid and 2.5, 5 
and 10 w/v% dextran in DMEM at a constant shear rate of 2000. 
 
Figure 5.63 above illustrates the rheological behaviour of bovine synovial fluid and a 
range of w/v% dextran concentrations in DMEM with time at a constant shear rate 
of 2000. With constant shear rate Bovine synovial fluid exhibits a stable dynamic 
viscosity of 0.0062 PaS. At this constant shear rate a concentration of 5 w/v% 
dextran in DMEM exhibits a very similar viscosity of 0.0061 PaS, additions of 2.5 and 
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Figure 5.64 The change in dynamic viscosity with time of bovine synovial fluid and 1, 2.5, 5 
and 10 w/v% CMC in DMEM at a constant shear rate of 2000. 
 
Figure 5.64 above illustrates the rheological behaviour of bovine synovial fluid and a 
range of w/v% CMC concentrations in DMEM with time at a constant shear rate of 
2000. With constant shear rate Bovine synovial fluid again exhibits a stable dynamic 
viscosity of 0.0062 PaS. At this constant shear rate a concentration of 1 w/v% CMC 
in DMEM exhibits a viscosity of 0.0031 PaS, additions of 2.5, 5 and 10 w/v% CMC 
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Figure 5.65 Average rate of PrestoBlue dye reduction (fluorescence units / minute) over a 
60 minute period, in contact with bovine articular chondrocytes cultured for both 72 hours 
and 144 hours in standard cell culture medium (DMEM + 10 % FCS) and with the presence 
of; 2.5 w/v % PVP, 5 w/v % dextran and 1 w/v % CMC. Error bars represent the standard 
error of the mean (SEM), significance levels shown ** = P < 0.01 and ***P < 0.001. 
 
Figure 5.65 above illustrates the cytotoxic impact (72 hours) on bovine articular 
chondrocytes, and the impact on their longer term proliferation (144 hours) of 
three concentrations of dextran, PVP and CMC in DMEM selected due to their 
similar rheological behaviour to bovine synovial fluid. The impact on cell activity is 
represented through the average rate over a 60 minute period at which 
PrestoBlue™ dye incubated with each sample is reduced by cell metabolic activity. 
Both static and semi static culture conditions are represented, with 
spectrophotometric measurements being taken at 15, 30 and 60 minutes following 
dye application and the average rate of dye reduction in fluorescence units per 
minute being calculated. It should be noted that chondrocytes were sub-confluent 
at 72 hours and confluent at 144 hours following seeding.  
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A noticeable difference at 72 hours after cell seeding is visible between static and 
semi-static samples cultured in standard, unmodified DMEM with no viscosity 
modifying addition. Likewise a similar difference can be seen at 72 hours between 
semi-static samples in standard DMEM and the equivalent samples in DMEM 
containing 5 w/v % dextran. The use of PVP appeared to have a detrimental impact 
on not only cell proliferation but survival.  A less statistically significant but distinct 
difference is visible between semi-static samples  at 144 hours in standard DMEM 
and those in 5 w/v% dextran, likewise semi-static samples at 144 hours in 5 w/v % 
dextran exhibit a noticeably lower average rate of PrestoBlue dye reduction over 60 
minutes than the equivalent samples cultured with 1 w/v % CMC.  
 
 Development of a further increased viscosity medium 
 
An addition of 5 w/v % dextran to the culture medium was found to demonstrate 
similar rheological properties to bovine synovial fluid under physiologically 
representative strain conditions and its experimental use was continued due to this 
point of interest. However the viscosity increase was still not sufficient to provide 
support to large constructs in the rotating wall vessel bioreactor under 
experimental conditions as illustrated in figure 5.66 below, therefore the medium 
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Figure 5.66 Schematic illustrating the rotating wall vessel RPM required to maintain an 
average weight unseeded (PGA scaffold plus PTFE frame) and seeded (construct after 33 
days static culture) large plate construct in a satisfactorily stable orbit in the rotating wall 
vessel bioreactor. The culture medium used was modified with a direct addition of; 2.5, 5, 
7.5, 10, 12.5 or 15 w/v % dextran, successful support is represented by “” and 
unsuccessful “”. 
 
Figure 5.66 above illustrates the relationship between the weight of construct and 
the rotational RPM of the bioreactor required to maintain it in a stable orbit within 
the body of media without tumbling movement, taking into account the effect of 
the viscosity of the culture medium used. It can be seen that an addition directly to 
the culture medium of 5 w/v % dextran does not provide the required construct 
support to prevent tumbling and maintain a low shear culture environment. 
Concentrations tested of 10w/v % and above do provide adequate support at 
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o Rheological analysis 
 
Figure 5.67 Strain sweep analysis illustrating the change in dynamic viscosity with increasing 
shear rate for; bovine synovial fluid, 5 w/v % dextran in DMEM directly added to the 
medium, 6, 7, 8, 9 and 10 w/v% dextran in DMEM produced via the addition of a 40 w/v% 
dextran in PBS stock solution. 
 
Figure 5.67 above represents graphically the relationship between shearing rate and 
subsequent dynamic viscosity for bovine synovial fluid, a 5 w/v% dextran in DMEM 
solution produced via direct addition and a range of w/v% dextran concentrations in 
DMEM produced via the addition of a concentrated 40 w/v% dextran in PBS stock.  
As additions above 5 w/v % presented new difficulties in terms of handling and in 
particular sterilisation the addition instead of a pre-sterilised, 40 w/v % dextran in 
PBS stock solution to achieve the required final w/v % dextran in the culture 
medium was trialled. Bovine synovial fluid again exhibits clear non-Newtonian shear 
thinning behaviour whereby the measured dynamic viscosity decreases with 
increasing shear rate. All concentrations of dextran in DMEM exhibit shear thinning 
behaviour at shear rates below approximately 70, above which viscous behaviour 
becomes more Newtonian with the dynamic viscosity more stable.  An addition 
from 40 w/v% PBS stock of 7 w/v% in DMEM has a comparable dynamic viscosity 
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(taken above shear rate = 70) to that of 5 w/v% in DMEM from direct addition, 
these being 0.0064 and 0.0062 PaS respectively. At a shear rate of 2000 the 
dynamic viscosity of 10 w/v% dextran in DMEM from PBS stock addition is 0.0101 
PaS, 0.00417 PaS higher than that of the 5 w/v% solution produced via direct 




Figure 5.68 Schematic illustrating the rotating wall vessel RPM required to maintain an 
average weight unseeded (PGA scaffold plus PTFE frame) and seeded (construct after 33 
days static culture) large plate construct in a satisfactorily stable orbit in the rotating wall 
vessel bioreactor. The culture medium used was modified with an addition of; 2.5, 5, 7.5, 
10, 12.5 or 15 w/v % dextran from concentrated PBS stock, successful support is 
represented by “” and unsuccessful “”. 
 
Figure 5.68 above illustrates the relationship between the weight of construct and 
the rotational RPM of the bioreactor required to maintain it in a stable orbit within 
the body of media without tumbling movement, taking into account the effect of 
the viscosity of the culture medium used. An addition to the culture medium of 10 
w/v % dextran achieved via the addition of a 40 w/v % dextran in PBS stock to make 
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up 25 % of the final medium volume, although lower in viscosity as illustrated in 
figure 5.67 as the equivalent concentration achieved through direct addition, can be 
seen to still provide the required construct support at a vessel RPM significantly 
lower than the maximum of 45 RPM. Further increasing the dextran content up to 
15 w/v % only resulted in a reduction in the required RPM of around 7.5 RPM, 
whereas below 10 w/v % support of both seeded and unseeded test constructs in 
the bioreactor was not considered satisfactory. 
 
Figure 5.69 The change in dynamic viscosity with time of a 40 w/v% dextran in PBS stock 
solution both pre and post autoclave at 121ᵒC for 15 minutes. The shear rate was kept 
constant at 2000. 
 
Figure 5.69 above illustrates the rheological behaviour of a 40 w/v% dextran in PBS 
stock solution both pre and post autoclave for sterilisation purposes at 121ᵒC for 15 
minutes. Both solutions exhibit slight, consistent shear thickening behaviour over 
the two minute test period equating to a 9.5% and 7.7% increase in viscosity for pre 
and post autoclaved solutions respectively. The average observed difference in 
dynamic viscosity between the two solutions is 0.0879 PaS.  
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Figure 5.70 Average rate of PrestoBlue dye reduction (fluorescence units / minute) over a 
60 minute period, in contact with bovine articular chondrocytes cultured for both 72 hours 
and 144 hours in; standard cell culture medium (DMEM + 10 % FCS) and with the presence 
of directly added 5 w/v % dextran and 10 w/v % dextran added from 40 w/v % stock 
solution. Error bars represent the standard error of the mean (SEM), significance levels 
shown ** = P < 0.01 and *** = P < 0.001. 
 
Figure 5.70 above illustrates the cytotoxic impact (72 hours) on bovine articular 
chondrocytes, and the impact on their longer term proliferation (144 hours) of 5 
w/v % dextran added directly to the culture medium, and 10 w/v % achieved via the 
addition of a 40 w/v % dextran in PBS stock to make up 25 % of the final medium 
volume. The impact on cell activity is again represented through the average rate 
over a 60 minute period at which PrestoBlue™ dye incubated with each sample is 
reduced by cell metabolic activity. Both static and semi static culture conditions are 
represented, with spectrophotometric measurements being taken at 15, 30 and 60 
minutes following dye application and the average rate of dye reduction in 
fluorescence units per minute being calculated. 
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A statistically significant difference at 72 hours after cell seeding is visible between 
static samples cultured in DMEM containing 5 w/v % dextran and those cultured in 
DMEM containing 10 w/v % dextran from a stock solution addition. A very similar 
difference can be seen between the same samples cultured under semi-static 
conditions also at 72 hours. A less statistically significant but noticeable difference 
can be seen at 144 hours after cell seeding between static samples cultured in 
DMEM containing 5 w/v % dextran and those cultured in DMEM containing 10 w/v 
% dextran, again with a similar trend being visible at 144 hours between the same 
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o Dissolved Oxygen Tension (DOT) 
 
Figure 5.71 Graphical representation of percentage dissolved oxygen tension (DOT) in 
standard DMEM, and DMEM containing 2.5, 5 and 10 w/v% dextran produced via the 
addition of 40 w/v% dextran in PBS stock after incubation at 37ᵒC for 24 hours.  Error bars 
represent the standard error of the mean (SEM), significance level shown ***P < 0.001. 
 
Figure 5.71 above illustrates the change in dissolved oxygen tension (DOT) brought 
about by the addition of three different dextran concentrations. Dissolved oxygen 
levels can be seen to fall under both static and semi-static conditions as the w/v% 
dextran content increases. Placing samples cultured in standard DMEM under semi-
static agitation resulted in no statistically significant change in dissolved oxygen 
tension. A statistically significant increase in dissolved oxygen tension (*** = P < 
0.001) was seen between static and semi-static samples of DMEM containing all 
three percentage additions of dextran (not shown in figure for reasons of clarity). Of 
particular note is the decrease in DOT seen between both static and semi-static 
samples of unmodified DMEM, with the addition of 5 w/v % dextran and then again 
with the addition of 10 w/v % dextran.      
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 Tissue engineering with increased viscosity culture medium 
o Engineered pins in DMEM + 5 w/v % dextran 
 
 General appearance 
Tissue engineered articular cartilage pins cultured under semi-static and RWV 
bioreactor conditions in DMEM containing 5 w/v % dextran exhibited significant 
levels of contraction in their volume between day 0 and day 33 (please see figure 
5.72). Static constructs increased in their volume over this period, however all 
constructs exhibited relatively poor mechanical integrity, being difficult to handle 
and process for post-culture analysis. All constructs also lacked the same 
cartilaginous surface sheen observed in tissue cultured in standard DMEM, 
appearing dull brown in colour and slightly gelatinous to the touch. 
 
 Dimensions and weight 
The diameter of pin constructs cultured under static conditions was 7.19 ± 0.035 
mm (Mean ± SD, n=6), the thickness was 1.07 ± 0.038 mm (Mean ± SD, n=6) and the 
wet weight was 22.6 ± 2.41 mg (Mean ± SD, n=12). 
The diameter of pin constructs cultured under semi-static conditions was 
5.33 ± 0.033 mm (Mean ± SD, n=6), the thickness was 0.82 ± 0.049 mm (Mean ± SD, 
n=6) and the wet weight was 17.0 ± 1.69 mg (Mean ± SD, n=12). 
The diameter of pin constructs cultured in the rotating wall vessel (RWV) 
bioreactor was 3.77 ± 0.073 mm (Mean ± SD, n=6), the thickness was 0.45 ± 0.071 
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Figure 5.72 Graphical representation of percentage change in pin construct volume 
between day 0 and 33 under static, semi-static and RWV bioreactor conditions in DMEM 
plus 5 w/v% dextran. Error bars represent the standard error of the mean (SEM). 
 
Figure 5.72 above represents graphically the percentage volume change seen in 
constructs cultured under static (54.4 %), semi-static (-35.1 %) and rotating wall 
vessel bioreactor culture (-82.1 %) in DMEM containing 5 w/v% dextran. From the 
initial standard volume of 0.028 cm3, mean percentage volume increase or decrease 
is shown.    
 Water content 
Water accounted for 87.75 ± 1.40 % (Mean ± SD, n=12) of the pin constructs 
cultured under static conditions’ wet weight. This was calculated by weighing each 
sample before (wet weight) and after (dry weight) freeze dying through 
lyophilisation. 
 
Water also accounted for 80.70 ± 6.49 % (Mean ± SD, n=12) of the pin constructs 
cultured under semi-static conditions’ wet weight, and 31.28 ± 10.89 % (Mean ± SD, 
n=12) of the pin constructs cultured in the RWV bioreactors’ wet weight. 
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 Structure 
Figure 5.73 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
cultured under static conditions in DMEM containing 5 w/v% dextran.  
 
Figure 5.74 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
cultured under semi static conditions in DMEM containing 5 w/v% dextran.  
 
Figure 5.75 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
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Figures 5.73, 5.74 and 5.75 illustrate H&E staining of pin constructs cultured under 
static, semi-static and rotating wall vessel bioreactor conditions in DMEM 
containing 5 w/v% dextran respectively.  The cell density was again high in all 
constructs, with the vast majority of cells possessing a rounded morphology. 
Constructs from all three conditions demonstrate a large degree of tissue 
heterogeneity, with very little zonal organisation of the extra cellular matrix visible. 
A small but visibly distinctive superficial layer containing more flattened 
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 Collagen content 
o Type I 
Figure 5.76 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in DMEM 
containing 5 w/v% dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.77 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under semi static conditions in 
DMEM containing 5 w/v% dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.78 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under RWV bioreactor conditions in 
DMEM containing 5 w/v% dextran. Non-specific staining shown inset to image top right. 
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Collagen type I immunohistological staining of pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM containing 5 w/v % dextran 
can be seen on the previous page in figures 5.76, 5.77 and 5.78 respectively.  
Collagen type I staining is positive but weak under all culture conditions implying 
low levels of collagen type I are present in each. The non-specific staining controls 
show some cross-reactivity with other intra or pericellular components; remaining 
fibres of PGA scaffold have also stained in most cases. 
 
o QPCR analysis – COL1α2 expression 
 
 
Figure 5.79 Fold change in COL1α2 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under 
static, semi-static and RWV bioreactor conditions in DMEM + 5 w/v% dextran (n=6 for 
each). No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance levels shown ** = P < 0.01 and ***P < 0.001.  
 
Figure 5.79 above shows the relative expression of COL1α2 between static, semi-
static and RWV bioreactor constructs at termination of culture at 6.45, 4.63 and 
1.18 x 72 hour reference sample respectively. 
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o Type II 
Figure 5.80 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in DMEM 
containing 5 w/v% dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.81 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in DMEM 
containing 5 w/v% dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.82 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in DMEM 
containing 5 w/v% dextran. Non-specific staining shown inset to image top right. 
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Collagen type II immunohistological staining of pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM containing 5 w/v % dextran 
can be seen on the previous page in figures 5.80, 5.81 and 5.82 respectively.  
Staining is positive under all culture conditions implying low levels of collagen type II 
are present in each; however the colouring is very heterogeneous.  Non-specific 
staining controls again show some cross-reactivity with other intra or pericellular 
components; remaining fibres of PGA scaffold have also stained in most cases. 
 
o QPCR analysis – COL2α1 expression 
 
 
Figure 5.83 Fold change in COL2α1 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under 
static, semi-static and RWV bioreactor conditions in DMEM + 5 w/v% dextran (n=6 for 
each). No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown ***P < 0.001. 
 
Figure 5.83 above shows the relative expression of COL2α1 between static, semi-
static and RWV bioreactor constructs at termination of culture at 142.4, 58 and 0.64 
x 72 hour reference sample respectively. 
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 Glycosaminoglycan (GAG) content 
o Toluidine and alcian blue staining 
Figure 5.84 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under static conditions in DMEM containing 5 w/v% dextran. 
 
Figure 5.85 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under static conditions in DMEM containing 5 w/v% dextran. 
 
Figure 5.86 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under static conditions in DMEM containing 5 w/v% dextran. 
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Figure 5.87 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 
constructs cultured under static conditions in DMEM containing 5 w/v% dextran. 
 
Figure 5.88 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 
constructs cultured under semi static conditions in DMEM containing 5 w/v% dextran. 
 
Figure 5.89 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 
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Figures 5.84, 5.85 and 5.86 on page 139 show toluidine blue stained static, semi-
static and RWV bioreactor pin construct sections respectively. A strong, positive, 
light-purple staining for glycosaminoglycans (GAG’s) can be seen in static and semi-
static sections, with a slightly less intense colouration in RWV bioreactor sections 
confirming the presence of GAGs in all tissue. This observation further backed up by 
figure 5.87, 5.88 and 5.89 where the same sections are stained with Alcian blue. 
Toluidine blue staining demonstrates relative homogeneity under all culture 
conditions with sporadic localisation of more intense staining around remaining 
PGA scaffold fibres; this is most pronounced in semi-static constructs as shown in 
figure 5.85. 
 
Figure 5.90 (overleaf) illustrates graphically the percentage sulphated GAG content 
in the tissue’s wet weight established by dimethylmethylene blue (DMB) assay. 
Again glycosaminoglycan content could not be shown as mg GAG per half (6 mm ø 
pin) or quarter (15 x 10 mm plate) construct analysed due to the variation in tissue 
wet weight to begin with.  
 Glycosaminoglycan content of engineered pin constructs cultured under 
static conditions’ wet weight was quantified as 1.83 ± 0.11 % (mean ± SD, n=12) or 
0.018 ± 0.006 mg per mg wet weight (mean ± SD, n=12) using the method as 
described in section 4.2.4. Glycosaminoglycans also accounted for 1.52 ± 0.38 % 
(Mean ± SD, n=12) or 0.015 ± 0.004 mg per mg wet weight (Mean ± SD, n=12) of the 
pin constructs cultured under semi-static conditions and 1.24 ± 0.27 % (Mean ± SD, 
n=12) or 0.011 ± 0.0005 (Mean ± SD, n=12) mg per mg wet weight of the pin 
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o Quantitative dimethylmethylene blue assay 
 
Figure 5.90 Percentage sulphated glycosminoglycan (GAG) content in the digested and 
lyophilised matrix of tissue engineered pin constructs (6 mm ø) cultured in DMEM + 5 w/v% 
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o QPCR analysis – ACAN expression 
Figure 5.91 Fold change in ACAN expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM + 5 w/v% dextran. For each condition 
n=6. No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown *** = P < 0.001. 
 
Figure 5.91 above illustrates the relative expression of ACAN seen between static, 
semi-static and RWV bioreactor pin construct chondrocytes cultured in DMEM 
containing 5 w/v % dextran at the end of the culture period.  At day 33 
chondrocytes seeded to RWV bioreactor constructs’ expression of ACAN had 
reduced to 0.04 x 72 hour reference expression. This and the 0.14 x reference 
sample reduction demonstrated by semi-static construct chondrocytes is 
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 Surface zone protein content 
Figure 5.92 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 6 mm Ø pin constructs cultured under static conditions in 
DMEM containing 5 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.93 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 6 mm Ø pin constructs cultured under RWV bioreactor 
conditions in DMEM containing 5 w/v % dextran. Non-specific staining shown inset to 
image top right 
 
Figures 5.92 and 5.93 shows the immunohistolocalisation of surface zone protein 
(SZP) in static and RWV bioreactor 6 mm Ø pin constructs respectively. Constructs 
cultured under both conditions demonstrate positive but low intensity staining 
throughout. In both cases this is quite diffuse however some localisation within the 
tissue’s periphery is visible. All three figures show very little cross reactivity with 
other matrix components in their non-specific staining controls. Unfortunately no 
results are available for semi-static culture conditions due to the poor quality of the 
cryopreserved tissue.  
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o QPCR analysis – PRG4 expression 
 
 
Figure 5.94 Fold change in PRG4 expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM + 5 w/v% dextran. For each condition 
n=6. No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown ***P < 0.001. 
 
Figure 5.94 above shows the mean relative expression of PRG4 in chondrocytes 
seeded to static, semi-static and RWV bioreactor 6 mm Ø pin constructs at 
termination of culture in DMEM containing 5 w/v % dextran. Statistically significant 
differences in expression can be seen between RWV bioreactor and both static and 
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Engineered pins in DMEM + 10 w/v % dextran 
 
 General appearance 
Tissue engineered articular cartilage pins cultured under semi-static and RWV 
bioreactor conditions in DMEM containing 10 w/v % dextran still exhibited 
noticeable levels of contraction in their volume between day 0 and day 33 (please 
see figure 5.95). Static constructs again demonstrated a volume increase over this 
period, however all constructs exhibited very poor mechanical integrity, their 
almost gelatinous consistency making them difficult to handle and process for post-
culture analysis. No one construct from any culture environment possessed the 
cartilaginous surface sheen observed in tissue cultured in standard DMEM, 
appearing a matt, dull brown in colour. 
 
 Dimensions and weight 
The diameter of pin constructs cultured under static conditions was 6.74 ± 0.46 mm 
(Mean ± SD, n=9), the thickness was 1.19 ± 0.10 mm (Mean ± SD, n=9) and the wet 
weight was 37.35 ± 7.47 mg (Mean ± SD, n=12). 
The diameter of pin constructs cultured under semi-static conditions was 
6.06 ± 0.18 mm (Mean ± SD, n=6), the thickness was 0.95 ± 0.059 mm (Mean ± SD, 
n=6) and the wet weight was 44.67 ± 9.92 mg (Mean ± SD, n=12). 
The diameter of pin constructs cultured in the rotating wall vessel (RWV) 
bioreactor was 3.25 ± 0.59 mm (Mean ± SD, n=6), the thickness was 0.89 ± 0.028 
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Figure 5.95 Graphical representation of percentage change in pin construct volume 
between day 0 and 33 under static, semi-static and RWV bioreactor conditions in DMEM 
containing 10 w/v% dextran. Error bars represent the standard error of the mean (SEM). 
 
Figure 5.95 above represents graphically the percentage volume change seen in 
constructs cultured under static (51.5 %), semi-static (-2.7 %) and rotating wall 
vessel bioreactor culture (-72.9 %) in DMEM containing 10 w/v % dextran. From the 
initial standard volume of 0.028 cm3, mean percentage volume increase or decrease 
is shown. 
 
 Water content 
Water accounted for 90.57 ± 2.69 % (Mean ± SD, n=12) of the pin constructs 
cultured under static conditions’ wet weight. This was calculated by weighing each 
sample before (wet weight) and after (dry weight) freeze dying through 
lyophilisation. 
 
Water also accounted for 65.45 ± 14.76 % (Mean ± SD, n=12) of the pin constructs 
cultured under semi-static conditions’ wet weight, and 66.99 ± 13.62 % (Mean ± SD, 
n=12) of the pin constructs cultured in the RWV bioreactors’ wet weight. 
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 Structure 
Figure 5.96 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
cultured under static conditions in DMEM containing 10 w/v % dextran. 
 
Figure 5.97 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
cultured under semi static conditions in DMEM containing 10 w/v % dextran. 
Figure 5.98 Representative H&E stained sections of engineered 6 mm Ø pin constructs 
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Figures 5.96, 5.97 and 5.98 illustrate H&E staining of large plate constructs cultured 
under static, semi-static and rotating wall vessel bioreactor conditions respectively 
in DMEM containing 10 w/v % dextran. Constructs cultured under static and semi-
static conditions as shown in figures 5.96 and 5.97 show a very porous, poorly 
coherent structure, only staining very lightly with eosin this suggests low levels of a 
poor quality matrix are present. The cell density was again high in all constructs as 
demonstrated by a large number of haematoxylin stained nuclei. Again the vast 
majority of cells possess a rounded morphology. Constructs cultured under static 
and semi-static conditions show a large degree of tissue heterogeneity, with no 
apparent zonal organisation of the extra cellular matrix visible. RWV bioreactor 
constructs demonstrate not only positive, intense eosin extra cellular matrix 
staining but significantly more mechanical integrity, the damage to the sections 
visible in figure 5.98 most likely resulting from the cryosectioning process. A small 
but visibly distinctive superficial layer containing more flattened chondrocytes is 
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 Collagen content 
o Type I 
Figure 5.99 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in DMEM 
containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.100 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in DMEM 
containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.101 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in DMEM 
containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
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Collagen type I immunohistological staining of pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM containing 10 w/v % dextran 
can be seen on the previous page in figures 5.99, 5.100 and 5.101 respectively.  
Collagen type I staining is positive but very weak under all culture conditions 
implying low levels of collagen type I are present in each, particularly static and 
semi-static sections. Only RWV bioreactor tissue demonstrates any coherent 
structure, with collagen type I appearing mainly localised in a region 100 – 200 µm 
deep around the construct periphery.  Non-specific staining controls show some 
cross-reactivity with other intra or pericellular components; whilst remaining fibres 
of PGA scaffold have also stained and are most visible in figures 5.99 and 5.100, 
static and semi-static culture conditions respectively. 
 
 
o QPCR analysis – COL1α2 expression 
 
Unfortunately no qPCR data for type I collagen in 6 mm Ø pin constructs in DMEM 
plus 10 w/v% dextran could be generated due to insufficient volumes of RNA that 
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o Type II 
Figure 5.102 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under static conditions in DMEM 
containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.103 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under semi static conditions in 
DMEM containing 10 w/v % dextran. Non-specific staining shown inset to image top right  
Figure 5.104 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 6 mm Ø pin constructs cultured under RWV bioreactor conditions in 
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Collagen type II immunohistological staining of pin constructs cultured in DMEM 
containing 10 w/v % dextran can be seen on the previous page in figures 5.102, 
5.103 and 5.104 respectively.  Staining is very weak in static and semi-statically 
cultured tissue, no more positive staining over and above the non-specific cross 
reactivity apparent in inserted control micrographs is visible. Again only RWV 
bioreactor tissue demonstrates any coherent structure, with positive staining 
appearing localised in a region 100 – 200 µm deep around the construct periphery.   
 
o QPCR analysis – COL2α1 expression 
 
 
Figure 5.105 Fold change in COL2α1 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under 
static, semi-static and RWV bioreactor conditions in DMEM + 10 w/v% dextran (n=6 for 
each). No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown ***P < 0.001. 
 
Figure 5.105 above shows the relative expression of COL2α1 between static, semi-
static and RWV bioreactor constructs at termination of culture at 247.4 and 11.4  x 
72 hour reference sample respectively. No qPCR data for SS conditions available. 
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 Glycosaminoglycan (GAG) analysis 
o Toluidine and alcian blue staining 
Figure 5.106 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under static conditions in DMEM containing 10 w/v % dextran. 
 
Figure 5.107 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under semi static conditions in DMEM containing 10 w/v % dextran. 
 
Figure 5.108 Light micrographs showing toluidine blue staining of engineered 6 mm Ø pin 
constructs cultured under RWV bioreactor conditions in DMEM containing 10 w/v % 
dextran. 
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Figure 5.109 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 
constructs cultured under static conditions in DMEM containing 10 w/v % dextran. 
 
Figure 5.110 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 
constructs cultured under semi static conditions in DMEM containing 10 w/v % dextran. 
 
Figure 5.111 Light micrographs showing alcian blue staining of engineered 6 mm Ø pin 








Richard A. Senior                                                                                                                                               2014 
 
 Page 162 
 
Figures 5.106, 5.107 and 5.108 on page 154 show toluidine blue stained static, semi-
static and RWV bioreactor pin construct sections respectively. A fairly strong, 
positive, light-purple staining for glycosaminoglycans (GAG’s) can be seen in static 
and semi-static sections confirming the presence of GAGs in the tissue.  A much less 
positive staining can be seen in RWV bioreactor sections, where the colouring is 
much more blue than purple. This observation further backed up by figures 5.109, 
5.110 and 5.111 on page 155 where the same sections are stained with Alcian blue. 
Toluidine blue staining in all conditions, static, semi-static and RWV bioreactor 
sections is relatively homogeneous throughout the patchy tissue that is present, 
although all sections exhibit a highly porous and discontinuous matrix.  
 
Figure 5.112 (overleaf) illustrates graphically the percentage sulphated GAG content 
in the tissue’s wet weight established by dimethylmethylene blue (DMB) assay.   
 Glycosaminoglycan content of engineered pin constructs cultured under 
static conditions’ wet weight was quantified as 1.19 ± 0.57 % (mean ± SD, n=12) or 
0.010 ± 0.0036 mg per mg wet weight (mean ± SD, n=12) using the method as 
described in section 4.2.4. Glycosaminoglycans also accounted for 0.80 ± 0.51 % 
(Mean ± SD, n=12) or 0.007 ± 0.0034 mg per mg wet weight (Mean ± SD, n=12) of 
the pin constructs cultured under semi-static conditions and 1.30 ± 0.24 % (Mean ± 
SD, n=12) or 0.013 ± 0.0003 (Mean ± SD, n=12) mg per mg wet weight of the pin 
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o Quantitative dimethylmethylene blue assay 
 
Figure 5.112 Percentage sulphated glycosminoglycan (GAG) content in the digested and 
lyophilised matrix of tissue engineered pin constructs (6 mm ø) cultured in DMEM + 10 w/v 
% dextran. Error bars represent the standard error of the mean (SEM), significance level 
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o QPCR analysis – ACAN expression 
 
Figure 5.113 Fold change in ACAN expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM + 10 w/v% dextran. For each condition 
n=6. No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown ** = P < 0.01. 
 
Figure 5.113 above illustrates the relative expression of ACAN seen between static, 
semi-static and RWV bioreactor pin construct chondrocytes cultured in DMEM 
containing 10 w/v% dextran at the end of the culture period.  At day 33 
chondrocytes seeded to RWV bioreactor constructs’ expression of ACAN had 
reduced to 0.19 x 72 hour reference expression. This is statistically significantly 
lower than the 0.60 x reduction demonstrated by static construct chondrocytes. 
Unfortunately again due to insufficient quantities of RNA being available at the 
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 Surface zone protein content 
Figure 5.114 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 6 mm Ø pin constructs cultured under static conditions. Non-
specific staining shown inset to image top right. 
 
Figure 5.115 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 6 mm Ø pin constructs cultured under semi-static conditions. 
Non-specific staining shown inset to image top right. 
 
Figure 5.116 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 6 mm Ø pin constructs cultured under RWV bioreactor 
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Figures 5.114, 5.115 and 5.116 shows the immunohistolocalisation of surface zone 
protein (SZP) in static, semi-static and RWV bioreactor 6 mm Ø pin constructs 
respectively. Constructs cultured under all three conditions demonstrate positive 
but very low intensity, diffuse staining throughout. Although there is little tissue 
remaining, static and semi-static sections show no peripheral localisation of what 
SZP staining can be seen Rotating wall vessel bioreactor tissue as can be seen in 
figure 5.116 does demonstrate to a minor extent some SZP localisation in the 
peripheral layers of the construct. All three figures show very little cross reactivity 
with other matrix components in their non-specific staining controls.  
 
o QPCR analysis – PRG4 expression 
 
 
Figure 5.117 Fold change in PRG4 expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 6 mm Ø pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM + 10 w/v% dextran. For each condition 
n=6. No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown ** = P < 0.01. 
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Figure 5.117 on the previous page shows the mean relative expression of PRG4 in 
chondrocytes seeded to static, semi-static and RWV bioreactor 6 mm Ø pin 
constructs at termination of culture in DMEM containing 10 w/v % dextran. A 
statistically significant difference in expression can be seen between static and RWV 
bioreactor conditions, at 1.71 and 3.18 x 72 hour reference respectively. 
Unfortunately again due to insufficient quantities of RNA being available at the 
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Engineered plates in DMEM + 5 w/v % dextran 
 
 General appearance 
Static constructs had relatively poor mechanical integrity but were still easily 
released from the PTFE retention frames upon removal of the nylon sutures. The 
constructs barely held their shape whilst being handled with tweezers, lacking 
rigidity and the same cartilaginous ‘crunch’ when being divided up with a scalpel 
blade at culture termination that was seen in constructs cultured in standard 
DMEM. Constructs cultured under semi-static conditions were much better in terms 
of ease of handling, apparently possessing more mechanical integrity making them 
much easier to process for post-culture analysis. Large plate constructs cultured in 
the rotating wall vessel bioreactor were unfortunately found to be still too heavy to 
be sustained in a stable orbit within the culture medium with the addition of 5 
w/v% dextran. Unavoidable construct ‘tumbling’ again resulted and contact with 
the vessel walls occurred, for this reason further experimentation along this line 
was not pursued. 
 
 Construct weight 
The wet weight of 15 x 10 mm plate constructs cultured under static conditions was 
145 ± 2.5 mg (Mean ± SD, n=9) and under semi-static conditions 137 ± 3.9 mg 
(Mean ± SD, n=9). 
 
 Water content 
Water accounted for 89.53 ± 1.49 % (Mean ± SD, n=9) of the plate constructs 
cultured under static conditions’ wet weight. This was calculated by weighing each 
sample before (wet weight) and after (dry weight) freeze dying through 
lyophilisation. 
 
Water also accounted for 85.33 ± 5.43 % (Mean ± SD, n=9) of the plate constructs 
cultured under semi-static conditions’ wet weight. 
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 Structure 
Figure 5.118 Representative H&E stained sections of engineered 15 x 10 mm plate 
constructs cultured under static conditions in DMEM containing 5 w/v % dextran. 
 
Figure 5.119 Representative H&E stained sections of engineered 15 x 10 mm plate 
constructs cultured under semi-static conditions in DMEM containing 5 w/v % dextran. 
 
Figures 5.118 and 5.119 above illustrate H&E staining of large plate constructs 
cultured under static and semi-static conditions respectively in DMEM containing 5 
w/v % dextran. Constructs cultured under both conditions demonstrate a fragile, 
weakly stained matrix with a porous, poorly coherent structure. The cell density in 
both cases is relatively high as demonstrated by a large number of haematoxylin 
stained nuclei, however acellular areas of extra cellular matrix are visible. Tissue 
cultured under both conditions show a large degree of heterogeneity, but still with 
no apparent zonal organisation visible.  
 
 
Richard A. Senior                                                                                                                                               2014 
 
 Page 170 
 
 Collagen content 
o Type I 
Figure 5.120 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 15 x 10 mm plate constructs cultured under static conditions in 
DMEM containing 5 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.121 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 15 x 10 mm plate constructs cultured under semi-static conditions in 
DMEM containing 5 w/v % dextran. Non-specific staining shown inset to image top right. 
  
Figures 5.120 and 5.121 above illustrate collagen type I immunohistological staining 
of plate constructs cultured under static and semi-static conditions respectively in 
DMEM containing 5 w/v % dextran. In both cases staining is positive suggesting 
collagen I presence throughout the tissue, distribution is relatively homogenous in 
areas where the fragile tissue remained after the cryosectioning process. Non-
specific staining controls show some cross-reactivity with other intra or pericellular 
components; whilst remaining fibres of PGA scaffold have also stained and are most 
visible in figure 5.120. 
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o QPCR analysis – COL1α2 expression 
 
 
Figure 5.122 Fold change in COL1α2 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured 
under static and semi-static conditions in DMEM + 5 w/v% dextran. For each condition n=6. 
No change in 18s RNA endogenous control was observed. Error bars represent the standard 
error of the mean (SEM). 
 
 
Figure 5.122 above shows the relative expression of COL1α2 between static and 
semi-static constructs at culture termination, 3.12 and 3.51 x 72 hour reference 
sample respectively. No RWV bioreactor constructs were run in this instance due to 
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o Type II 
Figure 5.123 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 15 x 10 mm plate constructs cultured under static conditions in 
DMEM containing 5 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.124 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 15 x 10 mm plate constructs cultured under semi static conditions in 
DMEM containing 5 w/v % dextran. Non-specific staining shown inset to image top right. 
 
 
Figures 5.123 and 5.124 above illustrate collagen type II immunohistological staining 
of plate constructs cultured under static and semi-static conditions respectively in 
DMEM containing 5 w/v % dextran. Sections of construct from both culture 
conditions demonstrate positive staining with relatively homogeneous, intense 
colouration; suggesting high levels of collagen type II were present in the extra 
cellular matrix. The non-specific staining controls show low levels of cross-reactivity 
with other components in the matrix, Remaining fibres of PGA scaffold have stained 
in most cases. 
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o QPCR analysis – COL2α1 expression 
 
 
Figure 5.125 Fold change in COL2α1 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured 
under static and semi-static conditions in DMEM + 5 w/v% dextran. For each condition n=6. 
No change in 18s RNA endogenous control was observed. Error bars represent the standard 
error of the mean (SEM), significance level shown ** = P < 0.01. 
 
Figure 5.125 above shows the relative COL2α1 expression in chondrocytes seeded 
to static and semi-static constructs at the termination of culture. Statically seeded 
chondrocytes demonstrated 0.69 x the relative expression seen in the 72 hour 
reference sample, with a statistically significant reduction to 0.21 x 72 hour 
reference sample in semi-statically seeded chondrocytes. Unfortunately no qPCR 
data for RWV bioreactor conditions is available again for the aforementioned 
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 Glycosaminoglycan (GAG) content 
o Toluidine and alcian blue staining 
Figure 5.126 Light micrographs showing toluidine blue staining of engineered 15 x 10 mm 
plate constructs cultured under static conditions in DMEM containing 5 w/v % dextran. 
 
Figure 5.127 Light micrographs showing toluidine blue staining of engineered 15 x 10 mm 




Figures 5.126 and 5.127 show positive toluidine blue glycosaminoglycan staining in 
large plate constructs cultured in DMEM containing 5 w/v% dextran under static 
and semi-static conditions respectively. The deep purple colouring confirms the 
presence of GAGs in the tissue, with both static and semi-static constructs 
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Figure 5.128 Light micrographs showing alcian blue staining of engineered 15 x 10 mm plate 
constructs cultured under static conditions in DMEM containing 5 w/v % dextran. 
  
Figure 5.129 Light micrographs showing alcian blue staining of engineered 15 x 10 mm plate 
constructs cultured under semi static conditions in DMEM containing 5 w/v % dextran. 
   
 
Figures 5.128 and 5.129 show positive alcian blue glycosaminoglycan staining in 
large plate constructs cultured in DMEM containing 5 w/v% dextran under static 
and semi-static conditions respectively. The intense, light blue colouring confirms 
the presence of GAGs in the tissue, with both static and semi-static constructs 
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o Quantitative dimethylmethylene blue assay 
 
Figure 5.130 Percentage sulphated glycosminoglycan (GAG) content in the digested and 
lyophilised matrix of tissue engineered plate constructs (15 x 10 mm) cultured in DMEM + 5 
w/v % dextran Error bars represent the standard error of the mean (SEM), significance level 
shown ** = P < 0.01. 
 
Figure 5.130 on the previous page show the percentage and mg per mg wet weight 
GAG content in plate constructs cultured in DMEM containing 5 w/v % dextran. 
GAG content of constructs cultured under static conditions’ wet weight was 
quantified as 3.22 ± 0.55 % (mean ± SD, n=9) or 0.032 ± 0.0009 mg per mg wet 
weight (mean ± SD, n=9) using the method as described in section 4.2.4. GAGs also 
accounted for 4.74 ± 0.89 % (Mean ± SD, n=9) or 0.047 ± 0.0020 mg per mg wet 
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o QPCR analysis – ACAN expression 
 
 
Figure 5.131 Fold change in ACAN expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured under 
static and semi-static conditions in DMEM + 5 w/v% dextran (n=6 for each). No change in 
18s RNA endogenous control was observed. Error bars represent the standard error of the 
mean (SEM), significance level shown * = P < 0.05. 
 
Figure 5.131 above shows the relative expression of ACAN between static and semi-
static constructs at termination of culture at 0.13 and 0.05 x 72 hour reference 
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 Surface zone protein content 
Figure 5.132 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 15 x 10 mm plate constructs cultured under static conditions in 
DMEM containing 5  w/v % dextran. Non-specific staining shown inset to image top right 
 
Figure 5.133 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 15 x 10 mm plate constructs cultured under semi-static 
conditions in DMEM containing 5  w/v % dextran. Non-specific staining shown inset to 
image top right. 
 
Figures 5.132 and 5.133 show the immunohistolocalisation of surface zone protein 
(SZP) in large plate constructs cultured under static and semi-static conditions 
respectively. Constructs cultured under both conditions demonstrate positive but 
very low intensity, diffuse staining. Some pericellular localisation of SZP can been 
seen at higher magnification in tissue cultured under semi-static conditions as 
shown in figure 5.133, no localisation of SZP can be seen in the tissue periphery 
under either culture condition. Constructs cultured under both conditions showed 
very little cross reactivity with other matrix components in their non-specific 
staining controls.  
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o QPCR analysis – PRG4 expression 
 
 
Figure 5.134 Fold change in PRG4 expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured under 
static and semi-static conditions in DMEM + 5 w/v% dextran. For each condition n=6. No 
change in 18s RNA endogenous control was observed. Error bars represent the standard 
error of the mean (SEM), significance level shown ** = P < 0.01. 
 
Figure 5.134 above shows the mean relative expression of PRG4 in chondrocytes 
seeded to static and semi-static large plate constructs at termination of culture in 
DMEM containing 5 w/v% dextran. A statistically significant difference in expression 
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Engineered plates in DMEM + 10 w/v % dextran 
 
 General appearance 
Large plate constructs cultured under all culture conditions, static, semi-static and 
RWV bioreactor, exhibited a very poor condition when processed at the end of the 
culture period. All tissue was of particularly poor mechanical integrity, very easily 
deforming and tearing upon handling in any circumstances. All constructs were very 
easily removed from the PTFE retention frames even without full removal of the 
nylon sutures, however did not remain intact in the process. There was no real 
resemblance in any of the cultured tissue to native articular cartilage, appearing dull 
brown in colour and lacking a cartilaginous ‘crunch’ when being divided up with a 
scalpel blade at culture termination.   
 
 Construct weight 
The wet weight of 15 x 10 mm plate constructs cultured under static conditions was 
153 ± 9.6 mg (Mean ± SD, n=10), under semi-static conditions 142 ± 7.6 mg (Mean ± 
SD, n=10) and in the rotating wall vessel bioreactor 73 ±  5.2 mg (Mean ± SD, n=9). 
 
 Water content 
Water accounted for 49.57 ± 9.85 % (Mean ± SD, n=10) of the plate constructs 
cultured under static conditions’ wet weight. This was calculated by weighing each 
sample before (wet weight) and after (dry weight) freeze dying through 
lyophilisation. 
 
Water also accounted for 33.54 ± 6.24 % (Mean ± SD, n=10) of the plate constructs 
cultured under semi-static conditions’ wet weight, and 53.98 ± 6.88 % (Mean ± SD, 
n=9) of the plate constructs cultured in the RWV bioreactors’ wet weight. 
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 Structure 
Figure 5.135 Representative H&E stained sections of engineered 15 x 10 mm plate 
constructs cultured under static conditions in DMEM containing 10 w/v % dextran. 
Figure 5.136 Representative H&E stained sections of engineered 15 x 10 mm plate 
constructs cultured under semi-static conditions in DMEM containing 10 w/v % dextran. 
Figure 5.137 Representative H&E stained sections of engineered 15 x 10 mm plate 
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Figures 5.135, 5.136 and 5.137 illustrate H&E staining of large plate constructs 
cultured under static, semi-static and rotating wall vessel bioreactor conditions 
respectively in DMEM containing 10 w/v % dextran. Constructs cultured under both 
static and semi-static conditions demonstrates a very fragile, weakly stained matrix 
with a highly porous, poorly coherent structure. This is evident in the degree to 
which the tissue has visibly fragmented upon cryosectioning. Chondrocyte density 
in both cases is relatively high as demonstrated by a large number of haematoxylin 
stained nuclei in the areas where tissue remains. Constructs cultured under RWV 
bioreactor conditions show slightly more mechanical integrity upon cryosectioning 
then either static or semi-static tissue, as evident in figure 5.137. However there is 
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 Collagen content 
o Type I 
Figure 5.138 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 15 x 10 mm plate constructs cultured under static conditions in 
DMEM containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.139 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 15 x 10 mm plate constructs cultured under semi-static conditions in 
DMEM containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.140 Light micrographs showing the immunohistochemical localisation of type I 
collagen in engineered 15 x 10 mm plate constructs cultured under RWV bioreactor 
conditions in DMEM containing 10 w/v % dextran. Non-specific staining shown inset to 
image top right. 
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Collagen type I immunohistological staining of pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM containing 10 w/v % dextran 
can be seen on the previous page in figures 5.138, 5.139 and 5.140 respectively.  
Collagen type I staining is positive but very fragmented and weak under all culture 
conditions, implying collagen type I is present in the tissue but in very low levels. All 
tissue was of such poor quality that very little remained after the cryosectioning and 
immunohistological staining process. Non-specific staining controls show some 
cross-reactivity with other intra or pericellular components, particularly under RWV 




o QPCR analysis – COL1α2 expression 
 
Unfortunately no qPCR data for type I collagen in 15 x 10 mm plate constructs in 
DMEM plus 10 w/v% dextran could be generated due to the inadequate volumes of 
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o Type II 
Figure 5.141 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 15 x 10 mm plate constructs cultured under static conditions in 
DMEM containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.142 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 15 x 10 mm plate constructs cultured under semi-static conditions in 
DMEM containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.143 Light micrographs showing the immunohistochemical localisation of type II 
collagen in engineered 15 x 10 mm plate constructs cultured under RWV bioreactor 
conditions in DMEM containing 10 w/v % dextran. Non-specific staining shown inset to 
image top right. 
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Collagen type II immunohistological staining of pin constructs cultured under static, 
semi-static and RWV bioreactor conditions in DMEM containing 10 w/v % dextran 
can be seen on the previous page in figures 5.141, 5.142 and 5.143 respectively.  
Staining is again positive in areas where the tissue remains and in general stronger 
in intensity than collagen type I staining. Again however all tissue was of such poor 
quality that very little remained after the cryosectioning and immunohistological 
staining process. Non-specific staining controls show very little cross-reactivity with 
other intra or pericellular components. 
 
o QPCR analysis – COL2α1 expression 
 
 
Figure 5.144 Fold change in COL2α1 expression at experimental termination (33 days) 
relative to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured 
under static, semi-static and RWV bioreactor conditions in DMEM + 10 w/v% dextran (n=6 
for each). No change in 18s RNA endogenous control was observed. Error bars represent 
the standard error of the mean (SEM), significance levels shown ** = P < 0.01. 
Figure 5.144 above shows the relative expression of COL2α1 between static, semi-
static and RWV bioreactor constructs at termination of culture of 1453, 447 and 
63.39 x 72 hour reference sample respectively. 
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 Glycosaminoglycan (GAG) content 
o Toluidine and alcian blue staining 
Figure 5.145 Light micrographs showing toluidine blue staining of engineered 15 x 10 mm 
plate constructs cultured under static conditions in DMEM containing 10 w/v % dextran. 
 
Figure 5.146 Light micrographs showing toluidine blue staining of engineered 15 x 10 mm 
plate constructs cultured under semi-static conditions in DMEM containing 10 w/v % 
dextran. 
 
Figure 5.147 Light micrographs showing toluidine blue staining of engineered 15 x 10 mm 
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Figure 5.148 Light micrographs showing alcian blue staining of engineered 15 x 10 mm plate 
constructs cultured under static conditions in DMEM containing 10 w/v % dextran 
 
Figure 5.149 Light micrographs showing alcian blue staining of engineered 15 x 10 mm plate 
constructs cultured under semi-static conditions in DMEM containing 10 w/v % dextran 
 
Figure 5.150 Light micrographs showing alcian blue staining of engineered 15 x 10 mm plate 
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Figures 5.145, 5.146 and 5.147 on page 181 show toluidine blue stained static, semi-
static and RWV bioreactor plate construct sections respectively. A positive but 
relatively weak light-purple staining for glycosaminoglycans (GAG’s) can be seen in 
all three culture conditions, confirming the presence of GAGs in the tissue.  Tissue 
sections demonstrate an increasingly coherent matrix structure from static through 
semi-static and RWV bioreactor culture conditions however the light purple positive 
toluidine blue staining appears the strongest in semi-static sections as can be seen 
in figure 5.146. These observations are further backed up by figures 5.148, 5.149 
and 5.150 on page 182 where the same sections are stained with Alcian blue for 
sulphated glycosaminoglycans. Alcian blue staining in all conditions, static, semi-
static and RWV bioreactor sections is relatively intense and homogeneously 
distributed throughout the tissue. Again however all sections exhibit some degree 
of porosity and discontinuity in the matrix, this is most visible in tissue cultured 
under static conditions as can be seen in figure 5.148.  
 
Figure 5.151 (overleaf) illustrates graphically the percentage sulphated GAG content 
in the tissue’s wet weight established by dimethylmethylene blue (DMB) assay  
 Glycosaminoglycan content of engineered plate constructs cultured under 
static conditions’ wet weight was quantified as 0.51 ± 0.11 % (mean ± SD, n=10) or 
0.005 ± 0.003 mg per mg wet weight (mean ± SD, n=10) using the method as 
described in section 4.2.4. Glycosaminoglycans also accounted for 0.68 ± 0.10 % 
(Mean ± SD, n=10) or 0.007 ± 0.0024 mg per mg wet weight (Mean ± SD, n=10) of 
the pin constructs cultured under semi-static conditions and 0.20 ± 0.07 % (Mean ± 
SD, n=9) or 0.002 ± 0.0017 (Mean ± SD, n=9) mg per mg wet weight of the pin 







Richard A. Senior                                                                                                                                               2014 
 
 Page 190 
 
o Quantitative dimethylmethylene blue assay 
 
Figure 5.151 Percentage sulphated glycosaminoglycan (GAG) content in the digested and 
lyophilised matrix of tissue engineered plate constructs (15 x 10 mm) cultured in DMEM + 
10 w/v % dextran. Error bars represent the standard error of the mean (SEM), significance 
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o QPCR analysis – ACAN expression 
 
Figure 5.152 Fold change in ACAN expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured under 
static, semi-static and RWV bioreactor conditions in DMEM + 10 w/v% dextran. For each 
condition n=6. No change in 18s RNA endogenous control was observed. Error bars 
represent the standard error of the mean (SEM), significance level shown ** = P < 0.01. 
 
Figure 5.152 above illustrates the relative expression of ACAN seen between static, 
semi-static and RWV bioreactor large plate construct chondrocytes cultured in 
DMEM containing 10 w/v % dextran at the end of the culture period.  At day 33 
chondrocytes seeded to RWV bioreactor constructs’ expression of ACAN had 
reduced to 0.58 x 72 hour reference expression. This is statistically significantly 
lower than both the 2.14 x increase demonstrated by semi-static construct 
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 Surface zone protein content 
Figure 5.153 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 15 x 10 mm plate constructs cultured under static conditions in 
DMEM containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
 
Figure 5.154 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 15 x 10 mm plate constructs cultured under static conditions in 
DMEM containing 10 w/v % dextran . Non-specific staining shown inset to image top right.   
 
Figure 5.155 Light micrographs showing the immunohistochemical localisation of surface 
zone protein in engineered 15 x 10 mm plate constructs cultured under static conditions in 
DMEM containing 10 w/v % dextran. Non-specific staining shown inset to image top right. 
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Figures 5.153, 5.154 and 5.155 on the previous page show the 
immunohistolocalisation of surface zone protein (SZP) in large plate constructs 
cultured under static, semi-static and RWV bioreactor conditions respectively. 
Constructs cultured under all three conditions demonstrate some positive but very 
low intensity, fragmented staining localised mainly in pericellular or intracellular 
areas. Little cross reactivity with other matrix components can be seen in the non-
specific staining controls.  
 
o QPCR analysis – PRG4 expression 
 
Figure 5.156 Fold change in PRG4 expression at experimental termination (33 days) relative 
to control sample (72 hours post seeding) in 15 x 10 mm plate constructs cultured under 
static, semi-static and RWV bioreactor conditions in DMEM + 10 w/v % dextran (n=6 for 
each). No change in 18s RNA endogenous control was observed. Error bars represent the 
standard error of the mean (SEM), significance level shown ***P < 0.001. 
 
Figure 5.156 above shows the mean relative expression of PRG4 in chondrocytes 
seeded to static, semi-static and RWV bioreactor large plate constructs at 
termination of culture in DMEM containing 10 w/v % dextran of 0.77, 1.44 and 6.37 
x 72 hour reference respectively.  
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6. Discussion  
Before any discussion of the results of this investigation, it should be noted that any 
data derived from immunological staining (collagen type II and II, lubricin) can only 
be considered as subjective and therefore of limited reliability. Not all staining was 
carried out at the same time, using an identical batch of primary and secondary 
antibodies. Inevitable variation in the reagents and consumables used could 
therefore have resulted in variation in antibody specificity, and so subsequent 
variation in the intensity of colouration seen in the figures as presented.   
 Measures that could be taken in future to address this issue centre 
predominantly around the use of more comprehensive controls. This study utilised 
non-specific controls within each staining run, controls where the staining 
methodology differed only in lacking a primary antibody. A more complete 
approach would also include the use of a positive control, for example native bovine 
articular cartilage (with sections taken from the same cryopreserved sample 
throughout the study) to demonstrate where each component under investigation 
should be located. Alternatively, and arguably of more value in terms of collagen 
immunostaining would be the use of a full thickness skin section as a positive 
control. This would not only indicate that collagen was present but the gradient of 
collagen type II commonly known to be observed through a section of skin would 
provide a valuable comparison. 
     
6.1 Constructs cultured in standard DMEM – the effect of increasing size on 
biological quality 
 
Small, 6 mm diameter pin constructs were initially engineered under static, semi-
static and rotating wall vessel (RWV) bioreactor conditions in order that 
comparisons between the culture techniques used to produce these, and eventually 
larger pieces of tissue could be made with previous and published work.  
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It can be seen in figure 5.8 that pin constructs cultured under both semi-static and 
RWV bioreactor conditions undergo contraction in all dimensions resulting in a 
marked reduction in volume compared to the pin’s original dimensions, -67.7 % and 
-81.3 % respectively. This observation is backed up by the noticeable difference in 
mean tissue wet weights at the end of the culture period, 62.28 mg (static), 48.67 
mg (semi-static) and 5.10 mg (RWV). It is thought that the influence of detrimental, 
mainly shear forces push the chondrocytes to de-differentiate down a fibroblastic 
lineage [223-226] [95], resulting in the production of alpha smooth muscle actin 
(αSMA)[227, 228]. The chondrocytes then ‘pull’ on these αSMA filaments to 
effectively buckle and draw in the PGA scaffold fibres, construct contraction could 
therefore be an indication of chondrocyte de-differentiation (please see section 
2.2.1) . Construct contraction could be counteracted and reduced by up to 50% by 
the use of culture medium additions, for example staurosporine [228] or acting to 
ensure shear force levels are further reduced. Pin constructs cultured under static 
conditions demonstrated a 129.6 % increase in volume during the culture period 
(please see figure 5.8). This can be attributed to an increase in cartilage tissue 
matrix, as can be seen from the higher percentage glycosaminoglycan content, 1.87 
% (figure 5.26) and lower proportion of water (86.09 %) when compared to semi-
static (1.15 % GAG, 87.74 % water) and RWV (0.76 % GAG, 92.31 % water) 
constructs. This trend of decreasing glycosaminoglycan content from static to RWV 
bioreactor culture is not mirrored in the expression of ACAN at experimental 
termination as illustrated in figure 5.27. Static pin constructs however 
demonstrated inferior mechanical integrity to the smaller, denser semi-static and 
RWV constructs which made them much harder to handle with forceps post-
culture. The lack of rigidity seen in the tissue can be attributed to the high level of 
porosity seen at the centre of the construct as highlighted by H&E staining in figure 
5.9. There are no visible differences in both collagen type I and type II 
immunohistological staining intensity between the three culture conditions (figures 
5.12 – 5.14 and 5.16 – 5.18) however the core porosity in static constructs is still 
evident in figures 5.12 and 5.16. It is possible  that tissue necrosis occurred towards 
the centre of the constructs as the ECM developed and the construct thickness 
increased [229], this could only be confirmed with further investigation such as live-
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dead cell staining carried out on tissue at the instant of experimental termination.  
If this were responsible for the visible condition of the tissue, the increase in 
thickness means that there is a greater distance through the tissue over which gas 
and nutrient mass transfer must occur, diffusion rates would be reduced and so the 
chondrocytes would subsequently suffer – it is thought that currently 2 - 10 mm is 
the tissue-dependent upper limit to tissue engineered construct thickness without 
starting to severely reduce diffusion through it [229]. Studies have shown this issue 
circumvented by pre-vascularisation in tissues such as liver, adipose [230], cardiac 
[231] and smooth muscle [232, 233] but not unfortunately in the case of articular 
cartilage [229, 234, 235]. Chondrocytes in vivo naturally experience hypoxic 
conditions as discussed in section 2.2.3, it is unlikely therefore that lower oxygen 
levels in the tissue are of detriment to the cells and would be  the primary cause of 
any necrosis [15]. Chondrocytes in vivo however also experience cyclical loading 
driven diffusion of carbon dioxide, nutrients and metabolites through the tissue 
under conditions of normal loading and movement [236, 237]. The absence of this 
mechanism in in vitro culture could explain  any necrosis  were it confirmed at the 
centre of the constructs. 
 
Pin constructs cultured under semi-static and RWV vessel bioreactor conditions do 
not demonstrate much indication of extra cellular matrix discontinuity, it is likely 
that agitation of the culture medium under these conditions helping circulation and 
improving mass transfer within it [238]. Progressing from static, through semi-static 
to RWV bioreactor culture conditions proved favourable in terms of GAG expression 
and matrix retention, surface zone protein expression (figure 5.31) and surface 
localisation (figure 5.28 – 5.30), observations which are in agreement with current 
literature [239-246]. However it appears that the intensity of detrimental shear 
forces imparted on the constructs were, on balance, still too high.  
This is reflected both in the increasing expression of COL1α2 (figure 5.15) from 
static, through semi-static to RWV bioreactor culture (3.82, 4.29 and 6.45 x 72 hour 
reference sample respectively) and in the decreasing expression of COL2α1 (figure 
5.19) (114.56, 80.54 and 69.05 x 72 reference sample respectively). This is likely due 
to the fact that 6 mm diameter pin constructs are still very large in comparison to 
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what is routinely cultured in the RWV bioreactor and so shear is bound to be 
increased as a result. This ultimately results at the end of culture in a less hyaline-
like extra cellular matrix, observations that are again in agreement with the 
common consensus expressed in the literature [164, 247-249]. 
 
The effects of increasing construct size in standard DMEM 
The primary aim of this investigation was to explore the possibility of tissue 
engineering large, high biological quality articular cartilage constructs, with the use 
of the Synthecon™ rotating wall vessel bioreactor of particular interest. Coupled 
with the development of custom culture protocols and apparatus it was established 
that it is fundamentally possible to engineer large articular cartilage plates under 
both static and semi-static conditions as initially demonstrated with 6 mm diameter 
pins. The use of the RWV bioreactor however proved significantly more 
problematic. As outlined in result section 5.2.1, standard cell culture medium 
(DMEM) in the RWV bioreactor provided insufficient construct support to prevent 
‘tumbling’ and subsequent tissue damage.  
Increasing the size of the construct from 6 mm ø pin to 15 x 10 mm plate under 
static and semi-static conditions resulted in an apparent slight improvement in 
overall zonal organisation of the tissue. H&E stained pin constructs in figures 5.9 
and 5.10 illustrate some hierarchical organisation towards the periphery of the 
construct, with the chondrocytes becoming slightly more flattened and more 
densely packed. This is more evident in the equivalent staining of larger construct 
sections (figures 5.35 and 5.36) with more cell lacunae visible deeper into the 
tissue. As discussed in section 2.1.1 and illustrated in the H&E staining of native 
cartilage sections (figure 5.1) the hierarchical or zonal organisation of native 
articular cartilage plays a key role in the tissue’s ability to withstand compressive 
loading and also imparts its low friction properties. The lack of this zonal 
architecture would be severely detrimental to the tissue’s mechanical properties as 
recently shown by Khoshgoftar et al (2013) [250]. A substantial number of studies 
are currently focussed on capturing tissue zonality in engineered constructs [251], 
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for example; Chen et al (2013) [252] successfully reproduced the superficial zone, 
Kock et al (2013) [253] recreated depth dependent collagen distribution and Thorpe 
et al (2013) [254] demonstrated engineered constructs with a native-like 
glycosaminoglycan arrangement. These studies all highlight the importance of 
recapitulating the zonal, hierarchical tissue structure seen in native articular 
cartilage and whilst all have demonstrated success in engineering one or two of 
these in vitro, as far as the author is aware none have yet been successful in 
demonstrating them all concurrently. 
In this study, and most reported studies utilising primary articular chondrocytes, the 
cells are isolated from the full thickness of the cartilage tissue. Subtle phenotypic 
differences between cells from the different tissue zones could mean they will 
naturally respond differently to their mechanical environment, and so secrete a 
differing composition of extra cellular matrix components. Various studies are 
currently exploring the possibility of isolating primary chondrocytes and 
subsequently seeding them to a scaffold material taking into account their original 
zonal location. This area of work is in its infancy however and data is available that 
both supports [114, 255, 256] and rejects [257] the hypothesis that the approach 
could be beneficial. 
The most noticeable effect of increasing construct size from 6 mm ø pin to 15 x 10 
mm plate was a marked increase in percentage glycosaminoglycan content in the 
tissue wet weight under all conditions of culture; static, semi-static and RWV 
bioreactor. Under static conditions the percentage GAG content increased by 2.32% 
from pin to plate, under static conditions 7.60% and RWV bioreactor conditions 
2.26%. This increase is most noticeable under semi-static conditions; however is the 
most unexpected under RWV bioreactor conditions when considering the severe 
damage that was inflicted on the tissue in culture. These observations are 
reinforced by toluidine and alcian blue staining in figures 5.20 - 5.22 (pins, toluidine 
blue), 5.23 – 5.25 (pins, alcian blue), 5.46 - 5.48 (plates toluidine blue) and 5.49 – 
5.51 (plates, Alcian blue). The total glycosaminoglycan proportion seen in semi-
static large plate constructs, 8.75 % is very close to the 8.85 % seen in native 
articular cartilage. The expression of ACAN in chondrocytes seeded to large plate 
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constructs however was very much lower than that seen in pin constructs in 
equivalent culture conditions, 0.62 and 1.48 x 72 hour reference sample in static 
and semi-static tissue respectively as illustrated in figure 5.53. To account for such 
high GAG proportions being present at the end of culture it is likely that ACAN 
expression was somewhat higher in the intervening weeks between scaffold 
seeding and experimental termination [258-261]. This however would need to be 
established by undertaking further work, to include experimental time points with 
construct termination and qPCR analysis at each.      
 
It is not only the total GAG proportion in the tissue but the distribution of GAG in 
native articular cartilage as described in section 2.1.1 (literature review, native 
articular cartilage, healthy tissue, structure) that plays an important role in the 
hydration of the tissue, ensuring water is retained deep into the tissue during the 
loading / unloading cycle [4]. The intense toluidine and alcian blue staining 
demonstrated by large plate constructs cultured under static and semi-static 
conditions (figures 5.46, 5.47, 5.49, 5.50) increases in intensity with depth into the 
tissue, this distribution is similar to that demonstrated by native tissue (figures 5.4, 
5.5) and greatly improved over the heterogeneous, chaotic staining of the 
equivalent pin construct sections (figures 5.20, 5.21, 5.23, 5.24). Interestingly the 
percentage water content of the wet tissue is quite comparable between static pin 
and plate (86.09 and 88.93 % respectively) and semi-static pin and plate (87.74 and 
87.32 % respectively) constructs. This implies that although the percentage GAG 
proportion in the tissue is higher in the case of plate constructs, it doesn’t 
necessarily equate to increased hydration and water retention. It is possible the 
higher porosity seen in pin constructs acts to retain water via a capillary to a similar 
extent that the increased GAG proportion acts to retain water in the large plate 
construct tissue. 
Tissue cultured in the RWV bioreactor stained positively for glycosaminoglycans 
with toluidine (figure 5.48) and alcian blue (figure 5.51). However this is localised 
very much within the centre of the constructs, surrounded by a collagen-rich 
‘capsule’ approximately 100 µm thick (figures 5.40 and 5.44). This observation is 
consistent with the construct tumbling behaviour observed whilst in culture. The 
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chondrocytes response to elevated shear stress is the increased production of 
collagen type I in particular (please see section 2.2.3 literature review, bioreactors, 
low shear), In this case around the construct periphery where they ‘tumbled’ 
against the bottom surface of the vessel. As previously stated the impact of 
increased shear stress on chondrocytes is also known to result in the production of 
an extra cellular matrix deficient in sulphated glycosaminoglycans (please see 
section 2.2.3 literature review, bioreactors, low shear). It is theorised the still 
relatively high percentage glycosaminoglycan content seen towards the centre of 
the RWV bioreactor constructs was due to the development of the collagen-rich, 
shear protective ‘capsule’ at an early stage in culture thus providing a protective 
buffer against further shear stress exposure [262]. It is worth noting figures 5.40 
and 5.44 can be relied upon for an indication of staining intensity only due to the 
noticeable levels of non-specific secondary antibody binding visible in the inset, 
non-specifically stained micrographs. This implies the damage inflicted to the tissue 
in the bioreactor resulted in higher levels of non-specific, most likely hydrophobic 
binding interactions between the secondary antibody and non-collagen type II 
structures [263, 264].  
 
Plate constructs cultured under static and semi-static conditions demonstrate 
positive immunohistological staining for collagen type I as can be seen in figures 
5.38 and 5.39 respectively. The staining intensity is much higher than that seen in 
native tissue (figure 5.2), however appear to be of slightly lower intensity of staining 
than their pin counterparts (figures 5.12 and 5.13). This is not however reflected in 
the expression of COL1α2 at experimental termination, 18.87 and 15.31 x 72 hour 
reference sample under static and semi-static conditions respectively, 4.94 and 3.57 
times higher than their respective pin counterparts (please see figure 5.41).  
In contrast COL2α1 expression at culture termination was 48.15 and 75.47 x 72 hour 
reference sample in static and semi-static tissue respectively, 0.42 and 0.94 times 
that seen in their respective pin counterparts (please see figure 5.45). This 
conversely is not reflected in the immunohistological staining shown in figures 5.42 
and 5.43 where the staining intensity in both is particularly strong, with much more 
similarity shown to that seen in native tissue sections (figure 5.3) than  the intensity 
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of stain visible in pin construct sections (please see figures 5.16 and 5.17). This 
disparity between the expression of both COL1α2 and COL2α1 at culture 
termination and the immunohistological staining intensity for the respective protein 
suggests that the expression of both COL1α2 and COL2α1 vary considerably over 
the period of culture [265] [266] and their end point expression is not a reflection of 
a constant level of expression over the period of culture. Again only by undertaking 
further work, to include experimental time points with construct termination and 
qPCR analysis at each could this issue be better understood. As discussed in sections 
2.1.1 (literature review, native articular cartilage) collagen type I is normally found 
in relatively low levels in articular cartilage, playing an important structural and cell 
phenotype maintenance role. Its presence in higher levels however is associated 
with scar tissue or fibrous rather than hyaline cartilage formation. Fibrocartilage 
does not demonstrate the same resistance to shear and compressive loading as 
hyaline tissue therefore its presence in large amounts is not desirable.  
 
Immunohistological localisation of surface zone protein in small 6mm ø pin 
constructs cultured under static, semi-static and RWV bioreactor conditions and 
large, 15 x 10 mm plate constructs cultured under static and semi-static conditions 
are shown in figures 5.28, 5.29, 5.30, 5.54 and 5.55 respectively. The most 
physiologically representative localisation of SZP in tissue cultured in standard cell 
culture medium was achieved in 6mm pin constructs cultured under semi-static and 
RWV bioreactor conditions as can be seen in figures 5.29 and 5.30. A diffuse 
distribution of SZP is visible throughout both sections indicated by widespread light 
brown staining; however in both cases more intense staining can be seen in non-
continuous sections at the construct periphery implying a higher, localised 
concentration of SZP. As illustrated in figure 5.6 surface zone protein should be 
localised almost exclusively in the tissue periphery or surface amorphous layer [42]. 
Static pin constructs demonstrate a diffuse positive staining for SZP throughout the 
section as shown in figure 5.28. It is likely the influence of mechanical stimuli caused 
by the movement of culture medium relative to the surface of the tissue improved 
SZP localisation in semi-static and RWV constructs peripheries. These observations 
are reinforced by the increasing expression of PRG4 seen at culture termination 
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from static, through semi-static to RWV bioreactor culture of 2.26, 10.41 and 11.53 
x 72 hour reference sample respectively (please see figure 5.31). This is also in 
agreement with the findings of Ogawa et al (2014) [267], Sun et al (2013) [268] and 
others [43] [44] whereby it has been shown that low levels of shear stress in culture 
encourages SZP production. Immunohistological staining suggests that SZP 
expression in superficial tissue locations is improved under RWV bioreactor 
conditions; this cannot however be substantiated without quantitative analysis such 
as SDS-PAGE and subsequent immunoblotting, demonstrated for example by Khalafi 
et al (2007) [269] and Musumeci et al (2013) [270]. As described in section 2.2.3 
(literature review, culture conditions, bioreactors, low shear) the purpose of the 
RWV bioreactor design is to minimise the shear stress exerted on cells cultured 
within it as far as possible. It is possible therefore that either the constructs were 
tumbling to a greater extent in culture than was realised, or a more complex 
combination of forces than simply shear alone is responsible for the development of 
a surface amorphous layer rich in surface zone protein. In contrast to the much 
elevated PRG4 expression levels seen at culture termination in large plate static and 
semi-static constructs however (150.55 and 49.45 x  72 hour reference sample 
respectively – figure 5.56), immunohistological staining as shown in figures 5.54 and 
5.55. Both static and semi-static sections demonstrates low level staining intensity 
with little localisation in the construct periphery. It is possible therefore that PRG4 
expression remained very low until the final stages of culture before increasing 
dramatically, suggesting semi-static constructs in particular do not experience the 
same mechanical stimuli as small pin constructs under identical conditions of 
agitation It is also possible that surface zone protein was highly expressed 
throughout however was simply not incorporated into the extra cellular matrix. 
It appears, at a basic level that increasing construct size leads to increased GAG 
content, more intense immunological collagen type II staining and a more 
representative tissue structure. Although the cell seeding density remained the 
same between pin and plate constructs, five times the number of cells are seeded 
to large plate scaffolds in total initially. This higher number of cells, coupled with 
the overall increased mass of extra cellular matrix at any point in culture means that 
the chondrocytes might experience an environment that is overall more ‘in-vivo 
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like’. This, for example, could result in an environment having an increased 
concentration of growth factors or other cell-regulatory proteins [112, 181, 271]. 
The exact mechanisms by which this occurs would need much further investigation. 
Increasing the size of the construct in culture also means that particularly in semi-
static culture more energy is required to move the construct around due to inertia. 
As a result of this the same RPM setting of the orbital shaker would exert much 
lower levels of shear stress on large constructs perhaps as a result encouraging the 
chondrocytes to secrete a more GAG rich matrix (please see section 2.2.3, low shear 
culture). This would not fully explain the same higher levels of GAG observed in 
static and RWV bioreactor culture however.  
 
The absence of a strong collagen type II to type I ratio as visible following 
immunohistological staining of all engineered tissue is an indication of a lack of 
tissue maturity. It is thought that the maturation process is where the extra cellular 
matrix starts to demonstrates the correct cell density, zonal organisation, GAG 
content and distribution with depth and collagen type II to type I ratio and 
architecture [272-274]. As stated previously these biochemical features in their 
correct proportions in a hierarchical, zonal organisation is an indication of the 
tissue’s maturity [275] [276] and as yet remains a challenge to engineer [276]. As 
detailed in please see section 2.2.3 (literature review, bioreactors, low shear), it has 
been suggested that the Synthecon™ rotating wall vessel (RWV) bioreactor could 
provide an ideal, ultra-low shear culture environment that would allow this level of 
maturity to develop, its use therefore underpins one of the main aims of this study.  
In initially addressing the RWV based aims and objective as described in section 3 
(aims and objectives) however, large plate constructs plus the weight of the 
specially designed PTFE scaffold retention frames were too heavy to be supported 
by standard medium in the RWV bioreactor as described in section 5.2.1. Rotating 
vessel bioreactor constructs suffered extensive tissue damage, demonstrated a high 
collagen type I content, a low collagen type II to type I ratio and were not of a 
sufficient quality to permit rtPCR and qPCR preparation. Rotating wall vessel plate 
constructs still demonstrated mean glycosaminoglycan content at least 1.15 % 
higher than that seen in a 6 mm Ø pin constructs cultured under any condition, 
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suggesting definite advantages of the set-up if the culture process could be 
stabilised. The dimensions of the plate construct, scaffold material and construct 
retention frame as well as the frame shape and material had been carefully selected 
following an iterative optimisation procedure. Taking this into account it was 
decided that the composition of the cell culture medium must be adapted via 
viscosity modification (please see section 4.2.2), in order that large plate constructs 
could be fully supported, and effectively engineered within the rotating wall vessel 
bioreactor. 
 
6.2 The development of a modified viscosity cell culture medium 
 
Following identification of the need to provide increased mechanical support to 
large plate constructs in the rotating wall vessel bioreactor it was decided the ideal 
way to approach this would be by increasing the cell culture medium viscosity. 
Manipulation of culture medium viscosity has well established roots in commercial 
bioengineering for the purposes of supporting large scale bacterial and plant cell 
cultures, typically for the production of pharmaceuticals and recombinant products 
[200-204]. It has not, to the author’s knowledge been attempted in tissue 
engineering with bioreactors (please see section 2.3). Following the identification of 
three promising viscosity modifying medium additions (please see section 4.2.2) 
rheological analysis was carried out to establish their potential performance in the 
required role in comparison to standard cell culture medium. 
Dulbecco’s Modified Eagle’s Medium is very well characterised from a rheological 
point of view, dynamic viscosities have been reported that fall into a narrow range 
of between 0.00069 PaS to 0.00094 PaS [277-281]. As this viscosity was insufficient 
to support the weight of large plate constructs in a stable, low shear orbit in the 
RWV bioreactor the viscosity of the medium had to be increased significantly above 
this. Rheological analysis of fresh bovine synovial fluid confirmed that it 
demonstrates non-Newtonian, shear thinning behaviour (please see figures 5.59, 
5.60 and 5. 63). This is to say its dynamic viscosity decreases as the rate at which it 
is sheared increases; this is in good agreement with published analysis [282-285]. It 
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was decided that a more representative in-vitro bovine model could be achieved if 
culture medium viscosity could be matched as far as possible to that of bovine 
synovial fluid. For this to be achieved, the dynamic viscosity of synovial fluid needed 
to be measured at a specified shear rate. A shear rate of 2000 s-1 was chosen for the 
reasons outlined in section 4.2.2. 
 
Under strain sweep analysis all concentrations of dextran in DMEM demonstrated 
shear thinning behaviour at very low shear rates, however above a shear rate of 
approximately 70 s-1 viscous behaviour becomes more Newtonian with the dynamic 
viscosity more stable. This is in agreement with published data concerning the use 
of dextran solutions made using high molecular weight dextran (Mr≈500,000) [286]. 
All concentrations of CMC tested under strain sweep conditions exhibited shear 
thinning behaviour across the range of shear rates tested (please see figure 5.61) 
whereas in contrast all concentrations of PVP exhibited largely Newtonian rheology 
(figure 5.59) which again is in agreement with published data [287-289]. Both 1 
w/v% CMC and 2.5 w/v% PVP exhibited rheological instability at low shear rates of 
100 s-1. At a constant strain rate of 2000 s-1 bovine synovial fluid demonstrated an 
average dynamic viscosity of 0.00616 PaS (figures 5.62, 5.63 and 5.64). Figure 5.63 
illustrates the dynamic viscosity of DMEM containing 5 w/v% dextran is very 
comparable to that of bovine synovial fluid at 0.00614 PaS. A direct addition of 2.5 
w/v% PVP in DMEM likewise possesses a similar dynamic viscosity to bovine 
synovial fluid of 0.00672 PaS as can be seen in figure 55.62. Figure 5.64 
demonstrates that no concentration of CMC analysed demonstrated such a close 
rheological behaviour to BSF, it is very likely that an addition of between 1 and 2.5 
w/v % would provide such as result however due to handling difficulties 
encountered when dealing with concentrations of above 1 w/v % this avenue was 
not explored. At 0.00312 PaS however the dynamic viscosity of DMEM + 1 w/v % 
CMC is only 0.00304 PaS lower than that of BSF. For the reasons discussed above 
the main additions of interest carried forward into physicochemical analysis were 5 
w/v % dextran, 1 w/v % CMC and 2.5 w/v % PVP.  
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The change in culture medium pH and osmolality with increasing w/v percentage 
addition of PVP, dextran and CMC are shown in figures 5.57 and 5.58 respectively. 
An overall increase in pH was seen as the content is increased from 1 to 10 w/v % in 
all cases. This is most pronounced where CMC is concerned with an overall average 
increase in pH of 0.42, PVP and dextran demonstrate an overall average increase of 
0.07 and 0.12 respectively. The in vivo environment naturally presents chondrocytes 
with a slightly alkaline environment of around pH 7.4, and it is thought that whilst a 
deviation of 0.2 pH units above or below this could start to impact negatively on 
chondrocyte metabolism [290, 291], the expression of aggrecan and type II collagen 
is pH independent at low levels of change [292]. It is possible that even the lowest 
concentrations of the medium additions shown in figure 5.57 could therefore have 
a negative impact in terms of cell metabolism. However it should be taken into 
account that although great care was taken to ensure measurements were taken 
under the 5 % CO2 atmosphere of the incubator, it is possible all measurements 
have been shifted slightly towards the alkaline due to the medium’s carbonate 
buffer system and the need to remove samples from the incubator every so often 
[293]. The addition of CMC resulted in by far the largest change in pH, considering 
the use of CMC would not be feasible far above 1 w/v % addition anyway due to 
handleability issues this is not deemed to be too much of an issue.  
 
The increase in osmolality caused by the addition of CMC (178.67 mOsm kg-1) 
however as illustrated in figure 5.58, would likely be severely detrimental to cell 
function. Chondrocytes in vivo experience a hypertonic environment (280 mOsm kg-
1) compared with otherwise physiological osmolality (300 - 380 mOsm kg-1) [294].  
It has been shown that above 380 mOsm kg-1 chondrocyte viability and proliferative 
capacity is severely diminished [294-296]. The addition of PVP up to 10 w/v % (46.0 
mOsm kg-1 change) therefore is unlikely to have a negative impact, whereas the 
addition of dextran to the culture medium only resulted an overall average increase 
of 1.0 mOsm kg-1 which shouldn’t be enough to affect cell function, particularly at 
the lower end of the percentage range. 
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Figure 5.65 illustrates both the cytotoxic impact (72 hours exposure) and impact on 
proliferation (144 hours exposure) experienced by bovine articular chondrocytes 
cultured in DMEM supplemented with 2.5 w/v % PVP, 5 w/v % dextran or 1 w/v % 
CMC. This was assessed via culture under both static and semi-static conditions with 
PrestoBlue™ cell viability reagent at each time point, with spectrophotometric 
analysis of the reduced dye undertaken at 15, 30 and 60 minutes to allow 
calculation of an average rate of dye reduction in fluorescence units per minute. 
Following 72 hours of culture in standard DMEM, the rate of dye reduction in semi-
static samples was significantly lower than static samples. A reduction in overall 
cellular metabolism was likely due to the detrimental effects of shear stresses 
imparted by the motion of agitated culture medium relative to the cell surface [225, 
226, 297] (additionally please see section 2.2.3). An addition to the medium of 5 
w/v % dextran or + 1 w/v % CMC apparently went some way to counteracting this 
effect, a noticeably higher rate of dye reduction in semi-static culture can be seen 
as a result of the increased viscosity providing a shear protecting effect [298, 299]. A 
statistically significant reduction in the rate of dye reduction can be seen following 
the addition of 5 w/v % dextran or 1 w/v % CMC to static samples after 72 of 
culture. This is likely due to reduction in mass transfer through the medium [300]. 
Under both conditions involving the addition of a viscosity modifying medium 
addition, the rate of dye reduction was higher under semi-static than static 
conditions, most likely due to the increased mass transfer brought about by 
medium agitation. The addition of 2.5 w/v % PVP appeared to be of severe 
detriment to not only the viability but survival of the chondrocytes cultured in it and 
therefore its further use was ruled out. 
  
The rates of dye reduction in standard DMEM at 144 hours following set-up, under 
both static and semi-static conditions was vastly lower than their 72 hour 
counterparts. This suggests that the cells were now in a metabolically less active 
phase of extra cellular matrix synthesis rather than mitotic division [261, 301]; this 
effect is seen under all conditions of culture medium composition. A significantly 
higher rate of PrestoBlue dye reduction was seen at 144hours after setup in semi-
static conditions with the DMEM addition of 5 w/v % dextran over standard DMEM 
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alone, at the stage the addition of 1 w/v % CMC was found to have a detrimental 
effect on cell viability in comparison to the addition of 5 w/v % dextran. Only slight 
detriment was seen to cell viability by the addition of 5 w/v % dextran under 
conditions of static culture, whereas a statistically significant benefit was seen to be 
brought about by its addition to semi-static culture. These observations coupled 
with the aforementioned rheological and physicochemical investigation meant that 
the use of dextran as a viscosity modifying medium addition was taken forward into 
experimental use.  
 
The desire to establish a more representative bovine model in culture by adapting 
the viscosity of the culture medium to be close to that of BSF was more one of 
interest than of necessity. It was therefore disappointing but not catastrophic to 
find that this viscosity was not quite sufficient to support the weight of the large 
plate constructs plus PTFE retention frame in the rotating wall vessel bioreactor as 
can be seen in figure 5.66. As dextran was still considered to provide the best 
results in terms of its biocompatibility its continued use was preferred. Figure 5.68 
illustrates that a concentration of 10 w/v% provides adequate construct support at 
what is considered reasonable RPM (30-35). If the rotating wall vessel bioreactor 
was required to run at maximum RPM for extended periods of time in order to keep 
the constructs within it supported in a stable orbit this could result damage to the 
motorised base unit at the elevated temperatures experienced within the cell 
culture incubator. Further rheological analysis as shown in figure 5.67 established 
that an addition of 10 w/v % dextran from a concentrated 40 w/v % stock solution 
in PBS was of noticeably higher viscosity at a shear rate of 2000.  
The dynamic viscosity of 10 w/v% dextran in DMEM from PBS stock addition is 
0.0101 PaS, 1.7 x higher than that of the 5 w/v% solution produced via direct 
addition (0.00593 PaS).  
 
Issues then arose concerning the ease of sterilisation of such a viscous fluid. 
Dulbecco’s Modified Eagle’s Medium containing 5 w/v % dextran can be filter 
sterilised with a syringe and 0.22 µm filter with relative ease. This approach was not 
feasible with a concentration of 10 w/v % produced through direct addition of the 
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dextran to the DMEM. It was established that pre-sterilised, powdered dextran 
could not be purchased at a reasonable cost; therefore alternative sterilisation 
approaches were considered but unfortunately found to present major drawbacks. 
It couldn’t be guaranteed for example that gamma irradiation would not break 
down the molecular weight of the dextran [302], whereas autoclaving of the dry 
dextran powder would most likely lead to caramelisation (pyrolytic, 
thermochemical degradation) [303] [304]. This was circumnavigated by producing a 
saturated 40 w/v % dextran stock solution in PBS and autoclaving at 121ᵒC for 15 
minutes to ensure sterility, this was then added to the culture medium such that 
the final volume contained the required w/v % dextran, for example 100 ml 10 w/v 
% dextran in DMEM was achieved via the addition of 25 ml 40 w/v % PBS stock in 65 
ml DMEM plus 10 ml foetal calf serum. Rheological analysis was utilised to ensure 
that no reduction in viscosity resulted from the impact of the sterilisation process 
(please see figure 5.69). In reality figure 5.69 illustrates a small increase of 0.10732 
PaS in the viscosity of the stock solution pre and post-autoclave, most likely brought 
about by the loss of water from the PBS through evaporation. This small increase in 
viscosity is most likely to be of benefit to subsequent experiments rather than of 
detriment. 
 
Figure 5.70 again illustrates both the cytotoxic impact (72 hours exposure) and 
impact on proliferation (144 hours exposure) experienced by bovine articular 
chondrocytes cultured in standard and viscosity modified DMEM. To ensure no 
negative impact of using 10 w/v% dextran supplemented DMEM produced via the 
addition of a 40 w/v% PBS stock solution this was compared to DMEM plus directly 
added 5 w/v% dextran as assessed previously and shown in figure 5.65. A 
statistically significant viability drop can be seen between static samples containing 
5 and 10 w/v % dextran at 72 hours and at 144 hours and semi-static samples at 72 
and at 144 hours. These differences are most likely due to either the increase in 
medium viscosity reducing mass transfer through it, or the 25 % dilution to the 
overall volume of culture medium by the addition of PBS in the concentrated stock 
solution [305, 306]. Either way the reduction in cell viability was not deemed great 
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enough to warrant not pursuing the use of a 10 w/v % addition of dextran to the 
culture medium through the addition of a concentrated dextran stock solution. 
 
The effect of increasing percentage dextran concentration on mass transfer through 
the culture medium was explored through the measure of dissolved oxygen tension. 
Figure 5.71 shows the levels of dissolved oxygen seen in DMEM containing 2.5, 5 
and 10 w/v % dextran produced via the addition of 40 w/v % dextran in PBS stock 
after incubation at 37ᵒC for 24 hours. Placing samples cultured in standard DMEM 
under semi-static agitation resulted in no statistically significant change in dissolved 
oxygen tension. A significant increase in dissolved oxygen tension was seen 
however between static and semi-static samples in DMEM containing all three 
percentage additions of dextran suggesting a marked improvement in oxygen 
transfer through agitation when viscosity is increased. In its native environment 
articular cartilage experiences hypoxic conditions due to the lack of a vascular 
system, with oxygen levels typically around 6 % O2 in the superficial layer, and 1 % 
O2 towards the calcified zone [307]. It can be seen from figure 5.71 that a medium 
addition of up to 10 w/v % dextran under static conditions reduces the dissolved 
oxygen tension to an average of 3.63 %, as far as levels that would be seen in the 
intermediate tissue layers in vivo. 
 
As a result of the requirement to produce a DMEM plus 10 w/v% dextran solution in 
this way rather than via the direct addition of dextran to the media, it was 
recognised that the presence of a significant volume of PBS in the culture medium 
could actually bring about a reduction in dynamic viscosity. Further rheological 
analysis (figures 5.67) established that at a shear rate of 2000 s-1, the dynamic 
viscosity of DMEM plus 10 w/v% dextran produced via the addition of concentrated 
stock is 1.7 times that of DMEM plus 5 w/v% dextran produced via the direct 
addition of dextran at 0.0101 and 0.00593 PaS respectively. At strain rates above 
approximately 70 s-1 whereby the viscous behaviour is seen to be increasingly 
Newtonian with consistent viscosity the mean dynamic viscosity of DMEM plus 10 
w/v% dextran produced via the addition of concentrated stock is 1.696 times that of 
DMEM plus 5 w/v% dextran produced via the direct addition of dextran at 0.0104 
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and 0.00616 PaS respectively. This analysis coupled with the performance of DMEM 
plus 10 w/v% dextran produced via the addition of concentrated stock in the 
rotating wall vessel bioreactor as illustrated in figure 5.68 meant that the decision 
was taken to proceed with the use of this culture medium in subsequent 
experimentation. It was also recognised that the addition of a concentrated 40 w/v 
% stock solution, as previously stated, would also result in a 25 % dilution of the 
DMEM, meaning a 25 % reduction in the amount of glucose and other medium 
components available to the chondrocytes. This was counteracted by ensuring the 
culture medium was replenished at regular intervals, never being left unchanged for 
more than 48 hours. 
 
6.3 Constructs cultured in a modified cell culture medium – the effect of increased 
viscosity on the biological quality  
 
The addition of 5 w/v % dextran to the culture medium provided a very good level 
of support to small pin constructs in the rotating wall vessel bioreactor; this was 
very much expected as constructs of this size were also supported very well in 
standard DMEM. The addition of 5 w/v % dextran did however bring about a 
general trend of deteriorating tissue quality over that seen in standard DMEM.  
Static constructs increased in volume by an average of 54.4 % (figure 5.72) over the 
culture period, however exhibited the same poor mechanical integrity as both semi-
static and RWV bioreactor constructs that exhibited average contractions of -35.1 
and -82.1 % respectively. Static constructs increased in volume by 75.2 % less than 
the equivalent constructs cultured in standard DMEM. This is likely due to a lower 
volume of matrix having been produced as percentage water content remained 
largely the same at 87.75 %. Contraction levels seen in semi-static conditions 
however were 32.6 % lower than their standard DMEM cultured counterparts. 
Increasing the culture medium viscosity therefore resulted in reduced construct 
contraction which again is most likely due to the dextran providing a shear 
protecting effect [298, 299]. Contraction levels seen in RWV bioreactor constructs 
did not change appreciably only increasing by 0.8 %. The proportion of water was 
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61 % lower however whilst maintaining a comparable average wet weight of 5.8 mg 
to the standard DMEM’s 5.1 mg. This observation suggests that the extra cellular 
matrix in RWV bioreactor tissue was much denser when cultured in DMEM 
containing 5 w/v % dextran over standard medium. This observation is reinforced to 
a limited extent by H&E staining (figure 5.98), but not however by alcian blue or 
toluidine blue staining (figures 5.111 and 5.108), or by collagen type I and II 
immunohistological staining (figures 5.101 and 5.104) whereby the construct extra 
cellular matrix appeared to be very porous. It is very likely however that the visible 
porosity is an artefact of the cryosectioning process whereby the dense but low  
strength ECM has simply torn apart. Increasing the level of culture agitation from 
static, through semi-static to RWV bioreactor appears to have the effect of reducing 
both collagen type I and II immunohistological staining intensity (figures 5.76 to 
5.78 and 5.80 to 5.82 respectively). This observation is also reflected in the reducing 
expression of COL1α2 (6.45, 4.63 and 1.18 x 72 hour reference sample) and COL2α1 
(142.4, 58 and 0.64 x 72 hour reference sample) seen at culture termination in 
static, semi-static and RWV bioreactor samples respectively. Levels of COL2α1 
expression in particular were high in comparison with the amount of collagen type II 
present in the extra cellular matrix at culture termination as suggested through 
immunohistological staining. This again could be due to end point expression not 
being a true reflection of a constant level of expression over the period of culture. 
Again only by undertaking further work, to include experimental time points with 
construct termination and qPCR analysis at each could this issue be better 
understood.  
Collagen type II is a key marker of hyaline like cartilage tissue (see section 2.1.1) and 
from immunohistological staining appears to be present in the tissue to a noticeably 
lesser extent than the equivalent constructs in standard DMEM (figures 5.16 to 5.18 
and 5.80 to 5.82). High glycosaminoglycan content (again please see section 2.1.1) is 
also a key marker of a hyaline type extra cellular matrix. Both toluidine and alcian 
blue staining of static, semi-static and RWV bioreactor tissue (figures 5.84 to 5.86 
and 5.87 to 5.89 respectively) was very weak suggesting low levels of GAG present 
in the tissue. This observation is backed up by the quantitative DMB assay analysis 
Richard A. Senior                                                                                                                                               2014 
 
 Page 213 
 
in figure 5.90 (1.83, 1.52 and 1.24 % respectively) and ACAN qPCR expression 
analysis in figure 5.91 (0.96, 0.14 and 0.04 x 72 hour reference sample respectively). 
Such a low proportion GAG content seen across static, semi-static and RWV 
bioreactor culture conditions is very comparable to that seen in small pin constructs 
cultured in standard DMEM (figure 5.26) at 1.86, 1.15 and 0.76 % respectively. 
However ACAN expression between the two groups was very different (1.61, 3.56 
and 7.88 x 72 hour reference sample in pin construct chondrocytes cultured under 
static, semi-static and RWV bioreactor conditions respectively in standard DMEM - 
figure 5.27) suggesting that  ACAN expression levels were higher earlier in the 
DMEM + 5 w/v % dextran culture period and fell away towards termination. 
It is possible that as a result of the increased medium viscosity, glucose mass 
transfer towards the cells was restricted thus impacting on; cellular metabolism, the 
post-translational modification of procollagen and glycosaminoglycan components 
and the activity of matrix incorporating enzymes such as proteinases and 
hyaluronate synthase [308-311]. Any one or combination of these mechanisms 
could feasibly lead to lower levels of collagen type II and GAG extra cellular matrix 
incorporation. All small pin tissue engineered in DMEM containing 5 w/v % dextran 
remained however significantly more difficult to handle and manipulate for post-
culture analysis than that cultured in standard DMEM. An addition of 5% was still 
pursued in static and semi-static culture to enable comparison between all pin 
constructs but it was still not of sufficient viscosity to support large constructs in the 
RWV bioreactor. 
 
Increasing the culture medium viscosity brought about a similar general trend of 
deteriorating tissue quality in plate constructs over that seen in standard DMEM 
culture. The tissue was lacking in mechanical integrity however was  noticeably  less 
fragile than pin constructs engineered in the same medium. H&E staining of both 
static and semi-static large plate tissue (figures 5.118 and 5.119) was relatively 
weak in intensity and chaotic in structure with no sign of any hierarchical 
organisation or cellular organisation. Both collagen type I (figures 5.120 and 5.121) 
and II (figures 5.123 and 5.124) immunological staining was strong in intensity 
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under both culture conditions, however again shows none of the early signs of 
structural organisation seen in plate construct tissue engineered under semi-static 
conditions for example in standard DMEM (figures 5.39 and 5.43). The expression of 
both COL1α2 and COL2α1 (figures 5.122 and 5.125 respectively) are dramatically 
lower under both static (3.12 and 0.69 x 72 hour reference sample respectively) and 
semi-static (3.51 and 0.21 x 72 hour reference sample respectively) culture 
conditions than those levels seen in pin constructs engineered in the same culture 
medium, or pin and plate constructs engineered in standard DMEM. A noticeable 
improvement in glycosaminoglycan content was seen however in large plate 
constructs over smaller pin constructs cultured in DMEM containing 5 w/v % 
dextran. As can be seen in figures 5.126 and 5.127 (toluidine blue) and 5.128 and 
5.129 (alcian blue) staining intensity in tissue cultured under both conditions of 
agitation is very strong implying high levels of GAG in the tissue. This observation is 
reinforced by quantitative DMB assay results (figure 5.130) showing GAG 
proportions of 3.22 and 4.74 % in static and semi-static tissue respectively. Again 
however ACAN expression as analysed at culture termination was found to be very 
low, 0.13 and 0.05 x 72 hour reference sample for static and semi-static samples 
respectively (figure 5.131). These figures are comparable to those seen for pin 
constructs engineered using the same medium under semi-static and RWV 
bioreactor conditions (0.14 and 0.04 x 72 hour reference sample); however the 
DMB assay measured GAG proportions have in the least doubled. This again 
suggests that ACAN expression may vary quite considerably during the culture 
period and so the end-point expression is not necessarily a reliable indication of the 
average expression level throughout [258-261]. In contrast expression levels of 
PRG4 (lubricin or SZP – surface zone protein) were found to be relatively high in all 
constructs, pin and plate, engineered in DMEM supplemented with 5 w/v% dextran. 
Levels of expression were; 11.44, 8.04, 1.13, 5.95 and 8.38 x 72 hour reference 
sample in static pin, semi-static pin, RWV pin; static plate and semi-static plate 
respectively (please see figures 5.94 and 5.134). This however did not translate into 
intense immunological staining localised in the tissue lamina splendens as can be 
observed in native tissue samples (figure 5.6). Immunological staining in all cases 
was very weak and diffuse throughout the tissue (figures 5.92, 5.93 and 5.132, 
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5.133), only showing signs of localisation into the tissue periphery in the case of 
RWV bioreactor cultured pins (figure 5.93). 
 
Further increasing culture medium viscosity with an addition of 10 w/v % dextran 
provided a sufficient level of support to large plate constructs in the RWV 
bioreactor to maintain them in a satisfactory rotational orbit. By increasing the 
medium viscosity the internal friction of the body of medium more strongly resists 
being sheared, this greatly slows down or even stops the movement of the 
constructs through it [312]. However further increasing medium viscosity once 
again brought about a general trend of deteriorating quality in pins and plate 
constructs over that seen in both standard DMEM culture and that containing 5 w/v 
% dextran. Both pin and plate tissue cultured under static and semi-static conditions 
were gelatinous and of very poor mechanical integrity,  their fragility making 
handling and sectioning of the tissue very difficult. This is most evident in figures 
5.96, 5.97, 5.135 and 5.136 where weakly stained H&E sections show high levels of 
porosity and tissue damage. Both RWV bioreactor pin and plate tissue was of 
equally poor quality, however as illustrated in figures 5.98 and 5.137 H&E stained 
sections appear to have much more coherent extracellular matrix with low levels of 
organisation being visible particularly in figure 5.98. This is most likely due to the 
much smaller size of RWV pin constructs at culture termination subsequently 
making them much easier to cryosection, the smaller cross sectional area imparts 
less frictional resistance to passage of the sectioning blade and so damage as a 
result of the sectioning process is reduced. As in the case of pin constructs 
engineered in both standard DMEM and DMEM containing 5 w/v % dextran, 
statically cultured pins had increased in volume over the culture period by 51.5 % 
(figure 5.95). Again also constructs cultured under semi-static and RWV bioreactor 
conditions had contracted in volume by an average of 2.7 and 72.9 % respectively. 
This is however 32.38 and 9.15 % less than their respective counterparts cultured in 
DMEM containing 5 w/v % dextran, and 64.92 and 8.35 % less than their respective 
counterparts cultured in standard DMEM. This reduction in contraction, most 
noticeable in the case of semi-static culture again appears to be brought about by 
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the increase in medium viscosity, and is most likely due to the addition of dextran 
providing a shear protecting effect [298, 299]. 
 
A common feature in most of the sections of tissue engineered in medium 
containing 10 w/v % dextran is noticeably fewer remaining PGA scaffold fibres at 
culture termination than in either standard DMEM or DMEM containing 5 w/v % 
dextran. This is most likely due to there being much less extra cellular matrix  
present in general, a lack of which means that PGA scaffold fibres are unshielded 
from the culture environment and so undergo much more rapid degradation.  This 
in turn means there is not only very little matrix but no residual scaffold left to 
convey stiffness and mechanical integrity to the construct at the end of culture thus 
making handling and sectioning very difficult [313-315]. This observation is backed 
up by collagen type I immunological staining of both pin and plate tissue (figures 
5.99 – 5.101 and 5.138 – 5.140 respectively) where staining intensity is very weak at 
best in all cases, suggesting extremely low levels of collagen type I are present. 
Unfortunately no qPCR data for type I collagen (COL1α2) in either pin or plate 
constructs engineered in DMEM plus 10 w/v % dextran could be generated due to 
inadequate volumes of RNA that could be extracted from the tissue initially. 
Likewise as illustrated in figures 5.102 – 5.104 and 5.141 – 5.143 collagen type II 
immunological staining of static, semi-static and RWV bioreactor pin and plate 
constructs respectively was again very weak suggesting very low levels of collagen 
type II in the extra cellular matrix. In contrast however to the suggested levels of 
collagen type II seen through immunological staining, expression of COL2α1 at 
culture termination particularly in the case of static and semi-static samples was 
much higher than found previously in this study. Figures 5.105 and 5.144 illustrate 
COL2α1 expression of 247.41, 11.40, 1453, 447 and 63.39 x 72 hour reference 
sample in static and RWV bioreactor pins and static, semi-static and RWV bioreactor 
plates respectively. This observation is most likely as a result of hypoxic culture 
conditions induced by the increasing of the culture medium viscosity. Recent work 
by Schrobback et al (2012) [316] and Mhanna et al (2013) [317] agrees with these 
findings, with hypoxic dissolved oxygen levels of 1 – 5 % resulting in optimum 
collagen type II expression and incorporation into the extra cellular matrix. In this 
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work although the expression of genes encoding for collagen type were increased, 
this didn’t translate into ECM incorporation of the protein, implying a detrimental 
impact of the increased viscosity medium also causing this. Increased GAG 
expression and localisation is also something that should be seen with hypoxic 
culture as outlined in section 2.2.3 (literature review, culture conditions) and 
reported in many studies including Ysart and Mason (1994) [318], Coyle et al (2009) 
[319] and more recently Dahlin et al (2013) [154]. This is not seen however in the 
case of either pins or plates engineered in DMEM containing 10 w/v % dextran. 
Small pin constructs cultured under static and semi-static conditions demonstrated 
relatively strong colouring when stained with both toluidine and alcian blue (figures 
5.106, 5.107 and 5.109, 5.110 respectively).  
The proportion glycosaminoglycan contents were still quite low however at 1.19 
and 0.80 % respectively (figure 5.112). Rotating wall vessel bioreactor constructs 
average proportion GAG was higher at 1.30 %, however both toluidine and alcian 
blue staining levels were weak (figures 5.108 and 5.111) suggesting low levels of 
GAG in the tissue.  Unlike in the case of moving from static, semi-static and RWV 
bioreactor culture of small pins to large plates in both standard DMEM and in 
DMEM containing 5 w/v % dextran, moving from engineering small pins to large 
plates in DMEM containing 10 w/v % dextran did not result in a desirable increase in 
percentage glycosaminoglycan content in the tissue. In fact, it resulted in quite a 
marked reduction to 0.51, 0.68 and 0.20 % in static, semi-static and RWV bioreactor 
tissue respectively (figure 5.151). Interestingly the same pattern remains however 
whereby semi-static constructs demonstrate the highest proportion GAG, even 
considering ACAN expression falls away from static, through semi-static to RWV 
bioreactor culture of 2.57, 2.14 and 0.58 x 72 hour reference sample respectively 
(figure 5.152). 
 
As previously stated it is thought possible that hypoxic conditions induced by the 
viscosity of the culture medium being increased resulted in some beneficial tissue 
features such as increased COL2α1 II expression in constructs engineered in DMEM 
containing 10 w/v % dextran. However other effects of the same viscosity increase 
appear to have a detrimental impact, as dissolved oxygen levels are reduced it is 
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safe to assume that mass transfer through the medium in general is reduced.  This is 
likely to have an impact in two main areas; glucose, or other medium components 
such as leucine for example [320] will not diffuse towards the chondrocytes as 
quickly as required by them. Also carbon dioxide, metabolites such as lactate and 
damaging breakdown products of the PGA scaffold material such as glycolic acid will 
also not diffuse away from the cell vicinity [147, 313, 314]. The already very low rate 
of chondrocyte metabolism would be negatively impacted by restricted glucose 
availability or glycolytic inhibition [321]. Heywood, Knight and Lee (2010) [322]  
showed that the Crabtree Effect is prevalent in chondrocytes isolated from all tissue 
zones. The Crabtree Effect is characterised by a cell’s demand for oxygen increasing 
as the amount of glucose available for glycolysis decreases. [323]. Under conditions 
of hypoxia whereby dissolved oxygen is also restricted this can only be of detriment 
to the chondrocytes. The accumulation of metabolites, CO2 and scaffold breakdown 
products in areas concentrated in pericellular areas would effectively poison the 
chondrocytes. Under In vivo conditions mass transfer is aided by cyclical loading 
driven diffusion (see section 2.1.1). As there is no such mechanism in in vitro culture 
the rate of passive diffusion through the medium relies heavily on its viscosity, the 
higher the viscosity, the lower the rate of diffusion. It is very well documented that 
exposing cartilage constructs to compressive loading in vitro can be of great benefit 
to the biological quality of the tissue (please see section 2.2.3). Also this study has 
focussed primarily on the elimination of high levels of shear stress acting on the 
cells during culture; however it is acknowledged that low levels of shear have been 
shown to be beneficial to the development of zonal architecture in the tissue, 
particularly the development of a distinctive superficial zone and surface 
amorphous layer (please see section 6.1). Increasing the culture medium viscosity 
to such a high level could be surpassing the point of providing shear protection to 
the cells and instead, especially in static culture, could be shielding them from the 
influence of any external forces whatsoever be these detrimental or potentially 
beneficial.  
 
It is thought the biological quality of all tissue cultured in increased viscosity 
medium under all conditions of agitation has suffered due to the uncoupled effects 
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of reduced mass transfer through the medium and its action to shield the 
chondrocytes from the influence of potentially beneficial external forces. 
Particularly in culture medium containing 10 w/v % dextran the benefits to the 
biological quality brought about by increasing construct size (as seen in standard 
culture medium) have been outweighed by the aforementioned detrimental impact 
of the increased viscosity system.   
 
6.4 Discussion summary  
 
The general trend seen in this study is towards an improvement in biological quality 
in large plates over small pin constructs in both standard DMEM and DMEM 
supplemented with 5 w/v % dextran. This improvement was characterised by; an 
increase in proportion glycosaminoglycan content, increased collagen type II and 
decreased collagen type I immunological staining intensity and an improvement in 
certain features of tissue organisation such as more numerous lacunae. Pursuing 
the use of the RWV bioreactor however for reasons of eliminating shear forces 
acting on the cells in culture proved to have little benefit apart from the increasing 
expression (but not incorporation or localisation) of PRG4 (surface zone protein) in 
static, through semi-static to RWV bioreactor culture, in all environments except pin 
constructs in DMEM containing 5 w/v % dextran.  
 
Pursuing the use of the RWV bioreactor for the culture of large plate constructs 
specifically required the use of an increased viscosity culture medium; the overall 
result was largely much poorer quality tissue. The use of increasing viscosity 
medium showed some signs of a beneficial impact, mainly through the increased 
expression of key genes such as COL2α1 and most likely due to the influence of 
induced hypoxic conditions. However this was largely outweighed by the negative 
aspects of the medium use such as low matrix incorporation of GAG and collagen 
type II and an overall very poor matrix quality. It is thought this is caused by the 
uncoupled effects of greatly reduced nutrient and waste product mass transfer by 
diffusion through the increased viscosity medium, and it acting to shield the cells 
from not only shear but the influence of any external forces whatsoever. 
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The principle objective of this study was “to engineer in vitro; 15 x 10 mm articular 
cartilage ‘plate’ constructs using primary bovine articular chondrocytes, seeded on 
to poly(glycolic acid) (PGA) scaffolds and cultured in static, semi-static and RWV 
bioreactor conditions”. This was with the aim of producing large pieces of articular 
cartilage for the following reasons; 
 More clinically relevant sizing and better implant cohesion 
As described in section 2.1.2., the applicability of tissue engineered cartilage 
constructs to the treatment of a focal lesion would most likely be when the area of 
the lesion exceeded approximately 2.5 cm2. It was found that even well below these 
dimensions constructs would need to have their initial dimensions somehow 
retained during culture. Construct contraction would not be acceptable in the 
production of tissue for clinical applications unless this could be accurately 
characterised and predicted, then allowed for in the starting dimensions of the 
construct. Cartilage constructs for clinical applications would need to be produced 
to very well defined dimensions. 
 
It is thought, as outlined in section 2.2.3 that the fewer individual pieces of tissue 
required to ‘fill’ the lesion or injury site the better for overall successful integration 
of that tissue. This again relies on the ability to engineer large pieces of tissue of 
physiologically representative, high biological quality. No data resulting from this 
study suggests the production of tissue with features advantageous to its eventual 
integration into the wound bed and surrounding tissue but it is theorized this could 
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 Tribological mechanical analysis 
The production of tissue engineered cartilage constructs of large enough 
dimensions to allow as physiologically relevant tribological analysis as possible to be 
undertaken would be desirable for the reasons again described in section 2.2.3. 
Engineered constructs that have been found to be rich in collagen type I or 
demonstrate a low collagen type II to type I ratio will likely perform poorly in pin on 
plate friction testing. This composition is analogous to the fibrous or scar tissue that 
forms following smaller scale injury to mature human articular cartilage and is quite 
often observed following microfracture treatment (drilling of the subchondral bone 
releasing progenitor cells into the wound bed - please see section 2.1.2). This 
fibrocartilage is less flexible, more resistant to compressive deformation and breaks 
down more easily. It has been reported that this can give a false positive result of 
reduced coefficient of friction as a result of the engineered tissue fragmenting and 
the debris acting with a “ball bearing like effect” [186]. This composition 
unfortunately was seen in most large plate tissue engineered in this study and so 
suggests that whilst the final dimensions would be suited well to such tribological 
analysis, it would be known from the start that the composition of the tissue would 
not.  
 
Constructs demonstrating a high collagen type II to type I ratio similar to that seen 
in native tissue sections will also demonstrate a more hyaline composition, and if 
this is coupled with a high glycosaminoglycan (GAG) content most likely a lower 
coefficient of friction. A high GAG content means the tissue will hold retain water in 
the tissue bulk, imbibing and exuding it under loading to increase lubrication. Large 
plate constructs cultured under semi-static conditions in standard cell culture 
medium demonstrated a biological quality most similar to these basic requirements 
and so it is theorized may be used in the pin on plate, friction testing configuration 
as described in section 2.2.3. However these biological features are only the basic 
key markers of a hyaline phenotype and many other features including improved 
surface zone protein incorporation and localisation would be required before the 
engineered tissue may demonstrate native tissue-like low friction properties. 
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Few studies reported to date have explored the possibility of tissue engineering 
large-sized hyaline cartilage constructs. This study therefore makes a valuable 
contribution to the important field of cartilage tissue engineering. Both small pin (6 
mm Ø) and large plate (15 x 10 mm) constructs were engineered using primary 
bovine articular chondrocytes, a non-woven poly(glycolic acid) (PGA) scaffold 
material and static, semi-static and rotating wall vessel (RWV) bioreactor culture 
environments. The aim of this study was to investigate the potential for tissue 
engineering large, high quality cartilage constructs using several different culture 
methodologies, the main conclusions drawn from this research are presented 
below. 
 Large plate constructs may be engineered under static and semi-static 
culture conditions in conjunction with a custom-made scaffold retention 
frame and specially modified seeding protocol. Biochemical features in 
common with native articular cartilage can be achieved, and to an improved 
degree over small pin constructs. Increasing the size of the constructs from 
pin (6 mm ø) to plate (15 x 10 mm) in standard DMEM results in a noticeable 
percentage GAG proportion increase under all conditions of culture. The 
highest of which was seen in semi-static constructs and is comparable to 
that seen in native tissue. Immunological staining for collagen types I 
suggested a slightly lower collagen II to I ratio than large constructs under 
static conditions however levels of zonal organisation in semi-static tissue is 
more obvious. Although PCR data provides valuable experimental end-point 
data, it cannot be assumed that this provides any indication of levels of gene 
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 The Synthecon® RCCS (RWV bioreactor) although demonstrating great 
promise in published studies (section 2) for overcoming the major 
limitations associated with static and semi-static culture (low mass transfer 
and high levels of inflicted shear force respectively), does not provide a 
feasible culture methodology for engineering large constructs in standard 
cell culture media - within the range of RPM’s available from the standard 
Synthecon motor drive unit.  
 High molecular weight dextran may be used as a biocompatible, easily 
characterised medium addition for the purpose of increasing viscosity and 
providing mechanical support to large constructs in the RWV bioreactor. An 
addition of around 10 w/v % is required however and overall this was found 
to be severely detrimental to the final quality of the tissue in most 
circumstances. An addition of 5 w/v % whilst not being sufficient for the 
culture of 15 x 10 mm plate constructs in the RWV bioreactor does provide a 
viscosity similar to that of native synovial fluid at physiological strain rates 
and so could provide a basis for constructing a physiologically representative 
model for the culture of smaller dimension constructs. 
 This study ascertained that specific biological elements of native cartilage 
could be recreated in-vitro, however when viewed alongside native tissue it 
is clear there is still some way to go in recreating the zonal architecture 
required for a functional tissue. For the reasons outlined in section 6.1, it is 
thought this study does not approach achieving zonality in two main ways;   
o The use of primary articular chondrocytes isolated from the full 
depth of tissue means that a mix of cells with subtle phenotypic 
differences are potentially seeded to the scaffold. The isolation, 
expansion and seeding of cells taking this into account may result in 
engineered tissue with improved zonal hierarchy. 
o It is possible that the use of a static, semi-static or RWV bioreactor 
culture regime on its own is overly simplistic and will not result in full 
maturation of the engineered tissue. A mixed regime that 
incorporates elements of hypoxic conditions, compressive loading, 
low shear and good mass transfer could be beneficial.  
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8. Future Work  
 
The work carried out in this study demonstrates that tissue engineering techniques 
have the potential to provide a method of producing large cartilage constructs of an 
appropriate size for both clinical applications and tribological testing. Further work 
however could be carried out in several areas. In order to permit accelerated 
publication of the work contained in this thesis, areas in which further work could 
be carried out in preference to others are highlighted. 
 
Cell and tissue culture approaches 
 
 The use of atmospheric hypoxic conditions during culture, as previously 
stated (please see section 2.2.3), is well known to be of benefit to the 
biological quality of the engineered tissue.  Such conditions, if applied to the 
culture of large plate constructs, could lead to significant improvements in 
the generation of a hyaline-like extra cellular matrix. 
 The highest viscosity medium developed in this study was ultimately found 
to have a detrimental effect on the proliferation of chondrocytes cultured in 
it. DMEM containing 5 w/v % dextran, whilst not being appropriate for the 
culture of large plate constructs in the RWV bioreactor could possess 
hydrodynamic properties that are well suited to another bioreactor type. 
The influence of a compressive loading regime during culture, as described 
in section 2.2.3, has been established to be of benefit to the biological 
quality of the engineered tissue. DMEM containing 5 w/v % dextran could be 
of sufficient viscosity to transmit compressive force to a construct in a 
suitable pressure bioreactor set-up, thus removing the requirement direct 
tissue loading via mechanical means. Coupled with a medium perfusion 
system this would also allow for any reduction in mass transfer as a result of 
the increased medium viscosity. This approach could also be further 
developed to incorporate a culture methodology that permits the 
development of the osteochondral interface. Instead of approaching the 
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culture of cartilage and bone tissue separately and then afterwards 
investigating how best to establish an osteochondral interface, a bioreactor 
could be developed that permits separation of both tissues within the same 
construct under osteogenic and chondrogenic growth conditions. This 
approach, coupled with the aforementioned compressive loading regime 
and perfused medium circulation could allow the development of the 
optimum articular cartilage architecture.      
 The use of mature articular chondrocytes remains a valid experimental 
approach for reasons outline in section 2.2.1. However as also described in 
section 6.1, allowing for their original zonal location could be advantageous 
in ultimately engineering constructs with improved tissue hierarchy. 
 
Analysis of tissue engineered constructs  
 
 The three main hyaline cartilage components this study investigated were 
collagen type II, glycosaminoglycan and lubricin or surface zone protein. 
Quantitative analysis however was only undertaken for GAG content using 
the DMB assay. Quantification of collagen type II specifically is more 
technically challenging; however the total collagen content can be measured 
using the chloramine-T hydroxyproline total collagen assay as originally 
described by J.F. Woessner Jr. [324]. Lubricin accumulation in the tissue and 
also the culture medium could be quantified using SDS-PAGE and 
subsequent immunoblotting [269]. Establishing a negative control for 
toluidine and alcian blue GAG staining proved problematic in this study but 
would still be desirable. A chondroitinase ABC treatment protocol could be 
optimised for the full removal of GAG from tissue sections without also 
causing damage [325-327].In order than more data could be collected 
towards publication, chloramine-T hydroxyproline analysis of the total 
collagen in each construct could be carried out on existing tissue digests. 
This could be carried out quite easily using a standard protocol. 
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 The expression levels of several genes were measured using PCR during this 
study but only at the point of experimental termination. Such analysis but at 
multiple time points throughout culture would be highly desirable, allowing 
a profile of expression across the full period of culture to be collated and so 
correlated much more accurately with the histological, immunological and 
biochemical analysis techniques employed at culture termination. 
 Improving the physiological relevance of laboratory pin on plate friction 
testing configurations was amongst the justifications for engineering large 
sized cartilage constructs in this work. Although an appropriate level of 
biological quality to permit tribological testing was not achieved in this 
study, as the culture methods employed are modified and optimised, 
assessment of their mechanical properties will be a priority; this could also 
include measure of compressive modulus and wear analysis. In order to 
provide further data towards the publication of the data contained within 
this thesis, mechanical property assessment of tissue engineered plate 
constructs would be preferential. Further engineering of large plate 
constructs of the dimensions as produced in this study will enable the use of 
existing tribological analysis apparatus, specially designed for use in this 
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